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Abstract  
Jembrana disease was reported initially in Bali cattle (Bos javanicus) on Bali island in 1964 
and the causative agent was subsequently identified as a bovine lentivirus and designated 
Jembrana disease virus (JDV). This atypical lentivirus causes an acutely pathogenic disease 
that is associated with clinical signs and pathological lesions attributable to a disease 
primarily affecting the lymphoid system. Based on the intense proliferation of cells in the 
parafollicular (T-cell) areas of lymphoid tissue it has been assumed that the cellular tropism 
of the virus was for T-cells. 
An initial investigation of the pathological changes following JDV infection provided 
morphological evidence that JDV infection occurred not in T-cells but probably in 
centroblast-like cells containing IgG and presumably of B-cell lineage. The identity of the 
infected cells was confirmed by double immunofluorescence labelling techniques as being 
IgG-containing CD79α
+ cells, indicating that the virus replicated in mature B-cells.  Unlike 
other lentiviruses, no evidence of infection in T-cells or macrophages was obtained. These 
observations provide an explanation for suppression of the JDV-specific antibody response 
associated with JDV infection and the unique nature of the pathological response of Bali 
cattle to JDV infection.  
Flow cytometric analysis of peripheral blood leucocyte populations was used to further the 
understanding of the pathogenesis of JDV infection. Changes in lymphocyte subsets during 
the course of Jembrana disease were investigated and analysis of the results showed that 
lymphopenia, a characteristic of the acute febrile phase of Jembrana disease, was at least 
partly due to a significant decrease in CD4
+ and CD8
+ T-cells and CD21
+  B-cells. In the 
immediate post-febrile recovery phase, virus-infected cells were not detected in lymphoid 
tissue but both CD8
+  T-cells and CD21
+  B-cells increased significantly and CD4
+ 
 T-cells 
remained below normal levels resulting in a significantly reduced CD4
+:CD8
+ ratio.  
Changes in expression of CD8
+ T-cell regulated cytokine genes was examined during the 
course of the acute disease process by quantifying cytokine mRNA expression  using real-
time reverse-transcription polymerase chain reaction (RT-PCR). The results showed that both 
IL-2 and IFN-γ cytokine mRNA were strongly expressed during the febrile and early post-
febrile recovery phases, which coincided with the significant increase of CD8
+ T-cells and    iv 
reduction of viraemia during this phase. The results suggested the CD8
+ T-cell–associated 
cytokines IL-2 and IFN-γ probably play a significant role in the recovery process.    v 
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Chapter 1 
General introduction  
The research results reported in this thesis involved a study of the cellular response 
to Jembrana disease virus (JDV), an acutely pathogenic bovine lentivirus causing 
Jembrana disease in Bali cattle (Bos javanicus) in Indonesia, with the specific aim of 
identifying the principal target cell of JDV. As a background to the investigations 
that were undertaken, a review of the literature on lentiviruses was undertaken and is 
provided in Chapter 2. The review included information on lentiviruses and included 
the bovine lentiviruses, JDV and the closely related Bovine immunodeficiency virus 
(BIV). The review concentrated on aspects of the pathogenesis of the various 
lentivirus diseases, the cellular tropism and the immune response to virus infection. 
Potential methodologies for investigating cellular responses to lentiviral infections 
were also reviewed. 
An initial investigation of the histopathological lesions associated with JDV 
infection, in the febrile and immediate post-febrile phases, was undertaken and is 
reported in Chapter 3. The animal infections associated with this investigation were 
conducted in Indonesia and the study required the development of methods that 
could be used for the detection of JDV-infected cells and the identity of the various 
leucocyte subsets in formaldehyde-fixed tissues that could be imported into Australia 
from Indonesia. The characterisation and distribution of T-cells, B-cells and 
monocytes/macrophages was determined, as was the distribution of JDV-infected 
cells, in various lymphoid and visceral tissues of the infected animals. 
The investigations described in Chapter 3 determined that JDV antigen-positive cells 
were probably antibody-producing cells, based on morphological observations and 
the distribution patterns of various leucocyte subsets.  To confirm these observations, 
double immunofluorescence labelling techniques were developed for use on fixed 
tissues and then used to identify possible JDV infection in lymphocyte subsets and 
macrophages. These results are reported in Chapter 4.  
To provide insights into the possible mechanism of recovery from the acute disease 
process associated with JDV infection, further animal infections were conducted and 
fixed peripheral blood leucocyte preparations were imported and used for analysis of   2 
the changes in CD4
+ T-cells, CD8
+ T-cells and CD21
+ B-cells. These results are 
reported in Chapter 5.  
Cytokines have an important role in both the inflammatory disease process and 
recovery from infection, and a preliminary investigation of cytokine expression 
during the acute Jembrana disease process was undertaken. These results are 
reported in Chapter 6. A marked up-regulation of the pro-inflammatory cytokines 
IFN-γ and IL-2 was found to correlate with the significant CD8
+  T-cell proliferation 
that had been detected during the recovery phase of the disease.  
A general discussion of the major conclusions and recommendations for further 
investigations as a consequence of the research reported in Chapters 3-6 is presented 
in Chapter 7.   3 
Chapter 2 
Review of the literature  
This Chapter presents a review of literature relevant to the research project, and 
contains 5 major sections. The first section contains general information on the 
classification and properties of viruses in the family Retroviridae. The second 
section focuses on the features of the genome and replication of viruses in the genus 
Lentivirus. The third section describes aspects of Jembrana disease including the 
historical aspects, subsequent identification of the causative agent as a lentivirus, 
mode of transmission, clinico-pathology and diagnostic methods that are useful to 
confirm the disease. The fourth section reviews the literature relating to lentivirus 
infections in other host species. The final section reviews aspects of the immune 
response to lentivirus infections with particular emphasis on changes in lymphocyte 
subpopulations and cytokine expression.  
General features of Retroviridae 
The Retroviridae (retroviruses) comprise a large and diverse group of viruses found 
in all vertebrate cells and include many important human and animal pathogens. 
Viruses in this family are characterised by their unique life cycle and replication 
mechanisms that utilise an essential reverse transcriptase to convert the viral single-
stranded RNA (ssRNA) into a linear double-stranded DNA (dsDNA), entry and 
integration of this dsDNA into the genome of the host cells to form proviral-DNA. 
Transcription of RNA from the integrated proviral DNA with subsequent translation 
to form virus-coded proteins then results in the formation and release of new 
progeny virus (Baltimore, 1970; Luciw and Leung, 1992; Shibagaki and Chow, 
1997) 
Morphologically, retroviruses share a roughly similar structure but there are unique 
features of different genera.  They are all typically 80-130 nm in diameter, 
enveloped, and have an inner capsid enclosing 2 copies of a positive-sense ssRNA 
genome (Flint et al., 2004a; Flint et al., 2004b). The envelope is derived from the 
host cell plasma membrane during the budding process and has inserted into it 2 
viral-coded glycoproteins, the surface unit (SU) and trans-membrane (TM) 
glycoproteins. The envelope directly surrounds the matrix (MA) protein and the   4 
internal capsid formed by the capsid (CA) protein that contains 2 identical copies of 
the viral RNA genome bound by nucleoproteins, and several viral encoded enzymes 
including reverse transcriptase (RT), integrase (IN), and protease (PR) (Coffin, 1992; 
Goff, 2007) (Figure 2.1). 
 
 
 
Figure 2.1. Diagrammatic representation of the structure of a typical mature virion of 
retrovirus. Reproduced from Coffin (1992). 
 
Retroviruses can be divided into 3 subgroups based on their pathogenicity in host 
cells: spumaviruses, oncornaviruses, and lentiviruses (Burmeister, 2001; Wagner and 
Hewlett, 2004). They have also been grouped into 4 morphological types A, B, C 
and D, depending on their morphology during budding and maturation that can be 
observed by electron microscopy (Coffin, 1992; Luciw and Leung, 1992). Current 
taxonomy based on further genomic analysis distinguishes the retroviruses into 7 
genera: Alpharetrovirus, Betaretrovirus, Gammaretrovirus, Deltaretrovirus, 
Epsilonretrovirus, Spumavirus and Lentivirus (Burmeister, 2001; Goff, 2007). 
The genera Alpharetrovirus, Betaretrovirus, Gammaretrovirus, Deltaretrovirus, 
Epsilonretrovirus are the oncogenic retroviruses and they may trigger a variety of 
leukaemias and sarcomas in several animal species including man (Burmeister, 
2001). Members of the genus Alpharetrovirus cause sporadic lymphoid leukosis in 
avian species and these viruses are endemic in chicken flocks around the world. The 
genus Betaretrovirus contains 3 members that produce tumours in mammalian   5 
species: Mouse mammary tumour virus, Mason-Pfizer monkey virus and Jaagsiekte 
virus (Bauerova-Zabranska et al., 2005; Cousens et al., 2004; Maeda et al., 2001). 
Viruses in the genus Gammaretrovirus are also responsible for leukaemias in 
mammalian species including cats, sheep and gibbons. The genus Deltaretrovirus 
contains the human and simian T-cell lymphotropic viruses causing T-lymphomas 
and neurological disorders in man and non-human primates, respectively, and Bovine 
leukaemia virus (Burmeister, 2001). The genus Epsilonretrovirus includes viruses of 
fish and reptiles, many of which are associated with tumour induction. Viruses in the 
genus Spumaretrovirus are also termed “foamy” viruses because of the nature of 
their cytopathic effects in vitro, characterised by marked syncytium formation, 
cytoplasmic vacuolation and cell death, but they have not been reported to cause 
disease in vivo (Coffin, 1992; Flint et al., 2004b; Jones-Engel et al., 2005; Meiering 
and Linial, 2001). Viruses in the genus Lentivirus induce a variety of clinical 
syndromes including immunodeficiencies in man, non-human primates and feline 
species, and chronic pneumonia, arthritis and encephalitis in sheep and goats 
(Chadwick et al., 1995a; Goff, 2007). 
The genera Alpharetrovirus, Betaretrovirus and Gammaretrovirus are considered 
“simple retroviruses” as they encode only the 3 principal open reading frames 
(ORFs) gag, pol and env and require actively dividing cells for replication. The other 
genera are considered “complex retroviruses” as while they also encode the 3 
principal ORFs they also encode a number of accessory proteins that are important 
for replication in non-dividing cells (Chen and Temin, 1982; Goff, 2007; Pfeifer et 
al., 2002). 
Characteristics of lentiviruses  
This genus contains species that have been divided into 5 groups based on their host 
specificities: primate lentiviruses (Human immunodeficiency virus [HIV-1 and-2] 
and Simian immunodeficiency virus [SIV]), bovine lentiviruses (Bovine 
immunodeficiency virus [BIV] and Jembrana disease virus [JDV]), equine 
lentiviruses (Equine infectious anaemia virus [EIAV], feline lentiviruses (Feline 
immunodeficiency virus [FIV] and ovine/caprine lentiviruses or the small lentivirus 
group (Maedi-visna virus [MVV] and Caprine arthritis-encephalitis virus [CAEV]).   6 
A phylogenetic tree of several of these lentiviruses based on their pol genes is shown 
in Figure 2.2. 
 
 
Figure 2. 2. Phylogenetic tree of lentivirus based on complete pol gene sequences. The 
relationship of 10 lentiviruses in 5 different host groups and 2 members of the leukaemia 
group of retroviruses (as outliers) are shown. JDV, Jembrana disease virus; BIV, bovine 
immunodeficiency virus; HIV-1, Human immunodeficiency virus-1; HIV-2, Human 
immunodeficiency virus-2; SIVagm, Simian immunodeficiency virus (African green monkey); 
SIVcpz, SIV (chimpanzee); FIV, Feline immunodeficiency virus; OMVV, Maedi-visna virus; 
CAEV, Caprine arthritis encephalitis virus; EIAV, Equine infectious anaemia virus; HTLV-
1, Human T- lymphotropic virus type 1 and BLV, Bovine leukaemia virus. Figure sourced 
from Chadwick et al. (1995a). 
 
 
Lentiviruses induce a number of clinical diseases, in a diverse array of mammalian 
hosts. They are typically slowly progressive diseases affecting a variety of organs 
depending on the virus involved, usually with long incubation periods and 
suppressed immune responses, that invariably lead to death (Clements and Zink, 
1996; Goff, 2007).  There are, however, a number of exceptions to this 
generalisation. At least 3 viruses, JDV, SIVsmmPBj14, and EIAV induce acute clinical 
diseases (Chadwick et al., 1995b; Fultz, 1991; Issel and Coggins, 1979; Sellon et al., 
1994). Infection does not always lead to clinical disease or a fatal outcome: in some 
SIV infections the virus does not produce disease in its natural host, and disease 
occurs only if the virus is introduced into a different primate species (Brown et al., 
2007; Cranage et al., 1992; Veazey et al., 2000). Some lentiviruses do not cause an 
invariably fatal disease: JDV infections do not always result in the death of animal   7 
and the case fatality rate of the disease in experimentally infected animals is about 
17% (Soeharsono et al., 1990). Recovered animals appear to be persistently immune 
and do not develop any further lentivirus-associated diseases.  EIAV infections result 
in relapsing infections but animals that survive appear to eventually develop 
immunity and while still persistently infected appear able to control viral replication 
(Montelaro et al., 1993; Soesanto et al., 1990). 
Lentiviruses differ from other retroviruses in that they lack the ability to induce 
neoplastic disease, they characteristically replicate in non-dividing/terminally 
differentiated cells and they are relatively species-specific (Clements and Zink, 
1996; Lewis and Emerman, 1994). Their genome and replication cycle also differ 
and are more complex than the prototypic simple retroviruses (Vogt, 1997).  
Genomic organisation of lentiviruses 
As complex retroviruses, lentiviruses possess a number of regulatory and accessory 
genes that encode non-structural proteins in addition to those encoded by the 3 major 
ORFs gag, pol and env that are common to all retroviruses. They have similar 
genomic organisation to other genera, although there are species differences. The 
distinguishing feature of lentiviruses is the presence of additional and unique ORFs 
that encode accessory proteins involved in their replication (Vogt, 1997). The major 
distinctive regulatory and accessory genes of lentiviruses, found generally in the 
central region between the end of pol and the beginning of env, are shown in Table 
2.1. 
 
   8 
Table 2.1. Presence of accessory genes identified in lentiviruses. 
Lentivirus  Regulatory and accessory genes 
vif  vpr  vpu  vpx  vpy  vpw  OrfA  nef  tat  rev 
HIV-1  +  +  +  ND  ND  ND  ND  +  +  + 
HIV-2  +  +  ND  +  ND  ND  ND  +  +  + 
SIV  +  +  +  +  ND  ND  ND  +  +  + 
BIV  +  ND  ND  ND  +  +  ND  ND  +  + 
JDV  +  ND  ND  ND  ND  ND  ND  ND  +  + 
FIV  +  ND  ND  ND  ND  ND  +  ND  ND  + 
SRLV  +  ND  ND  ND  ND  ND  ND  ND  +  + 
EIAV  ND  ND  ND  ND  ND  ND  ND  ND  +  + 
Data sourced from: HIV-1 and HIV-2(Flint et al., 2004b); SIV (Gibbs and 
Desrosiers, 1993); BIV (Gonda, 1994); JDV (Chadwick et al., 1995b); FIV (Zou et 
al., 1997); the SRLV (CAEV and MMV) (Harmache et al., 1995; Narayan et al., 
1993); EIAV (Miller et al., 2000).  
ND denotes not detected. 
 
The most complex lentiviruses are the primate lentiviruses, typified by HIV-1 that 
has at least 6 additional genes including 2 regulatory genes (tat and rev) and 4 
accessory/auxiliary genes (vif, vpr, vpu, and nef). The organisation of the 3 major 
ORFS and the additional genes of HIV-1 with the respective encoded proteins in the 
virion structure are presented in Figure 2.3. The gag ORF encodes the structural 
matrix (MA), capsid (CA) and nucleocapsid (NC) proteins. MA facilitates 
localisation of the protein in the cytoplasmic membrane which is associated with 
assembly of infectious virus (Coffin, 1992; Kiernan et al., 1998). CA serves as a 
major structural component that forms the core shell of the virion; it is the most 
immunodominant viral protein (Coffin, 1979; Coffin, 1992). CA has a highly 
conserved major homology region (MHR) responsible for antigenic cross-reactivity 
of many lentiviruses (Grund et al., 1994; Melamed et al., 2004). NC has an affinity   9 
for the viral genome and is an essential protein for viral DNA synthesis is required 
for packaging RNA into the virion (Coffin, 1979; Coffin, 1992).  
 
 
Figure 2.3.  Structure and genomic organisation of HIV-1.  Sourced from Frankel 
and Young (1998). 
 
 
The pol ORF encodes 3 virion-associated enzymatic proteins, the reverse 
transcriptase (RT), integrase (IN), and protease (PR) that are incorporated into the 
capsid during assembly and are required for viral replication. RT has both RNAase 
and RNA-dependent polymerase activities that are essential for the transcription of 
the viral ssRNA genome to a dsDNA proviral form after entry of the virus into the 
host cell (Katz and Skalka, 1994; Temin, 1993). The gene encoding RT is relatively 
conserved among different genera of retroviruses, and therefore is useful for 
phylogenetic and evolutionary studies (Tobin et al., 1996). Integrase facilitates the 
stable integration of the provirus-DNA within the host cell DNA, and PR is essential 
for the proteolytic cleavage of the viral precursor polyproteins into individual 
subunit proteins during assembly and maturation of the virion (Coffin, 1979; Coffin, 
1992). The PR therefore has a special role in the maturation of new virus, making it a 
major target for contemporary anti-viral therapy (Frankel and Young, 1998).  
   10 
The env ORF encodes a polyprotein (Env) that is cleaved by proteases and modified 
in the endoplasmic reticulum to produce the 2 glycosylated envelope proteins, SU 
and TM (Coffin, 1992). The glycoproteins are translocated to and are incorporated 
into the host cell membrane, where the budding process takes place, and become 
exposed to the external environment (Luciw and Leung, 1992). The SU is required 
for the binding of the virus to target cell receptors. The TM projects from the 
envelope and anchors the SU component to the envelope and facilitates membrane 
fusion of the envelope with the plasma membrane of the host cell. Both TM and SU 
glycoproteins are determinants of tropism and virulence and are the major targets of 
the neutralising antibody response (Coffin, 1992). 
Of the 6 additional (accessory) genes in lentiviruses, tat and rev control viral 
transcription and RNA transport and translation, and are expressed early in viral 
replication from multiply spliced transcripts (Chen et al., 1998; Feed and Martin, 
2001; Frankel and Young, 1998; Miller et al., 2000). JDV Tat has a strong trans-
activator ability and not only transactivates its own long terminal repeat (LTR) but is 
also able to strongly activate the heterologous BIV and HIV in vitro, to a greater 
extent than the homologous Tat proteins (Chen et al., 1999). The vif gene is found in 
the genome of all lentiviruses, with the exception of EIAV, and encodes the viral 
infectivity factor (Vif), a virion-associated protein that is functional during in vivo 
viral replication and antagonises the anti-viral activity of cellular components 
(Gonda, 1992; Li et al., 1998; Miller et al., 2000; Sheehy et al., 2002). The accessory 
genes vpr, vpu, nef and vpx are detected only in the genome of primate lentiviruses 
and have specific biological functions. The vpr and vpx genes encode nuclear 
proteins with a role in transporting the pre-integrated dsDNA from the cytoplasm 
into the nucleus of infected cells (Cheng et al., 2008; Hamaia et al., 1997). In HIV-
2/SIVsm/SIVmac infections, Vpx is a virulence factor for monocyte-derived cells and 
dendritic cells, and is associated with the establishment of virus reservoir in 
macrophages (Fletcher et al., 1996; Goujon et al., 2007; Matsuda et al., 2009). Vpu 
is associated with release of the virion from the cell membranes (Binette et al., 2007; 
Ewart et al., 1996; Strebel et al., 1989). Nef is multifunctional, but mainly 
responsible for viral infectivity (Brugger et al., 2007; Marsh, 1999; Qi and Aiken, 
2008; Sol-Foulon et al., 2004). The nef gene is not present in the bovine lentiviruses 
(Table 2.1) but they have a tmx gene in a similar location to nef, and 2 unique genes   11 
vpw and vpy that seem to be analogous to the vpr and vpu/vpx genes of primate 
lentiviruses (Garvey et al., 1990).  
Replication cycle of lentiviruses 
The replication mechanism of lentiviruses involves conversion of the ssRNA 
genome to a dsDNA provirus and then integration of this provirus into the host cell 
DNA, typical of all retroviruses. The major steps are shown schematically in Figure 
2.4. Briefly, the early phase commences with attachment of the envelope 
glycoproteins of the virus to a cellular receptor, CD4 in the case of HIV, in 
conjunction with a co-receptor, followed by fusion of the virus envelope with the 
plasma membrane of the host cell. Uncoated viruses then release their ssRNA 
genome which is converted into dsDNA using the virus RT and this dsDNA is 
transported into the nucleus. Subsequently the viral integrase mediates the 
integration of the viral dsDNA (proviral DNA) into the host genome. In the late 
phase, the proviral-DNA is transcribed using cellular enzymes to produce viral 
mRNAs, which then migrate to the cytoplasm for translation. The Env proteins 
undergo glycosylation and are inserted into the plasma membrane of the cell. Finally, 
the viral RNA and structural proteins are assembled into the immature virion core on 
the plasma membrane, and via a budding process is released from the cell to form 
free virus that then undergoes further maturation steps to form fully mature 
infectious virus.  
 
 
Figure 2.4. Major steps in the replication of a typical retrovirus. Reproduced from 
Nisole and Saib (2004).  
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Virion attachment and fusion to host cells 
The first step in productive infection is the attachment of the virus to a host cell 
receptor, mediated by functional interactions between viral envelope glycoproteins 
and specific surface receptors on the target cell. This interaction is specific and 
selective between certain cell and virus types (Clapham and McKnight, 2002; Nisole 
and Saib, 2004; Overbaugh et al., 2001). This process has been extensively studied 
for HIV-1 and the related non-human primate lentiviruses as it offers a possible 
target for vaccines and antiretroviral therapy.  
In HIV-1 infections, the attachment is mediated by the viral SU protein, gp120, to 
the host cell CD4 molecule. CD4 molecules are the major receptor on the surface of 
T-helper lymphocytes (CD4
+ cells) that are the primary targets of the virus, but are 
also present on other antigen-presenting cells such as macrophages, monocytes and 
dendritic cells. This interaction triggers a conformational change of the SU that 
enables the SU to contact host cell chemokine receptors. A variety of chemokine 
receptors are used, including CCR5 on macrophages, CXCR4 on CD4
+ cells, CCR3 
on microglial cells of the brain, and a number of other co-receptors (Clapham and 
McKnight, 2001; Deng et al., 1996; He et al., 1997). These events in turn activate the 
TM to mediate fusion of the viral envelope with the host cell membrane (Clements 
and Zink, 1996; Sherman and Greene, 2002). Fusion leads to microinjection of the 
uncoated viral capsid component, containing the viral genome and enzymes, into the 
cytoplasm.  Although HIV-1 is commonly viewed as a prototypical example of a 
virus that enters cells by fusion of the plasma membrane (Marsh and Helenius, 
2006), more recently Miyauchi at al. (2009) reported that HIV-1 enters cells via 
endocytosis and complete viral fusion occurred subsequently in endosomes. 
Reverse transcription and integration of viral genome into the cellular genome 
When virus enters into the cytoplasm, it is partially uncoated and the viral ssRNA is 
converted into dsDNA provirus via RT activity. This reaction is common to all 
retroviruses, and takes place within the viral nucleocapsid complex in the cytoplasm 
and is initiated by the RT and RNAse H activity of the viral RT that is packaged into 
the viral RNA (Zhang et al., 1993). The first step in the reverse transcription process 
is the binding of the cellular tRNA (tRNALys) to the primer binding site (PBS)   13 
located in the 5’LTR of the viral genomic plus-stranded RNA (Freed and Martin, 
2001; Gerdts et al., 1997). Subsequently, the minus-sense ssDNA that is 
complementary to the 5’U5 and R region is synthesised and the RNA portion of the 
newly formed RNA/DNA hybrid is digested by the RNAseH activity. The new 
minus-sense ssDNA is transferred to the 3’end of the RNA and the plus-stranded 3’R 
sequence hybridises with the R sequence.  The minus sense DNA is elongated and 
most of the plus-sense RNA is then digested; only the polypurine tracts (PPT) are 
stable and these serve as a primer to synthesise the 3’ part of the complementary 
strand of DNA. RNAse H then removes the PPT RNA sequences and a second 
strand transfer of the minus-sense DNA strand permits the hybridisation of PBS 
sequences of both DNA strands. At the end of this process, 3’ends for the 
completion of the synthesis of both minus and plus strand of DNA are provided to 
make the linear dsDNA that is contained in the pre-integration complex (PIC) ready 
for integration (Miller et al., 1997; Nisole and Saib, 2004).  
Integration is not always successful and several blocks may occur before integration 
into the DNA of resting CD4
+ lymphocytes (Wong et al., 1997). Such blocks may 
delay reverse transcription due to a limited pool of dNTPs or to the inability to 
import the PIC into the nucleus. Because of these blocks, full-length viral DNA 
molecules can remain in the cytoplasm, and this is known as pre-integration latency 
(Bukrinsky et al., 1992; Korin and Zack, 1999; Lassen et al., 2004; Zack et al., 
1990). Although, replication is delayed in this circumstance, mitotic stimuli are able 
to trigger further replication (Bukrinsky et al., 1991; Finzi et al., 1997; Zack et al., 
1992).  
Details of the integration of provirus with the PIC component and its migration into 
the nucleus remains unclear, as in vitro studies do not fully reproduce in vivo 
integration events (Devroe et al., 2003; Fletcher et al., 1997). In the simple 
retroviruses the viral PIC requires dividing cells for nuclear importation (Lewis and 
Emerman, 1994; Roe et al., 1993) but with lentiviruses this process can occur in non-
dividing cells (Connolly, 2002; Lewis et al., 1992b; Naldini, 1998; Vodicka, 2001).  
The proviral DNA is assumed to cross the nuclear pore complex from the cytoplasm 
to enter the nucleus where it serves as precursor for the formation of the integrated 
virus dsDNA (Brown, 1997; Jenkins et al., 1998). The process of integration 
involves a specific interaction between the IN and 2 inverted repeats located at the   14 
end of each LTR (Esposito and Craigie, 1998). As a product of integration, this 
process forms a gapped intermediate where the non-joined 5’-viral DNA ends are 
flanked by short single-stranded gaps in the host DNA, and typically HIV-1 
integration sites are in introns of the relevant genes (Engelman, 2003; Esposito and 
Craigie, 1998; Lassen et al., 2004). It was reported that SIV integration preference is 
similar to that of HIV-1, suggesting that both lentiviruses may share a similar 
mechanism for target site selection (Crise et al., 2005). 
Integration of the proviral DNA into the host genome allows survival of the virus as 
in this form it can persist in a latent form or it can directly proceed to productive 
replication, depending on the virus strain and the type of infected cells. In HIV 
infections, the virus can only replicate in activated cells (actively dividing CD4
+ T-
cells and not naïve CD4
+ T-cells) that generally comprise 93-95% of productively 
infected cells. A majority of proviral DNA integrates into the host chromosome, and 
once integrated the Orf-B gene is responsible for latency via an interaction with 
cellular factor to slow down viral replication. However, most activated CD4
+ 
lymphocytes will die quickly as a result of infection, and only a small proportion 
become dormant, the so-called resting T-cells or memory T-cells that carry stable 
integrated provirus but are not permissive for viral replication unless they are further 
activated (Lassen et al., 2004; Marcello, 2006). CD4
+ lymphocytes reactivated by the 
same antigen and/or cytokines express both genes for immune responses and for HIV 
replication, leading to production of new virus particles. This unremitting replication 
is also reported for SIV, enabling them to replicate continuously in their natural host 
without CD4
+ lymphocyte depletion (Silvestri et al., 2003).  
The integration of the provirus into the host genome is referred to as post-integration 
latency and is of immense practical importance because it provides a reservoir of 
virus that is protected from immune clearance and the effects of antiviral drugs 
(Chun et al., 1995; Chun et al., 1997; Finzi et al., 1997; Mok and Lever, 2007; 
Siliciano and Siliciano, 2004). There may be post-integration blocks to viral 
expression that can lead to viral latency in resting T-cells, which have an estimated 
half-life of at least 44 months (Finzi et al., 1999; Lassen et al., 2004; Williams and 
Greene, 2005). For these reasons, HIV-1 latency represents a known barrier to 
eradication of HIV infection (Lassen et al., 2004). Other types of infected cell such 
as monocytes, macrophages and dendritic cells are also considered as latently   15 
infected resting cells and can provide reservoirs of HIV capable of escaping host 
immune surveillance and antiviral treatments (Blankson et al., 2002; Esposito and 
Craigie, 1998; Zhang et al., 1999). However, it was suggested (Marcello, 2006) that 
while dendritic cells and macrophages play an important role in viral spread and cell-
cell transmission, their involvement in long-term latency has not been demonstrated 
unequivocally. 
Transcription of mRNA 
Transcription of lentivirus genes relies on their interaction with one of the 3 forms of 
RNA polymerase (Schmidt, 1993). Transcription produces an array of mRNA 
species that can be grouped into 3 classes based on the splicing process involved: an 
unspliced primary transcript (~9 kb), singly spliced RNAs (~4 kb) lacking the gag-
pol coding region, and multiply spliced RNAs (~2 kb) lacking the env coding region 
(Purcell and Martin, 1993; Schwartz et al., 1990; Seguin et al., 1998). 
Approximately one half of the HIV-1 RNA transcripts that are unspliced are 
essential for gag and pol gene products. Singly spliced mRNAs encode the Env 
proteins and the viral regulatory proteins Vif, Vpr, Vpu, while the multiply spliced 
RNAs encode proteins Tat, Rev and Nef  (Purcell and Martin, 1993).  
The transcription of mRNA can be divided into early and late phases much like most 
virus infections. In the early phase, only multiply-spliced viral mRNAs are exported 
to the cytoplasm and are then translated into early non-structural regulatory proteins 
Rev and Tat, and in some viruses also Nef, and S2 (Purcell and Martin, 1993; 
Saltarelli et al., 1996). The late phase of replication is characterised by the 
production of unspliced or singly-spliced viral mRNAs that include the transcripts of 
gag, pol and env that will form the structural proteins and glycoproteins for new 
virions (Saltarelli et al., 1996). The accessory genes vif, vpu, vpx, vpw, vpy, and OrfA 
are also translated during this phase and are crucial in assembly, infectivity and viral 
pathogenicity (Saltarelli et al., 1996; Seguin et al., 1998).  
Assembly and release from the cell 
Virus assembly and release of the virus from the host cell takes place in areas 
adjacent to the plasma membrane and involves a number of sequential steps. The 
Env glycoproteins (SU and TM) that are translated from the singly-spliced env 
mRNA in the endoplasmic reticulum are transported to the plasma membrane via the   16 
Golgi apparatus where they are glycosylated. At the same stage, the Gag and Gag-
pol polyprotein precursor are translated and transported, by an unknown mechanism, 
and directed toward the plasma membrane. During and after transport, the Gag 
precursors, 2 copies of viral RNA genome, and other Gag-pol precursors form 
immature virus particles move close to the plasma membrane and assemble. 
Thereafter, the assembled Gag protein complex induces membrane curvature, 
leading to the formation of a bud into which the viral Env glycoproteins are 
incorporated. The bud develops and pinches off from the plasma membrane to 
produce a complete virion with an envelope acquired from the bilayered plasma 
membrane with incorporated Env glycoproteins (Freed, 1998; Grode, 2007).  
After release from the host cell, there is further maturation of virus into the final 
mature forms. At this final stage, the Gag and Gag-pol polyprotein precursors are 
cleaved by the viral PR to the mature Gag (MA, CA, NC and p6) and Pol (PR, RT 
and IN) proteins, causing condensation of the core and formation of a mature 
infectious virion which is ready to initiate a new round of infection (Freed, 1998).  
Bovine lentivirus diseases 
Jembrana disease 
Historical aspects 
An outbreak of a highly infectious disease affecting Bali cattle (Bos javanicus) was 
first reported in the village of Sangkaragung, in the Jembrana district of Bali, 
Indonesia, in December 1964 (Adiwinata, 1967). The name Jembrana disease was 
derived from the district where the disease first occurred. During the initial stages of 
the outbreak, it was reported that an estimated 60% of Bali cattle were affected with 
a mortality rate of 98.9% (Ramachandran, 1996) but at the time there were no 
veterinary facilities on the island and this high case fatality rate has not been 
substantiated. Within 12 months, the disease spread to all 8 districts of Bali with a 
mortality rate of about 20% within a total Bali cattle population of approximately 
300,000 cattle on the island (Pranoto and Pudjiastono, 1967; Wilcox et al., 1995). 
Some buffalo (Bubalus bubalis) were also reported to have died during the outbreak 
(Pranoto and Pudjiastono, 1967) although it was not confirmed that this was due to 
Jembrana disease and subsequent events suggest that buffalo are not clinically 
affected. The disease outbreak then waned and it was not reported further until 2   17 
further smaller outbreaks were reported, one in 1972 and one in 1981 in the districts 
of Tabanan and Karangasem, respectively, where the clinical and pathological 
aspects of the disease detected were similar to those reported during the 1964 
outbreak  (Hardjosworo and Budiarso, 1973; Putra et al., 1983). However, although 
similar, the disease during these later outbreaks was considered milder with reduced 
morbidity and mortality rates, probably due to a level of immune protection among 
the local cattle population (Ramachandran, 1996). The disease is now endemic in 
Bali cattle on Bali island.  
The first outbreak of a Jembrana-like disease outside Bali was in 1976 in Lampung 
province of the island of Sumatra. In this area, the disease was initially designated as 
“Rama Dewa disease,” after the name of a village in which the cases were first 
reported and where it caused the death of 885 cattle (Prabowo, 1996). Interestingly, 
only Bali cattle were affected in this outbreak, although crossbred Bali cattle (Bos 
javanicus x Bos indicus), Bos indicus cattle, buffalo, goats and sheep were also 
present in the affected locations (Ramachandran, 1996). A further outbreak was 
reported in 1978 in East Java, which affected a total of 1,202 Bali cattle and caused 
449 deaths (Ramachandran, 1996). A similar outbreak was reported in 1992 in West 
Sumatra where the morbidity rate was estimated as 70.8% and 133 out of 498 
(26.7%) affected Bali cattle died (Tembok and Erinaldi, 1996). In 1993, serological 
evidence of Jembrana disease was detected in South Kalimantan, although 
mortalities attributed to the disease were relatively low, possibly associated with the 
low number of Bali cattle in that area (Hartaningsih et al., 1993). Jembrana disease is 
currently endemic in Bali, Java, Sumatra island and all 3 Kalimantan provinces of 
Borneo island (Hartaningsih et al., 1993). 
The mechanism for the transmission of Jembrana disease to other islands where the 
disease is now endemic remains unknown. A recent genetic analysis of proviral-
DNA samples obtained from cases of Jembrana disease in Bali and Sumatra showed 
that JDV strains from the 2 islands were very similar, with 97-100% nucleotide 
homology in gag sequences (Desport et al., 2007). These data would support the 
hypothesis that the most likely method for the spread of JDV to Sumatra was due to 
the illegal transportation of persistently infected cattle from Bali (Hartaningsih et al., 
1993; Soeharsono et al., 1995a), although the origin of JDV in Kalimantan remains 
unclear.    18 
The susceptibility of Bali cattle to Jembrana disease is important to the economy of 
Indonesia.  These cattle have been widely distributed throughout Indonesia, they 
form about 27% of the total cattle population of Indonesia, and they make the 
highest contribution to beef production in Indonesia (Wiryosuhanto, 1996) 
Aetiology  
Rinderpest virus was initially considered the cause of the cases of Jembrana disease 
based on clinical signs and pathological lesions (Adiwinata, 1967; Pranoto and 
Pudjiastono, 1967). No serological test or virus isolation was conducted to support 
the diagnosis of rinderpest, and histopathological changes of Jembrana disease in 
infected Bali cattle were subsequently determined to be distinctly different to 
rinderpest (Ramachandran, 1996). A rickettsia was subsequently hypothesised as a 
causative agent on the basis of putative intracytoplasmic rickettsia-like particles 
observed within monocytes of infected cattle (Budiarso and Hardjosworo, 1976). 
The clinical signs, pathological and haematological changes of Jembrana disease 
were also similar to those found in bovine ehrlichiosis (Ondiri disease) in East Africa 
(Ressang et al., 1985). However, the presence of rickettsia was never confirmed and 
it was noted also that anti-rickettsial drugs had no effect on the recovery of cattle 
from experimentally induced disease (Ramachandran, 1996). Subsequently, a virus 
was suspected based on the ability of the infectious agent to pass through a 220 nm 
membrane filter, its resistance to antibiotics and the nature of histopathological 
changes (Ramachandran, 1981; Teuscher et al., 1981). 
Soeharsono et al (1990) reported that during the febrile period of the disease, the 
infectious agent occurred in the blood and plasma to a high titre of about 10
8 cattle 
infectious doses per ml. The infectious agent persisted at a low titre of less than 10
2 
infectious particles/ml of plasma in recovered animals for at least 25 months after 
recovery from the acute disease (Soeharsono et al., 1990). The infectious agent in the 
plasma was subsequently identified as a retrovirus on the basis of size, determined 
by filtration studies as less than 100 nm, by electron microscopic observations in 
tissues as a spherical enveloped virus of about 100 nm diameter with an eccentric 
core and C-type budding from the plasma membrane, and by the detection of RT 
activity in virus detected in plasma (Kertayadnya et al., 1993; Wilcox et al., 1992). 
Further genetic and antigenic analysis identified the virus as a lentivirus, closely 
related to BIV (Chadwick et al., 1995b; Kertayadnya et al., 1993). Further genetic   19 
analysis of multiple isolates showed that it was a genetically stable lentivirus with 
only minimal genetic changes in isolates obtained from cattle in Bali over a 20 year 
period (Desport et al., 2007).  
Clinical signs and post-mortem lesions  
Infection of Bali cattle by intravenous inoculation of virus into susceptible cattle 
induces an acute disease syndrome after a short incubation period of 4-12 days. The 
short incubation period and acute nature of JDV infection with high morbidity rate 
and 17% case fatality rate is unusual for most lentivirus infections as lentiviruses 
generally result in a chronic and inevitably progressive disease terminating in death 
after a long incubation period. The major clinical signs of Jembrana disease during 
the acute disease are a fever persisting most commonly for 5-7 days, lethargy, 
anorexia, enlargement of superficial lymph nodes, a mild ocular and nasal discharge, 
diarrhoea with blood in the faeces, and pallor of the mucous membranes (Soeharsono 
et al., 1996; Soesanto et al., 1990). In natural cases, “blood sweating” (haemhidrosis) 
was reported on the back, flank, abdominal region and scrotum (Putra et al., 1983; 
Teuscher et al., 1981) but this is absent in experimentally infected cattle kept in 
insect proof stables, suggesting it was bleeding associated with biting arthropods 
(Soesanto et al., 1990). 
The most easily observed and striking clinical feature of Jembrana disease is 
enlargement of the superficial lymph nodes, especially the prescapular and 
prefemoral lymph nodes, that can be a useful indicator of Jembrana disease under 
field conditions (Figure 2.5). Lymph node enlargement is not generally found in 
other common cattle diseases in Indonesia, including haemorrhagic septicaemia, 
bovine viral diarrhoea and bovine ephemeral fever, although it is observed in 
malignant catarrhal fever to which Bali cattle are particularly susceptible  (Dharma, 
1992).   20 
 
     
Figure 2.5. A. Marked enlargement of the prescapular lymph node and spleen are 
consistent feature of Jembrana disease. B. The spleen from affected cattle (bottom) is 
about 5 times larger than that in a normal animal (top). Photographs courtesy of the 
staff of BPPH, Indonesia. 
 
 
The acute febrile phase of Jembrana disease experimentally induced by intravenous 
inoculation of virus is characterised by marked haematological changes that include 
leucopenia due to lymphopenia, eosinopenia, and slight neutropenia, 
thrombocytopenia, a normocytic normochromic anaemia, uraemia and 
hypoproteinaemia (Soesanto et al., 1990). The thrombocytopenia may be a factor 
contributing to the presence of the “blood sweating” reported in the field cases and 
likely associated with a poor clotting mechanism in association with biting 
arthropods such as tabanids.  
The striking post-mortem lesions in Jembrana disease experimentally induced by 
intravenous inoculation of virus are lymphadenopathy and splenomegaly (Figure 2.5) 
and haemorrhages, and these are all invariably detected in cattle euthanised during 
the acute phase of the disease. Other lesions, including kidney lesions and lung 
consolidation, may also be observed (Dharma, 1992). Histopathological changes are 
found in all major organs except the central nervous system and reflect a rapid, 
intense lymphoproliferative disorder (Budiarso and Rikihisa, 1992; Dharma et al., 
1991). The typical progression of pathological changes after JDV infection can be 
divided into 3 distinguishable phases (Dharma et al., 1991). Phase 1 is characterised 
by a generalised lymphoreticular reaction during the first week after infection, prior 
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to the development of clinical signs. In phase 2, from 1-5 weeks after infection, the 
spleen and lymph nodes become markedly enlarged, petechial haemorrhages may 
occur on serosal surfaces, and ulceration of the oral and intestinal mucosa can be 
detected. Phase 2 is associated with an infiltration of lymphoid cells into the 
parenchyma of most organs except the central nervous system (Dharma et al., 1991). 
In lymphoid organs particularly spleen and lymph nodes, there is a marked non-
follicular lymphoproliferative reaction characterised by an intense proliferation of 
pleomorphic lymphoblastoid cells in the parafollicular (T-cell) regions and there is 
depletion of follicles (B-cell germinal centres) that results in total destruction of the 
normal follicular architecture. In addition, the prevalence of IgG-containing cells in 
tissues is decreased and the CD4
+:CD8
+ T-cell ratio in blood is also decreased 
significantly, which is associated with suppression of humoral responses and 
extensive T-cell proliferation (Dharma et al., 1994; Hartaningsih et al., 1994).  A 
similar infiltrative and proliferative reaction was also detected in other organs 
including liver, kidneys, adrenal medulla and lungs. In the recovery phase or Phase 3 
(4-5 weeks after infection) when there is remission of the clinical signs and a 
reduction in the viraemia, a marked lymphoid follicular reaction with plasma cell 
formation, and significant increase in CD4
+ and CD8
+ T-cell populations in 
lymphoid tissues is detected (Dharma et al., 1994; Hartaningsih et al., 1994).  
The acute febrile phase is associated with a high titre of circulating infectious virus 
in the plasma of up to 10
8 infectious doses/ml (Soeharsono et al., 1990; Soeharsono 
et al., 1995a). This was determined by titration of the virus in susceptible cattle. 
Subsequent JDV-specific quantitative real-time reverse transcription PCR assay (RT-
PCR) detected up to 10
12 copies of the JDV RNA/ml plasma during the febrile phase 
(Stewart et al., 2005). The significance of the difference in titre determined by the 
infectious and the RNA genome assays has not been defined. Strain differences in 
the titre detected by qRT-PCR have been detected and on the second day of the 
febrile phase, the mean plasma viral titre in cattle infected with JDVTab/87 was 
significantly higher than in cattle infected with JDVPul/01 (Desport et al., 2007). The 
high titre of virus might be associated with JDV Tat that is a potent transactivator 
and thought to be at partly responsible for the high level of viral gene expression in 
vitro (Chen et al., 1999). A typical clinical response to JDV infection and viral load 
is shown in Figure 2.6.   22 
 
 
Figure 2.6. A typical clinical response of JDV-infected cattle. During the acute stage, 
an increased rectal body temperature coincides with an increased plasma viral load 
and a decreased leucocyte count. Reproduced from Desport et al (2007). 
 
Animals that recover from the acute disease experimentally induced by intravenous 
inoculation of virus remain viraemic although at a low titre only, for at least 24 
months and possibly for life, suggesting they may be a potential source of infection 
(Soeharsono et al., 1995a; Wilcox et al., 1992). JDV proviral DNA can be detected 
in the peripheral blood mononuclear cells (PBMC) of recovered animals for at least 
18 months after the initial infection (Tenaya and Hartaningsih, 2004). There is no 
recurrence of disease following recovery from the acute clinical disease and animals 
resist challenge with homologous and heterologous strains of virus for at least 2 
years after primary infection (Soeharsono et al., 1990). The lack of recurrence of 
disease in the recovered animals and the resistance to reinfection after recovery from 
the acute disease indicates the development of a protective immune response. 
Experimental inoculation of JDV into other cattle types such as Friesian (Bos 
taurus), crossbred Bali cattle (Bos javanicus x Bos indicus) and Ongole cattle (Bos 
indicus), and buffalo (Bubalus bubalis) induces either an inapparent infection or a 
mild clinical disease that would be difficult to be detect under field conditions. This 
is consistent with the lack of reports of disease in these other cattle types in 
Indonesia. Experimental infection of sheep and goats was reported to induce a 
transient viraemia and no clinical signs (Soeharsono et al., 1990). The unique 
susceptibility of Bali cattle, descendent from wild banteng of South East Asia 
(Soeharsono et al., 1995b), is intriguing but the reason for this susceptibility, 
although apparently genetically based, is not understood.    23 
The cellular tropism of JDV has not yet been defined and this is critical to 
understanding the disease process involved. The possibilities are that JDV could 
have a broad cell tropism like BIV in infecting B-cells (as shown by follicular 
atrophy early in the disease process), T-cells (as shown by the parafollicular 
hyperplasia and detection of virus in these cells), and macrophages (Chadwick et al., 
1998; Dharma et al., 1991). There is unpublished evidence that JDV can be cultured 
in myeloma (NS1) cells fused with lymphocytes derived from non-JDV infected Bali 
cattle. The hybridoma cells could be infected with JDV and maintained up to one 
year during which time they continue to demonstrate a strong reaction with anti-JDV 
CA monoclonal antibody in Western immunoblots, suggesting that JDV may infect 
B-cells (Astawa, personal communication) but this report needs to be confirmed. 
However, as JDV strains in Bali are genetically stable with minor variation only in 
env (Desport et al., 2007). Therefore, it could also be possible that JDV has a narrow 
host cell range, potentially targeting long-lived cells with a slow turnover rate. 
Mode of transmission of JDV 
As consequence of the high titre of infectious virus in the blood of about 10
8/ml 
during the acute phase of Jembrana disease, transmission of JDV in 2 different ways 
has been hypothesised. First, mechanical transmission by vehicles such as multi-use 
needles during vaccination programs, and by blood sucking arthropods, has been 
considered to have a high probability of transferring infection from cattle during the 
acute disease phase (Soeharsono et al., 1995a). However, mechanical transmission of 
virus by arthropods is unlikely to be responsible for the extensive spread of 
Jembrana disease from island to island as the disease has not spread from Bali island 
to the closely adjacent islands of Nusa Penida and Lombok since the disease was 
initially reported in Bali in 1964 (Hartaningsih et al., 1993; Soeharsono et al., 
1995a). There has also been limited spread of the disease from infected areas to 
neighbouring areas (Hartaningsih et al., 1993). During the acute phase when there is 
a high titre of virus in blood, close contact between animals might enable 
transmission of virus present in saliva of infected animals and infection of 
susceptible cattle by conjunctival, nasal or respiratory routes (Soeharsono et al., 
1995a). Close contact between animals does result in transmission of MVV and 
CAEV in sheep and goats (Gufler et al., 2007; Shah et al., 2004a).    24 
Transmission of JDV from the persistently infected animals wherein there is only a 
low titre viraemia, to susceptible animals has also been hypothesised (Soeharsono et 
al., 1995a) but how this occurs is unknown. However, transportation of persistently 
infected recovered cattle from JDV-infected areas to JDV-free regions is the most 
logical reason for the occurrence of Jembrana disease in other regions outside Bali 
(Soeharsono et al., 1995a).  
Diagnosis of Jembrana disease 
Diagnosis of Jembrana disease is based on clinical signs and pathological 
observations, in conjunction with the detection of JDV infection by immunological 
procedures and molecular techniques. 
Serological assays 
Two serological assays, an enzyme-linked immunosorbent assay (ELISA) and 
Western immunoblot, have been developed for the detection of an antibody response 
to JDV in infected animals (Hartaningsih et al., 1994; Kertayadnya et al., 1993). The 
initial ELISA utilised an antigen prepared by sucrose gradient centrifugation to 
purify and concentrate virus from plasma of acutely infected animals. With this 
assay, antibodies were not detected in a majority of cattle until 11 weeks after 
infection, with the maximum antibody response occurring between 23 and 33 weeks 
after infection. A Western immunoblot using a similar whole virus antigen indicated 
that the initial positive ELISA sera reacted strongly with the p26 JDV CA protein 
(Hartaningsih et al., 1994; Kertayadnya et al., 1993), typical of other lentivirus 
infections (Battles et al., 1992; Grund et al., 1994). The absence of a detectable 
antibody response until 11 weeks after JDV infection may be associated with the 
absence of a significant follicular reaction and scarcity of plasma cells in lymphoid 
organs during the acute phase and early recovery phase (Hartaningsih et al., 1994).  
ELISA, supported by Western immunoblotting, has been used as a routine 
surveillance technique for detection of JDV infection in the Indonesian cattle 
population (Hartaningsih et al., 1993; Soeharsono, 1996). The predominant antibody 
detected by ELISA and by Western immunoblotting was reactive with the p26 JDV 
CA, a response that was similar to that detected in other lentiviruses. There could 
therefore be a problem with the specificity of the assay as this protein is known to be 
cross-reactive in many lentivirus infections and particularly between JDV and BIV   25 
(Kertayadnya et al., 1993). Potential problems with cross-reactivity could occur 
because of cross-reactions with a putative BIV-like virus detected in Bali cattle in 
Sulawesi, a Jembrana disease-free island, where positive ELISA results with this 
assay have been detected but where there is no evidence of Jembrana disease 
(Hartaningsih, personal communication). More recently, a recombinant JDV CA 
antigen was used in ELISA and Western immunoblotting procedures for the 
detection of BIV infection in dairy cattle in Australia, where it detected antibody 
presumably due to BIV infection in 3.8% of 690 serum samples (Burkala et al., 
1999). Evidence of similar cross-reactivity of CA was reported in the small ruminant 
lentiviruses MVV and CAEV (Grego et al., 2002).  
The use of recombinant CA antigens (Burkala et al., 1999) offers advantages 
compared to the whole virus antigen prepared from the plasma of infected cattle, 
although it has not reduced the potential problem of antigenic cross-reactivity 
between BIV and JDV.  Attempts to identify possible type-specific epitopes in the 
MA, CA, and NC of JDV have been made by preparation of a series of truncated 
recombinant proteins, but none of these were able to differentiate sera from JDV-
infected or BIV-infected cattle (Desport et al., 2005).  
  Immunohistochemistry 
Immunohistochemical labelling techniques have been widely used for determining 
the pathogenesis of lentivirus-infected hosts, including SIV infection in monkeys 
(Zhang et al., 2007), HIV in humans (Bhoopat et al., 2001; Geijtenbeek et al., 2001; 
McCarthy et al., 2002; Wheeler et al., 2006), BIV in cattle (Heaton et al., 1998; 
Whetstone et al., 1997) and MVV in sheep (Brodie et al., 1995; Gendelman et al., 
1985). An immunohistochemical test utilising a JDV p26 CA monoclonal antibody 
(Kertayadnya et al., 1993) was developed and used to detect JDV infection in tissues 
of infected cattle (Dharma et al., 1994).  
In situ hybridisation (ISH)  
Determination of the nucleotide sequence of the genome of JDV has allowed the 
development of an in situ hybridisation technique to detect viral RNA in tissues at 
different stage of the disease process (Chadwick et al., 1998). This ISH assay 
detected JDV RNA at the onset of the febrile period, mainly in the parafollicular 
areas of the spleen, and to a lesser extent in the lymph nodes, bone marrow, lungs   26 
and kidneys. On the second day of the febrile period, viral RNA was detected at 
elevated levels in the lymph nodes and in the cellular infiltrate in other organs. On 
the fourth day of the febrile period, JDV-infected cells were widely distributed in all 
tissues. While the identity of the JDV-infected cells could not be determined, the 
prevalence and morphology of infected cells in lymphoid tissues suggested that the 
infected cells were of lymphoid origin and possibly of the monocyte/macrophage 
lineage (Chadwick et al., 1998).  
  Polymerase chain reaction (PCR) 
PCR  is the technique of choice for detection and analysis of minute amounts of 
DNA (Glick and Pasternak, 2003). It has been widely used for sensitive and specific 
detection of many lentiviruses, including HIV-1 (Nyambi et al., 1994) and BIV 
(Suarez et al., 1995).  
For the detection of JDV proviral DNA, the first reported PCR assay involved a 
nested set of 4 oligonucleotide primers selected from sequences in the gag genes of 
JDV. These provided a sensitive assay that was specific for JDV, and did not 
recognise proviral DNA of the closely related BIV (Chadwick, 1995).  Additional 
JDV-specific PCR assays have been developed to detect JDV proviral-DNA in 
PBMC isolated from JDV-infected cattle as early as 3 days after infection, before 
clinical signs developed, and until at least 18 months after infection (Tenaya and 
Hartaningsih, 2004; Tenaya et al., 2003). This test enabled the early detection of 
JDV after infection, whereas serological assays such as ELISA were generally 
unable to detect antibody until at least 11 weeks after infection (Hartaningsih et al., 
1994). PCR assays have been used to monitor the effect of vaccination with a tissue-
derived vaccine (Hartaningsih et al., 2001) on virus persistence and it was 
determined that the number of cattle in which proviral DNA could be detected in 
PBMC was reduced significantly after vaccination (Tenaya and Hartaningsih, 2005)  
Bovine immunodeficiency virus 
BIV was originally isolated in Louisiana from a dairy cow (R29) with persistent 
lymphocytosis, lymphadenopathy, progressive weakness and emaciation (Van der 
Maaten et al., 1972). The virus induced syncytium formation and was antigenically 
distinct from bovine spumavirus. Reinoculation of the R29 isolate into colostrum-
deprived calves caused only a mild lymphocytosis and enlargement of subcutaneous   27 
lymph nodes without any overt clinical signs, very different to the clinical signs 
observed in the animal from which it was isolated. Probably due to the absence of 
marked clinical signs in cattle experimentally infected with BIV, little further 
investigation of this virus did until the discovery that HIV-1 was also a lentivirus. It 
was not until later that Gonda et al. (1987) characterised the R29 strain of BIV as a 
lentivirus based on virion structure, budding characteristics and genetic homology 
with other lentiviruses. Antigenic cross-reactivity between the CA protein of BIV 
and the other known lentiviruses including HIV-1, EIAV, CAEV and MVV was 
demonstrated (Gonda et al., 1987; Jacobs et al., 1992). 
Only rarely has BIV infection been associated with naturally occurring clinical 
disease and its distribution is worldwide, in contrast to JDV that seems to be 
confined to Indonesia (Brownlie et al., 1994; Chadwick et al., 1995b; Muluneh, 
1994; Polack et al., 1996; Whetstone et al., 1990). Inoculation of cattle with R29 and 
other BIV-isolates has resulted in mild changes including a mild lymphocytosis 
predominantly due to B-cells, a transient increase of mononuclear cells and immune 
suppression (Whetstone et al., 1997; Zhang et al., 1997a). The difference in severity 
of the lesions between those observed in the cow from which the virus was isolated 
and those seen in the experimentally infected cattle has been attributed to loss of 
virulence of the R29 isolate since its original isolation, due to extensive attenuation 
following multiple passages in vitro (Suarez et al., 1993) but attenuation may not 
have occurred and other factors might well have been responsible for these 
differences. Experimental infections with other strains of BIV have also not 
produced lesions typical of those observed in the cow from which R29 was isolated. 
The apparent lack of pathogenicity of BIV, in marked contrast to the closely related 
JDV in Bali cattle, suggested that BIV may have a greater pathogenicity in Bali 
cattle. However, infection of 2 young Bali cattle with BIV did not induce clinical 
signs, although all animals became BIV positive by PCR and the virus was re-
isolated from the infected cattle (Whetstone et al., 1996).  
Recent studies with the R29 strain of BIV in Bali cattle confirmed previous 
observations (Whetstone et al., 1996) that this strain did not produce clinical signs of 
disease in this species and there was no greater susceptibility of Bali cattle to BIV as 
there is to JDV. Proviral BIV DNA was detected in PBMC from 4-60 days after 
infection when the experiment was terminated, with peak titres 20 days after   28 
infection.  There was a transient viraemia from 4-14 days after infection with a 
maximum 1 x 10
4 genome copies/ml of plasma. An antibody response to the TM 
protein occurred commencing 12 days after infection but an antibody response to the 
to the CA protein was detected in only 1 of 13 cattle before 60 days and only after 34 
days (McNab et al., 2010). Apart from the lack of pathogenicity of BIV in Bali cattle 
there are interesting comparisons between BIV and JDV infection in Bali cattle: the 
transient viraemia soon after infection with BIV is similar to that observed after JDV 
infection but the level of viraemia after BIV infection is markedly less than that 
which occurs with JDV infection. The antibody response to BIV infection was also 
markedly earlier than that detected following JDV infection. 
BIV is genetically closely related and shares common antigens with JDV (Barboni et 
al., 2001; Burkala et al., 1998; Desport et al., 2005; Kertayadnya et al., 1993). The 
similarity of the gag encoded proteins of BIV and JDV is approximately 62% at the 
amino acid level, the CA of both viruses share 75% identity whereas the identity of 
the TM of the 2 viruses is only 31% (Chadwick et al., 1995b; Kertayadnya et al., 
1993). Using JDV CA in serological assays does not differentiate antibody to BIV 
and JDV (Barboni et al., 2001; Wilcox et al., 1995) even though unique epitopes 
have been described on the Gag protein of BIV and JDV (Lu et al., 2002).  
BIV appears to have a broad host range and infection of sheep, goats and rabbits also 
induced a persistent infection and antibody response (Carpenter et al., 2000; Forman 
et al., 1992; Jacobs et al., 1996; Smith and Jacobs, 1993; Whetstone et al., 1991). 
BIV also appears to be pantropic and infect a wide variety of cell types including B-
cells, T-cells and cells of the monocyte/macrophage lineage (Heaton et al., 1998; 
Rovid et al., 1995; Whetstone et al., 1997; Wu et al., 2003). The cellular receptor 
used by BIV has not been determined.  
Lentivirus infection in other species  
Human immunodeficiency virus type 1 (HIV-1)  
HIV-1 was first identified in 1983 as the causative agent of acquired immune 
deficiency syndrome (AIDS) (Barre-Sinoussi et al., 2004; Clements and Zink, 1996). 
Although a second human immunodeficiency virus, HIV-2, was subsequently 
identified, HIV-1 is responsible for the majority of HIV infections globally, although   29 
features of the 2 virus infections are similar (Azevedo-Pereira et al., 2005; Azevedo-
Pereira et al., 2003; Reeves and Doms, 2002). The route of transmission of HIV-1 
and HIV-2 are the same (Grant and De Cock, 2001), mainly as a cell-associated virus 
in semen transmitted by sexual contact, or in blood where it is transmitted as a 
consequence of needle-sharing amongst intravenous drug users or during blood 
transfusions, and maternally both in utero and from breast milk (Buonaguro et al., 
2007; Friedland and Klein, 1987). 
HIV-1 induces a transient and acute clinical disease 3-4 weeks after infection, as do 
a number of other lentiviruses, which could be likened to a mild form of the acute 
clinical disease that is a consequence of JDV infection in Bali cattle. However, the 
acute disease following HIV infection is much milder than that which occurs as a 
consequence of JDV infection in cattle. HIV-infected individuals invariably recover 
and then go on to develop acquired immune deficiency disease (AIDS), whereas the 
case fatality rate associated with Jembrana disease is about 20% and animals that 
recover do not develop any further clinical disease.  The major characteristics of the 
HIV disease process are depicted schematically in Figure 2.7. After infection, HIV-1 
disseminates to and replicates in cells of regional lymphoid organs until a threshold 
of replication is reached 2-6 weeks post-infection (Alcami, 2004a; Brenchley et al., 
2004; Weiss, 2000). There is then an occurrence of mild flu-like illness associated 
with a transient decrease in the number of circulating CD4
+ T-cells and a concurrent 
transient increase in the plasma viral load. This is followed by a rapid clearance of 
virus probably due to the ability of the immune system to generate an effective 
response to control replication (Blattner et al., 2004) and thought to be 
predominantly associated with cell-mediated responses but not with the development 
of neutralising antibodies (D'Souza and Mathieson, 1996). The ensuing virus 
infection is associated with a limited proliferation of the virus due to host defence 
mechanisms, but a minimal viraemia is nonetheless maintained (Tyler and Fields, 
1996). In the presence of neutralising antibody, the viraemia is drastically reduced 
and becomes cell-associated to facilitate persistence of the virus and remission of 
clinical signs (Forthal et al., 2001; Tyler and Fields, 1996). Viral replication 
continues at a lower level during a long symptom-free period until the level of 
viraemia progressively increases again and this coincides with a progressive 
reduction in CD4
+ T-cells leading to onset of immunosuppression and opportunistic   30 
secondary infection that manifest as AIDS (Figure 2.7).  The period from initial 
infection until the occurrence of severe clinical symptoms leading to AIDS can range 
from months to years. 
 
 
 
Figure 2.7. A typical time-course of HIV infection. After initial infection, CD4
+ cells 
decrease transiently in association with a transient high plasma virus load shortly 
after infection and this is associated with a flu-like illness. This is followed by a 
progressive slow decrease in CD4
+ cells during a long asymptomatic period but 
eventually there is a further increase in virus load and very low levels of CD4
+ cells 
leading to the onset of AIDS. Sourced from Weber (2001). 
 
 
HIV-1 infects several primary cell types, predominantly the CD4
+ T-helper subset of 
lymphocytes, the macrophage lineage, and some populations of dendritic cells 
(Clapham and McKnight, 2002). The depletion of CD4
+ T-cells, the hallmark of 
HIV-1 infection, occurs predominantly in the gastrointestinal tract, similar to SIV 
infections (Brenchley et al., 2004; Canto-Nogues et al., 2001; O'Neil et al., 1999) 
and as a direct consequence of viral replication the infected cells are destroyed, 
leading to mass destruction of the immune system (Alcami, 2004a; Brenchley et al., 
2004; Penn et al., 1999; Picker, 2006). The development of these changes is 
associated with a progressive change in virus replication from a slow replicating 
low-titre virus to a rapidly replicating high-titre virus, caused in part by a switch in 
the predominant receptor used by the virus that enables the virus to broaden its cell 
tropism (Fenyo et al., 1989; Weber, 2001).    31 
Changes observed during AIDS include weight loss, diarrhoea and a range of 
secondary infections associated with opportunistic pathogens (Grant and De Cock, 
2001; Mwachari et al., 2003; Stack et al., 1996; Ullrich et al., 1992). 
Immunosuppression leads to opportunistic infections (Mwachari et al., 2003; Zhang 
et al., 2007; Zhang et al., 2004) resulting in secondary infections, e.g. Pneumocystis 
carinii associated with pneumonia, Mycobacterium leading to tuberculosis, herpes 
zoster infections, toxoplasmosis, cytomegalovirus, oral candidiasis and other viral, 
bacterial, fungal and protozoal agents (Soriano et al., 2000; Sungkanuparph et al., 
2003; Ullrich et al., 1992). Kaposi’s sarcoma due to Human herpesvirus type 8 is a 
common skin tumour seen in AIDS patients and growth of the tumour cells is 
thought to be stimulated by the extracellular Tat secreted from HIV-1 infected cells 
(Dupon et al., 1997; Engels et al., 2003; Rubartelli et al., 1998).  
In individuals with AIDS, infected tissue macrophages have been detected in lung, 
colon, brain, liver and kidney (Cao et al., 1992; Donaldson et al., 1994). Other 
tissues that harbour persistently-infected macrophages include lymph node, spleen 
and bone marrow (Gorry et al., 2001). Infection of macrophages in certain organs 
results in some primary diseases including encephalitis, lymphoid interstitial 
pneumonia and bone marrow disorders leading to anaemia and thrombocytopenia 
(Hanna et al., 1998; Pise et al., 1992; Wheeler et al., 2006).  About 30% of HIV-
infected patients exhibit encephalitis in which HIV-1 is assumed to enter into the 
brain tissue via circulating infected monocytes that cross the blood brain barrier and 
mature into macrophages (Gonzalez-Scarano and Martin-Garcia, 2005; Wheeler et 
al., 2006). 
The ability of HIV-1 to also infect and deplete CD4
+ lymphocyte populations is 
partly due to its ability to infect follicular dendritic cells in the germinal centres of 
lymphoid follicles. This causes gradual disruption of the follicular dendritic network 
and functional perturbations of B-cells in the tissue, ultimately leading to the onset 
of AIDS (Moir et al., 2003; Moir et al., 2001). B-cell dysfunction in HIV infection is 
largely associated with cell hyperactivation and can lead to 
hypergammaglobulinaemia (Shirai et al., 1992), increased spontaneous secretion of 
Ig (Conge et al., 1994; Fournier et al., 2002), and increased susceptibility to 
apoptosis (Muro-Cacho et al., 1995; Samuelsson et al., 1997). In HIV infections, B-
cells respond poorly to mitogenic or antigenic stimuli in vitro and produce poor   32 
antibody responses in vivo (Conge et al., 1998; Opravil et al., 1991). A similar 
phenomenon has been reported in SIV and FIV infections (Zhang et al., 2007; Zhang 
et al., 2004).  
Dendritic cells are a main target for HIV-1 at the mucosal level and are among the 
first cell targets during early infection (Hu et al., 2000; Knight, 2001; Miller et al., 
1994; Sewell and Price, 2001). These cells were the predominant cell type infected 
following vaginal exposure of macaques to SIV (Hu et al., 2000; Miller et al., 1994; 
Spira et al., 1996). They play a significant role as antigen-presenting cells (APC) that 
capture, transport and present the virus from mucosal membranes to CD4
+ and CD8
+ 
T-cells in lymph nodes (Cella et al., 1999; Geijtenbeek and van Kooyk, 2003; 
Rowland-Jones, 1999). Whether dendritic cells are directly infected by HIV-1 or are 
carriers of the virus has been controversial. The dendritic cell-specific protein (DC-
SIGN) does act as a novel HIV-1 trans-receptor for binding and transmitting the 
virus to target cells but it does not function as a receptor for viral entry (Clapham and 
McKnight, 2001; Geijtenbeek and van Kooyk, 2003; Geijtenbeek et al., 2000b). 
Some have reported that HIV-1 infects dendritic cells that then secrete soluble HIV-1 
gp120 which hampers CD4
+ T-cell proliferation and IL-2 production, and leads to 
immune dysfunction in AIDS patients (Fantuzzi et al., 2004; Kawamura et al., 2003).  
Others have reported that dendritic cells support viral replication dependent on their 
state of maturation (Bakri et al., 2001; Granelli-Piperno et al., 1998). Immature 
dendritic cells and Langerhans cells at the genital tract mucosal membranes were 
considered more permissive than mature cells to HIV-1 infection (Bakri et al., 2001; 
Bhoopat et al., 2001; Clapham and McKnight, 2001). These cells are different to 
other dendritic cells from other tissues in that they do not possess DC-SIGN 
associated with transmission events (Geijtenbeek et al., 2000a; Prakash et al., 2004), 
and they express C-type lectins such as mannose receptors that are thought to be 
involved in initial attachment of HIV-1 (Turville et al., 2003). Follicular dendritic 
cells that trap and retain HIV-1 in the follicles of secondary lymphoid tissues have 
also been considered as a significant reservoir of infectious virus (Brandon et al., 
2008).  
Equine infectious anaemia virus (EIAV)  
Equine infectious anaemia was first described in 1904 but the causative virus was 
not identified as a lentivirus until more recently (Charman et al., 1976; Cook et al.,   33 
2001; Montelaro et al., 1993). It is a lentivirus that occurs to a sufficient titre in 
blood that it can be transmitted mechanically by arthropods (Issel and Coggins, 
1979; Montelaro et al., 1993; Sellon et al., 1994) but it can also be experimentally 
transmitted by inoculation of blood from naturally infected animals into susceptible 
animals (Spyrou et al., 2003). 
EIAV induces a clinically variable disease with acute, chronic and inapparent carrier 
phases. The acute stage is atypical of most lentiviruses in that it is characterised by 
an early viraemic period after infection and this is associated with the rapid 
development of clinical signs including fever, depression, anorexia, weight loss, 
oedema and anaemia that sometimes results in death (Issel and Coggins, 1979; Valli, 
1993). During this period, lymphocyte counts are reduced due to significant 
reduction of CD4
+ and CD8
+ T-cell populations (Murakami et al., 1999).  
Animals that recover from the initial acute disease may develop intermittent or 
recurrent clinical episodes characterised by fever, thrombocytopenia, lethargy, 
inappetence, progressive anaemia and cachexia (Sellon et al., 1994; Valli, 1993). 
Periodic clinical relapses initially occur at 1-2 week intervals but the interval 
between relapses progressively increases until complete recovery is attained (Leroux 
et al., 2004) perhaps 12 months later. Most infected horses then develop a prolonged 
subclinical virus infection during which the cellular reservoir of virus is 
macrophages (Oaks et al., 1998; Sellon et al., 1994). The reduction of viral load is 
associated with the presence of neutralising antibodies (Sponseller et al., 2007).  
Maedi-visna virus (MVV).  
The MVV-related diseases, maedi and visna, were first reported in Icelandic sheep in 
Iceland (Narayan et al., 1993). Infected animals develop a chronic wasting disease 
characterised by interstitial pneumonia (maedi) or nervous signs (visna) (Benavides 
et al., 2006; Bolea et al., 2006; Cutlip et al., 1988) although mastitis is also common 
in infected lactating animals (Cutlip et al., 1988; Dawson, 1980; Dow et al., 1990; 
Lujan et al., 1991; Narayan et al., 1993). The diseases have been recognised in most 
sheep-rearing countries of the world, with the notable exception of Australia and 
New Zealand (Shuljak, 2006). The causative virus MVV is closely related to CAEV 
with which it shares approximately 75%, 78% and 60% identity to nucleotide 
sequences in gag, pol and env genes, respectively (Saltarelli et al., 1990).    34 
Typical of lentivirus infections, infected sheep remain carriers for life (Dawson, 
1987; Pepin et al., 1998) and transmission is possible in many ways but mainly by 
ingestion of infected colostrum or milk, or by aerosol transmission of virus from the 
respiratory tract of infected animals (Blacklaws et al., 2004; Leginagoikoa et al., 
2006; Peterhans et al., 2004; Preziuso et al., 2004; Straub, 2004). There is a close 
genetic and antigenic relationship between MVV and CAEV (Gogolewski et al., 
1985; Grego et al., 2002; Rosati et al., 1999) and natural cross-species transmission 
by close contact between sheep and goats is possible (Banks et al., 1983; Castro et 
al., 1999; Gjerset et al., 2007; Grego et al., 2007; Lacerenza et al., 2006; Pisoni et al., 
2005; Rolland et al., 2002). The potential for cross-species transmission has been 
supported by recent phylogenetic analysis of sheep isolates that revealed the 
presence of strains that had greater genetic identity to CAEV than to MVV (Karr et 
al., 1996; Leroux et al., 1997; Shah et al., 2004b; Valas et al., 1997).  
The virus predominantly infects fixed-tissue macrophages and it does not infect T-
cells, in contrast to many other lentiviruses and including those of man, monkeys and 
cats (Brodie et al., 1995; Gendelman et al., 1985; Gendelman et al., 1986; Gorrell et 
al., 1992; Narayan et al., 1983). MVV has also been detected in dendritic cells that 
not only carry infectious MVV but are also host to virus replication (Ryan et al., 
2000).    
Caprine arthritis encephalitis virus 
CAEV was first isolated in the early 1970s from synovial fluid of an arthritic goat 
and goat kids with encephalitis (Cheevers et al., 1988; Cork et al., 1974). The virus 
has a close genetic relationship to MVV and induces a similar disease in goats to 
those detected in sheep with MVV, and is widespread in many countries including 
Australia (Contreras et al., 1998; Cutlip et al., 1992; de la Concha-Bermejillo et al., 
1998; Guiguen et al., 2000; Surman et al., 1987). In contrast to MVV infection, the 
main pathological forms described in infected goats are a chronic degenerative 
polyarthritis and a leukoencephalitis in mature goats and kids, respectively, and 
pneumonia less commonly (Cork et al., 1974; Rowe and East, 1997). As in sheep 
with MVV, horizontal transmission is mainly via ingestion by the newborn of 
infected colostrum and milk from the mother (East et al., 1993; Greenwood et al., 
1995; Le Jan et al., 2005; Mselli-Lakhal et al., 1999; Peterhans et al., 2004). The 
virus in the ingested milk infects mononuclear cells of the monocyte/macrophage   35 
lineage which are the primary target cells of CAEV, similar to MVV (Lechat et al., 
2005; Narayan and Kennedy-Stoskopf, 1983).  
Feline immunodeficiency virus (FIV)  
FIV is a T-lymphotropic lentivirus of domestic cats first isolated from feline 
leukaemia virus (FeLV) serologically-negative cats showing an immunodeficiency-
like syndrome (Pedersen et al., 1987). Although FIV and FeLV both may induce 
immunodeficiency, the infections can be specifically differentiated based on 
serological assays (Fontenot et al., 1992; Shelton et al., 1990).  
Clinical manifestations of FIV infection occur in 3 phases: an acute, an 
asymptomatic, and a subsequent immunodeficiency condition, all of which appear 
analogous to that observed in HIV-infected patients (Ishida and Tomoda, 1990; 
Pedersen et al., 1987; Pedersen et al., 1989). The acute stage soon after infection is a 
transient disease with generalised lymphadenopathy, fever and leucopenia (Barlough 
et al., 1991; Obert and Hoover, 2002). This is then followed by a subclinical stage 
and finally by a terminal stage characterised by a number of chronic infections, 
wasting and a low level plasma viraemia (Pedersen et al., 1989). The terminal stage 
is similar to that seen in HIV and SIV infections (Pedersen et al., 1987; Yamamoto et 
al., 1988).  
The virus targets activated CD4
+  T-cells by specifically binding to a CD134 receptor 
expressed on the surface of the cell and in conjunction with co-receptor, CXC 
chemokine receptor 4 (de Parseval et al., 2004; Shimojima et al., 2004). FIV 
infections cause a gradual depletion of CD4
+ T-cell subsets and impair immune 
function (Ackley et al., 1990; Olmsted et al., 1989; Talbott et al., 1989; Yamamoto 
et al., 1988). FIV, however, can also infect monocytes/macrophages and B-cells, and 
B-cells are considered to be a principal target in the later stages of infection (Brunner 
and Pedersen, 1989; Dean et al., 1999; Dean et al., 1996; English et al., 1993; Troth 
et al., 2008; Yang et al., 1996). Replication of the virus in cells of macrophage 
lineage has been considered to be responsible for disease manifestations of the 
central nervous system (Clements and Zink, 1996; Dow et al., 1990; Hartmann, 
1998) and virus has been detected in the cerebrospinal fluid of seropositive cats 
experimentally infected with a Maryland strain of the virus (Prospero-Garcia et al., 
1994).    36 
Simian immunodeficiency viruses (SIV)  
SIVs are a diverse group of nonhuman African primate lentiviruses that share many 
of the biological properties of HIV-1 and HIV-2 and tend to cause a disease 
remarkably similar to human AIDS, not in the primary host but in other heterologous 
primate species that are not the natural host (Brown et al., 2007; Desrosiers, 1990; 
Letvin et al., 1985; Veazey et al., 2000). SIV in their native hosts have adapted to 
survive in these hosts and the infected primates do not develop disease despite high 
levels of virus replication and a limited antiviral CD8
+ T-cell response (Broussard et 
al., 2001; Cumont et al., 2008; Rey-Cuille et al., 1998; Silvestri et al., 2003). These 
viruses are transmitted between individuals in association with sexual activity and 
male to male aggression (Whetter et al., 1999). An AIDS-like disease in non-human 
primates was first reported in rhesus macaques infected with SIV isolated from sooty 
mangabeys (Letvin et al., 1985). This finding subsequently provided a model for the 
study of human AIDS that is amenable to manipulation of a variety of experimental 
parameters. The major application of the model has been for study of pathogenesis 
(Hirsch and Johnson, 1994; Zink et al., 1998), transmission (Harouse et al., 2001; 
Tsai et al., 2004), genomic integration (Crise et al., 2005), treatment (Clements et al., 
2005; North et al., 2005; Shen et al., 2003; Zink et al., 2005) and vaccine 
development (Egan et al., 2000; Haga et al., 1998; Hayami and Igarashi, 1997; Nath 
et al., 2000; Parker et al., 2001). 
Clinical signs of simian AIDS generally include rapid weight loss, poor fluid intake, 
diarrhoea, loss of appetite and ataxia (Dykhuizen et al., 1998; Sopper et al., 1998). 
Primary components of the disease include giant cell interstitial pneumonia, 
meningitis, glomerulonephropathy, severe enteritis, persistent lymphadenopathy and 
bone marrow disorders (Brown et al., 2007; Dykhuizen et al., 1998; Kitagawa et al., 
1991). Immunosuppression enables secondary opportunistic infections (Clements 
and Zink, 1996; Yanai et al., 1999). The development of lesions seen in the early 
stage of AIDS have been shown to be related to changes in the cellular tropism of the 
virus (Clements and Zink, 1996). Replication of some strains of SIV in cells of 
monocyte/macrophage lineage has been considered to cause primary neurological 
signs and pneumonia (Kim et al., 2003; Mankowski et al., 1998; Sharma et al., 1992) 
while strains that replicate in lymphocytes are predominantly responsible for 
decreasing absolute number of CD4
+ cells leading to opportunistic infections (Brown   37 
et al., 2007; Dykhuizen et al., 1998; Mattapallil et al., 2005; Veazey et al., 2003; 
Veazey et al., 2000).  
Infection with some strains of SIV has induced disease that is more rapidly 
progressive than is normally seen in lentivirus infections, and there are analogies of 
these infections to JDV infection in Bali cattle. Infection with SIVmac or the hybrid 
simian/human immunodeficiency virus SHIV89.6PD caused rapid AIDS development 
in which some infected monkeys died within 6 months of virus infection (Dykhuizen 
et al., 1998; Smith et al., 1999; Steger et al., 1998; Zhang et al., 2007). In this rapidly 
progressive AIDS-like condition the plasma viral loads were found to be higher than 
is usual and there was frequently a lack of any virus-specific humoral immune 
response (Watson et al., 1997; Zhang et al., 2002; Zhang et al., 2004). In this 
condition, an early severe depletion of B-cells in germinal centres and disruption of 
the follicular dendritic cell network was evident, and were thought to be associated 
with the lack of antibody response that ultimately led to rapid disease progression 
(Dykhuizen et al., 1998; Zhang et al., 2007; Zhang et al., 2004).   
Infection with SIVsmmPBj14 also produces a disease with some similarities to 
Jembrana disease but the infection is even more virulent than JDV infection.  
SIVsmmPBj14 is the most virulent primate lentivirus that has been described, causing a 
fatal disease in nearly all infected pig-tailed macaques (Macaca nemestrina) within 
days instead of months and years as in HIV and most SIV infections (Fultz et al., 
1989). This highly atypical variant of SIV was originally isolated from lymphoid 
tissues of a macaque (PBj) that had previously been infected with SIVsm for 14 
months. The virus also infects and induces disease in other strains of monkeys 
including sooty mangabeys and rhesus macaques, but a more variable form of the 
acute disease is seen in rhesus monkeys (Fultz et al., 1989; Lewis et al., 1992a). 
Transmission of disease occurs only by means of experimental inoculation after 
which the virus induces a high titre viraemia, extensive cellular activation and 
proliferation and a high level of cytokine production, leading to acute severe clinical 
signs (Fultz and Zack, 1994; Lewis et al., 1992a). The acute clinical signs in pig-
tailed macaques include depression, anorexia, fever, an erythematous skin rash, 
profuse diarrhoea and death, all within 6-10 days of infection (Fultz et al., 1989; 
Hodge et al., 1999; Lewis et al., 1992a; Mossman et al., 1996; O'Neil et al., 1999). 
Animals develop a severe lymphopenia involving all circulating lymphocytes, and a   38 
moderate neutrophilia (Novembre et al., 1993; O'Neil et al., 1999; Schwiebert and 
Fultz, 1994). Pathological changes include a generalised lymphadenomegaly, 
splenomegaly and, unlike Jembrana disease, marked gastrointestinal lesions. The 
most prominent pathologic feature is a rapid and extensive lymphoid hyperplasia of 
the T-cell areas of lymph nodes, spleen and particularly the gut-associated lymphoid 
tissues (Fultz and Zack, 1994; O'Neil et al., 1999), and a similar T-cell proliferation 
is also seen in Jembrana disease. These expanded T-cell zones contained a high 
proportion of lymphoblasts, activated macrophages and syncytial cells, indicating 
high levels of viral replication and immune system hyperactivation. These 
histological changes are atypical of those observed with primary HIV-1 infections 
(Fultz, 1994; Fultz and Zack, 1994). SIVsmmPBj14  infects CD4
+ T-cells, macrophages, 
CD8
+ T-cells and B-cells in vivo (O'Neil et al., 1999). Additional in vitro studies 
have indicated that the virus also replicates efficiently in resting pig-tailed macaque 
PBMC (Fultz, 1991; Novembre et al., 1993), activates and induces proliferation of 
CD4
+ and CD8
+ lymphocyte subsets, and resting lymphocytes (Fultz, 1991; Fultz 
and Zack, 1994; Novembre et al., 1993; Schwiebert and Fultz, 1994). The mitogenic 
properties of Nef encoded by this virus have been assumed to play a major role in the 
activation of resting lymphocytes (Stephens et al., 1998). Animals that have survived 
the acute disease associated with SIVsmmPBj14 have shown a reduction of viraemia 
and production of antiviral-antibodies after about 2 weeks (Fultz, 1994). Attempts to 
develop prevention strategies have found that recombinant vaccines and a potent 
antiretroviral agent provided macaques with protection from lethal SIVsmmPBj14 
challenge but not from natural infection (Hodge et al., 1999; Mossman et al., 1996).   
Immune response to lentivirus infections  
There are 2 main types of immune response to virus infections, involving the innate 
and adaptive immune systems (Cotran et al., 1999; Flint et al., 2000). The adaptive 
immune response can be humoral or cell-mediated, both of which seem important in 
lentivirus infections. The innate immune system can be activated within hours of 
infection and is the body’s first response to the virus. This system produces 
interferons, complement and inflammatory responses (Cotran et al., 1999). 
Interferons at this stage have many roles: they induce an antiviral state in 
neighbouring cells that inhibit virus replication and enhance clearance of infected 
cells by activating the complement cascade, natural killer cells (NK), dendritic cells,   39 
macrophages, neutrophils and eosinophils, and releasing innate cytokines (Levy, 
2001). In contrast to the innate immune system, the adaptive immune response is 
highly specific for a particular pathogen and takes longer to reach optimal activity 
(Roitt et al., 2001a). The longer time is required for activation of APC before the 
process of differentiation and maturation of the cell-mediated and humoral immune 
responses. 
Perturbations of the immune system are a consequence of many lentivirus infections 
and can affect the virus-specific immune response. One example is the lack of a 
virus-specific humoral immune response seen in rapid progressors that can occur in 
HIV and SIV infections (Dykhuizen et al., 1998; Michael et al., 1997; Zhang et al., 
2007). Another example is the late development of an antibody response seen in JDV 
infections in Bali cattle (Hartaningsih et al., 1994; Wareing et al., 1999) presumably 
due to the extensive early lesions in lymphoid tissues. A poor or minimal 
neutralising antibody response to HIV-1 can be a problem, permitting superinfection 
(Smith et al., 2006), or even when there is a robust neutralising antibody response 
this may fail to protect against infection with heterologous virus isolates (Blish et al., 
2008; Yeh et al., 2009).  
Cytokines produced by sensitised lymphocytes in response to lentivirus infections 
appear to have a significant role in the disease process associated with many 
lentiviruses. Lentivirus-infected cells and especially macrophages secrete pro-
inflammatory cytokines such as interleukin 1 (IL-1) and tumour necrosis factor-alpha 
(TNF-α) that tend to trigger clinical signs. They cause neural impairment at the late-
stage of HIV and in SIV infections, by stimulating infiltration of macrophages into 
the central nervous system (CNS) and inducing production of neurotoxic substances 
(Orandle et al., 2001; Sopper et al., 1996; Xiong et al., 2000). In animals infected 
with virulent virus strains of EIAV, the activated macrophages predominantly 
produce pro-inflammatory cytokines such as IL-1α, IL-1β, IL-6 and TNF-α (Lim et 
al., 2005). These cytokines are responsible for fever, anorexia and hypermetabolism 
leading to the wasting diseases that are commonly seen in HIV-induced AIDS 
(Chang et al., 1998). The mechanism by which the cytokines enhance in vivo virus 
replication include the recruitment of uninfected monocytes to the site of viral 
replication as found in HIV-1 and SIV (Schmidtmayerova et al., 1996; Zink et al., 
2001), stimulation of an adhesion molecule that encourages monocyte migration into   40 
tissues (Sampson et al., 2002), and the induction of viral activating molecules by 
non-monocytic cells as found in EIAV infection (Lim et al., 2005). Macrophages 
also secrete other cytokines and chemokines including IFN-type 1, RANTES, and 
macrophage inflammatory proteins-1α and 1β that regulate the replication of HIV in 
macrophages and CD
+4 T-cells (Fauci, 1996; Vicenzi et al., 1997). 
Many lentivirus infections have a direct or an indirect affect on CD4
+ and CD8
+ T-
cell populations, in the process affecting the production of cytokines. The kinetics of 
cytokine response in FIV, SIV and HIV infections and the level of their production is 
correlated with the development of clinical signs (Dean and Pedersen, 1998). CD4
+ 
T-cells, following contact with viral epitopes presented by MHC class II, secrete 
cytokines that promote the development of antigen-specific responses by both B and 
CD8
+ T- cells (Battegay et al., 1994; Clerici et al., 1994; DeKruyff et al., 1993). In 
FIV infections, activated CD4
+ T-cells release predominantly IL-2, IL-4, IL-10 and 
IFN-γ (Dean and Pedersen, 1998) but CD
+8 T-cells are also a source of IFN-γ (Dean 
and Pedersen, 1998; Maggi et al., 1997). In early HIV-1 infections, viral replication 
is also controlled by virus-specific CD8
+ T-cells (Pantaleo et al., 1997b).  
A cytotoxic response by activated CD8
+ cells (cytotoxic T-cells; CTL) is critical in 
controlling viral replication. For example, the response to viral core proteins is 
associated with slower disease progression (Klein et al., 1995; Pantaleo et al., 
1997b). CD8
+ T-cells inhibit virus replication by recognising and killing infected 
cells before completion of the virus replication cycle and the release of new virions 
(Mandl et al., 2007). Soluble factors secreted by CD8
+ T-cells include antiviral 
factors and cytokines that interfere with viral transcription and viral entry, 
respectively, and these are strongly associated with HIV non-progressive forms of 
HIV infection (Copeland et al., 1995; Zagury et al., 1998). Moreover, specific CD8
+ 
T-cell proliferation was associated with perforin expression that was maintained in 
nonprogressors (Migueles et al., 2002). However due to clonal exhaustion at later 
stage of disease the process, the HIV-specific CTL population decreases rapidly 
contributing to the inability of the immune system to control viral replication and 
spread of the virus (Pantaleo et al., 1997a). In order to investigate a candidate for 
anti-HIV-1 live-attenuated vaccines, gene-mutated HIV-1/SIV chimeric viruses were 
generated by recombination between HIV-1 and SIVmac genomes (Haga et al., 1998; 
Hayami and Igarashi, 1997). The infection of the chimeric virus in naïve macaques   41 
was associated with a depletion of CD8
+ T-cells, resulting in the inability of 
macaques to clear infection and led to a high plasma viral load, indicating that CD8
+ 
T-cells were actively involved in controlling the acute phase of primate lentivirus 
infections (Jin et al., 1999; Matano et al., 1998).   
The humoral immune response is also important in controlling viral replication and 
this response is initiated by the presentation of antigens to immature B-lymphocytes 
that then develop into plasma cells secreting antibody. There are 5 classes of 
antibodies IgA, IgM, IgD, IgE and IgG, all of which have different antigen binding 
properties (Roitt et al., 2001a) and only 3 of the Ig classes appear important in viral 
infections: IgA involved in mucosal viral defence, IgM responsible for early viral 
agglutination and activation of the complement cascade, and IgG with a major role in 
viral clearance (Cavacini et al., 2003). The majority (about 75%) of all antibodies 
present in plasma are IgG subclasses that are released predominantly after 
consecutive exposure to an antigen. Although there are 4 IgG subclasses (IgG1, IgG2, 
IgG3 and IgG4), IgG1 is the most abundant in human infections (Flint et al., 2000; 
Roitt et al., 2001a). Although the nomenclature describing human IgG subclasses is 
also used for bovine IgG subclasses, they may not necessarily be the same as the 
human equivalents. The presence of specific IgG subclasses has been correlated with 
the presence of certain types of cytokines, for example, in vitro studies have shown 
that the addition of IFN-γ (a Th1 cytokine) to stimulated bovine B-lymphocytes 
increased the turnover of IgG2 mRNA and reduced the turnover of IgM and IgG1 
mRNA, suggesting that IFN-γ controlled IgG2 production at the transcriptional level. 
In contrast, the addition of IL-4 (a Th2 cytokine) to stimulated bovine B 
lymphocytes enhanced the release of IgG1 (Estes, 1996).   
Neutralising antibody activity, while critical in controlling many virus infections, has 
a less obvious and uncertain role in lentivirus infections. In HIV-1 infections, IgG1 
and IgG3 are involved in binding and neutralisation of virus, and essentially all 
neutralising antibodies are directed toward the envelope proteins, particularly gp120 
(Cavacini et al., 2003; Parren et al., 1997; Rusche et al., 1988; Wyatt and Sodroski, 
1998). HIV-specific antibodies are detectable in plasma of HIV-infected individuals 
within a few weeks of infection, but generally do not control viraemia (Aasa-
Chapman et al., 2004; Binley et al., 1997) although several recent reports have 
indicated that neutralisation activity found within weeks of infection is associated   42 
with early viral clearance (Frost et al., 2005; Richman et al., 2003; Wei et al., 2003). 
The neutralising antibody response improves with time and broader neutralisation 
activity against heterologous viral strains is found in chronic infections (Moog et al., 
1997; Pilgrim et al., 1997). High levels of neutralising antibody have been detected 
in some long-term nonprogressors (Aasa-Chapman et al., 2004; Cao et al., 1995; 
Pilgrim et al., 1997; Zhang et al., 1997b). However, this non-progressor condition is 
not universal, and it is possible that the neutralising antibody response may 
contribute to inhibition of HIV replication in long term infections in some patients 
while not protecting against HIV superinfection in most patients (Bailey et al., 2006; 
Deeks et al., 2006). There was a strong correlation between the presence of a broadly 
cross-neutralising antibody response and non-progression to an AIDS-like syndrome 
in cynomolgus macaques infected with SIVsm, indicating the important potential of 
neutralising antibodies to control viraemia in at least some lentivirus infections 
(Lauren et al., 2006). 
Despite the comprehensively documented in vivo and in vitro activity of neutralising 
antibodies, some HIV isolates are highly resistant to neutralisation and this has been 
attributed to several factors. It has been attributed to the inaccessibility of antibody 
binding sites of the native Env complex (Moore et al., 1995; Wyatt and Sodroski, 
1998; Zhu et al., 2006). It has been attributed to the variability of gp120, which 
allows new genotypes of HIV to escape neutralising antibodies produced in response 
to previous genotypes (Burton et al., 2004; Frost et al., 2005; Richman et al., 2003; 
Wei et al., 2003; Wyatt and Sodroski, 1998).  Similarly in JDV infection, recovered 
animals resist challenge with homologous and heterologous strains suggesting the 
production of neutralising antibodies (Hartaningsih et al., 1994; Soeharsono et al., 
1990) but it could be due to other immunological events. In Jembrana disease, the 
acute stage is associated with a significant reduction of peripheral blood 
lymphocytes and antibody production is delayed until about 11 weeks after infection 
(Dharma et al., 1994; Hartaningsih et al., 1994; Wareing et al., 1999). This suggests 
that T-cells may play an important role in controlling viral replication (Soeharsono et 
al., 1990). A significant reduction of the CD4
+:CD8
+ T-cell ratio in lymphoid tissues 
in the febrile and immediate post-febrile phase of Jembrana disease was reported 
(Dharma et al., 1994) suggesting that CD8
+ cells, increased during this phase and   43 
may be involved but further studies of the lymphocyte response during Jembrana 
disease are required to determine this.    44 
Chapter 3  
Histological and immunohistochemical characterisation of 
experimentally induced Jembrana disease in Bali cattle  
 
 
Summary  
The principal lesions during Jembrana disease are detected mainly in the lymphoid 
system with a non-follicular proliferation of lymphocytes and these changes are 
associated with immunological effects including a delayed humoral response to the 
virus and transient immunosuppression. Histological and immunological studies 
were conducted to further characterise the cellular responses to the virus infection. 
The major histological changes during the febrile and early post-febrile phase were 
characterised by severe attenuation of follicles with depletion of the germinal centres 
and expansion of the parafollicular T-cell zone by proliferation of centroblast-like 
cells. JDV CA protein was detected primarily in these proliferating centroblast-like 
cells, and as they were morphologically similar to IgG-containing cells, the results 
suggested the main target of JDV was IgG-producing cells and not T-cells. Further 
studies utilising double-immunolabelling are required to confirm this.    45 
Introduction 
JDV produces a disease that is atypical of most lentivirus diseases. Infection of Bali 
cattle with JDV causes an acute and sometimes fatal disease after a short incubation 
period of 5-12 days, with clinical signs characterised by fever, depression, anorexia 
and generalised lymphadenopathy (Soeharsono et al., 1990). During the acute phase 
disease there is a high titre viraemia with about 10
8 infectious virus particles/ml of 
plasma (Soeharsono et al., 1990). Haematological changes include leukopenia, 
eosinopenia, a mild thrombocytopenia, a normocytic normochromic anaemia, 
hypoproteinaemia and elevated blood urea levels in association with kidney lesions 
(Soesanto et al., 1990). 
Pathogenesis studies of JDV infection in Bali cattle have been undertaken (Dharma 
et al., 1991; Dharma et al., 1994) but many important biological questions remain 
unanswered. Initial studies describing the target organs and location of virus infected 
cells has been published (Chadwick et al., 1998) but comprehensive information 
regarding the location and identity of JDV-infected cells in infected organs is needed 
to facilitate a better understanding of the pathogenesis of JDV infection.  
Identification of target cells has played an important role in understanding the 
pathogenesis of many virus infections and of special value for this has been the use 
of immunoassays for detecting virus-specific antigens in tissue of infected animals, 
thereby enabling identification of the location of the target cells and their distribution 
in infected tissues. The availability of specific cell markers together with the 
development of fixation and antigen retrieval procedures with formalin-fixed, 
paraffin wax-embedded tissues, and improvement in immunolabelling kits, has 
increased the application and sensitivity of these tests (Gutierrez et al., 1999; Niku et 
al., 2006; Rathkolb et al., 1997).  
In this Chapter, histological and immunohistological studies to characterise JDV-
positive cells and other cells types in infected organs are described.  Tissues obtained 
during the febrile and immediate post-febrile phases of the infection were tested, to 
provide comprehensive data related to the distribution and kinetics of the cellular 
response to JDV infection.   46 
Materials and methods  
Experimental animals  
Bali cattle used in the experimental studies were female, approximately 12 months of 
age and weighed 80-100 kg. They were obtained from Nusa Penida, a small island 
adjacent to Bali, where Jembrana disease has never been reported and where 
antibodies to JDV have not been detected (Hartaningsih et al., 1994). Cattle 
purchased from the island have consistently developed clinical signs of Jembrana 
disease when infected with JDV (Soeharsono et al., 1990). Animals for these 
experiments were transported to Bali island to the Disease Investigation Centre 
Region VI Denpasar Bali. On arrival, they were sprayed with insecticide, kept in an 
insect-proof house and given water and elephant grass (Penecetum purpureum) ad 
libitum. Prior to use, all cattle were pre-treated with a broad spectrum antibiotic 
(oxytetracycline) at a dose rate of 5 mg/kg bodyweight for 3 consecutive days, a 
broad spectrum anthelmintic, and they were vaccinated against haemorrhagic 
septicaemia. Before inoculation with JDV, the absence of antibody to JDV was 
confirmed by ELISA test using a JDV recombinant CA antigen as described 
previously (Burkala et al., 1998). 
Experimental design and infection with JDV 
Two Bali cattle were infected with JDV and euthanised and sampled on the second 
day of the resulting febrile reaction. Five cattle were infected with JDV and 
euthanised and sampled 5-6 days after recovery from the febrile phase. Two cattle 
that had previously been infected with BIV-R29 as part of another experiment and 
housed separately were euthanised 42 days after BIV infection (Table 3.1) and used 
as controls. A total of 27 different tissues representing various organ systems were 
collected from all animals (Table 3.2). 
   47 
Table 3.1. Animals and stage of infection when they were euthanised for tissue 
collection. 
Animals  Virus infection  Time sampled 
CB10, CB212  JDVTab/87  Febrile phase  
(2
nd day of febrile reaction) 
CB203, CB205, 
CB206, CB208, 
CB.210  
JDVTab/87  Post-febrile phase 
(5-6 days after febrile phase) 
CB198, CB199  BIV-R29  42 days after infection 
 
 
Table 3.2. Tissues collected from experimental animals.  
Organ systems  Type of tissues 
Central nervous  Cerebrum 
Respiratory   Lung 
Digestive   Pancreas, liver, rumen, reticulum, omasum, abomasum, 
duodenum. jejunum, ilium and colon 
Lymphoreticular   Spleen, lymph nodes (prescapular, retropharyngeal, 
mediastinal, mesenteric), tonsil, thymus 
Haematopoietic/ 
circulatory 
Heart and bone marrow 
Reproductive   Ovaries, uterus and mammary glands 
Urinary   Urinary bladder, kidneys and adrenal cortex 
 
 
Animals were infected with an estimated 10
3 ID50 JDV using methods very similar to 
those described previously (Stewart et al., 2005). Briefly, to obtain infectious virus a 
donor animal was inoculated intravenously with a suspension of frozen spleen from 
an animal infected with JDVTab/87.  On the second day of the resulting febrile   48 
reaction, blood was removed and an approximate titre of infectious virus in the 
plasma was determined by an antigen-capture ELISA (Stewart et al., 2005). The 
plasma was then diluted to provide an estimated 10
3 ID50/ml and 1 ml was inoculated 
intravenously into the experimental cattle.  
Cattle were infected with the R29 strain of BIV as described previously (McNab et 
al., 2010).  
Clinical signs in all cattle were recorded daily until the animals were killed for tissue 
collection. 
Gross-pathological observation and sample collection  
At necropsy examination, all fresh tissue samples listed in Table 3.2 were cut to an 
approximate 2 x 1 x 0.5 cm size and fixed in 10% neutral-buffered formalin pH 7.5 
for 48-72 h. After further trimming, the tissues were then processed using an 
automatic tissue processor (Tissue Tek II) and embedded in paraffin wax. Sections 
of 4 µm thickness were cut from the formalin-fixed-paraffin wax-embedded tissues 
and these were mounted on silane coated glass slides (ProSciTech) and stored in 
incubator at 37
O C for not more than 3 days to ovoid tissue oxidation. Tissue sections 
were stained with haematoxylin and eosin (H&E) by standard procedures. 
All sections were viewed using an Olympus BX51 photomicroscope and images 
were acquired using an Olympus DP 70 camera and associated Olympus DP 
controller software. 
Immunohistochemical examinations 
Source and characteristics of antibody reagents  
A monoclonal antibody BD2 (mAb BD2) against JDV CA was produced by the 
Animal Virology Group, Murdoch University. Polyclonal rabbit anti-human CD3 
(DakoCytomation) and monoclonal mouse anti-human CD79αcγ (DakoCytomation), 
monoclonal mouse anti-human MAC 387 that binds to a 34kDa protein, mb-1, a 
member of the B-cell antigen receptor complex (DakoCytomation), were reported to 
be reactive in formalin-fixed bovine tissues that were subjected to microwave pre-
treatment (Gutierrez et al., 1999; Niku et al., 2006). Reactive antibodies were 
detected with a LSAB 2 system-HRP (DakoCytomation) that contained biotin-  49 
labelled affinity isolated goat anti-rabbit and goat anti-mouse immunoglobulins 
coupled with streptavidin conjugated to peroxidase and used in conjunction with the 
chromogen 3-3’ diaminobenzidine (DAB) for colour development. Polyclonal rabbit 
anti-bovine IgG was obtained from Jackson ImmmoResearch. The reactivity and 
properties of the antibodies used are summarised in Table 3.3. Normal mouse serum 
from adult Balb/C mice was used at a dilution of 1:50 as a negative control. 
 
Table 3.3. Summary of antibodies used for immunolabelling.  
Antibody  Antigen specificity  IgG isotype  Reactivity 
in cells 
Antibody 
concentration 
MAb BD2  JDV capsid (CA)   IgG1 kappa  Cytoplasmic  N/A 
Anti-human 
CD3 (F7.2.38) 
T-cell  N/A  Surface nor 
cytoplasmic 
0.6 mg/ml 
CD79αcγ 
(HM57) 
B-cell  IgG1 kappa  Cytoplasmic  0.25 mg/ml 
MAC387  Macrophage  IgG1 kappa  Cytoplasmic  0. 375 mg/ml 
Rabbit anti-
bovine IgG 
Whole molecule 
bovine IgG  
    2.4 mg/ml 
 
Immunoperoxidase labelling 
Immunoperoxidase labelling was performed on tissue sections as previously 
described by Niku et al. (2006) with slight modification. Briefly, slides containing 
sequential tissue sections (one for a positive reaction and the other as a negative 
control) were heated 3 times for 3 min each time with 3 min between treatments with 
a hair dryer to ensure firm adhesion of the tissue to the glass slide. The tissues were 
then dewaxed by treatment with xylene and were then hydrated by immersion in an 
alcohol gradient (absolute, 95%, 70%) and finally water. The slides were then 
immersed in Tris-EDTA buffer (10 mM Tris, 0.1 mM EDTA, pH 9.2) in a plastic jar 
and then microwaved (2 times for 4 min at 805 W and 2 times for 4 min at 230 W 
with 1 min between each period of microwaving). The slides were then cooled by 
placing them in distilled water at room temperature. The sections were then treated   50 
with 3% H2O2 in distilled water for 5 min to block endogenous peroxidise, then 
washed an additional 3 times with distilled water. The 2 tissue sections on each slide 
were circled using a wax pencil and 200 µl of primary antibody diluted in phosphate 
buffered saline (PBS) pH 7.2 containing 10% new born calf serum (NBCS) was 
added to the positive tissue sections, and PBS containing 10% NBCS to the control 
section. The dilution of antibody and time of incubation varied for each antibody and 
was determined by a series of preliminary experiments: MAb BD2 was diluted 1:200 
and incubated for 30 min, the CD79αcγ (B-cell marker) was diluted 1:200 and 
incubated for 15 min, anti-human CD3 (T-cell marker) was diluted 1:50 and 
incubated for 30 min, and the anti-bovine IgG was diluted 1:1000 and incubated for 
30 min. After incubation with the primary antibody, the slides were then washed 3 
times with PBS. Two drops of biotinylated secondary antibody were then added to 
the sections and incubated for 15 min. The slides were again washed 3 times with 
PBS, and then 2 drops of peroxidase-labelled streptavidin was added to the slides 
and incubated for 10 min. After a further 3 washes with PBS the colour reaction was 
developed by adding 3-3’diaminobenzidine (DAB) for 3-5 min. The slides were then 
washed with distilled water, then the sections were lightly counterstained with 
Mayer’s haematoxylin. The slides were then dehydrated in absolute ethanol, cleared 
with xylene and permanently mounted with DPX mounting medium before being 
examined by light microscopy. Negative controls were provided by omitting either 
the primary antibodies or secondary antibodies. 
 
Results  
Clinical signs and gross pathological findings 
All JDV-infected cattle developed typical clinical signs of Jembrana disease: a 
transient increase in rectal temperature (commencing 9.86 ± 4.4 days after infection 
and persisting for 4.6 ± 2.3 days), anorexia, lethargy and a concurrent leucopenia 
(data not shown). Animals CB10 and CB212 that were euthanised on the second day 
of fever had very similar gross pathological changes including an enlarged spleen 
(Figure 3.1), moderate diffuse lymphadenomegaly, moderate lung consolidation in 
apical and cardiac lobes, and some haemorrhages in visceral organs. Animals 
CB203, CB205, CB206, CB208 and CB210 that were euthanised 5-6 days after the   51 
resolution of fever had no macroscopic abnormalities. No gross pathological lesions 
were found in the control animals, CB198 and CB199, that had been infected with 
BIV 42 days previously. 
 
 
 
 
Figure 3.1. JDV-infected animal euthanised on the second day of the febrile reaction 
showing characteristic enlargement of the spleen to approximately 5 times normal 
size. 
 
 
Histological examination 
A range of tissues from 7 Bali cattle that were experimentally infected with JDVTab/87 
were stained with H&E and examined for histological changes and immunolabelled 
to identify JDV-infected cells, B-cells, T-cells and macrophage/monocytes.  
Histological changes during febrile phase 
Tissues prepared from animals on the second day of the febrile reaction showed 
typical microscopic changes of Jembrana disease.  
In the spleen the lymphoid follicles were severely attenuated with depletion and 
collapse of the germinal centre leaving focal aggregates of remnant mantle (dark 
zone) cells. The marginal zone (light zone) and periarteriolar lymphoid sheath were 
replaced by a population of medium sized pleomorphic round cells arranged in 
effacing sheets, leaving depleted remnants of the germinal centre and mantle zone 
(Figure 3.2A). These conditions were not observed in tissues prepared from control,   52 
BIV-infected animals (Figure 3.2B). Many pleomorphic cells were observed 
infiltrating the parafollicular zone (red pulp), aggregating around penicilliary arteries 
and disseminated loosely throughout the red pulp. These pleomorphic cells were 
observed to have variable amounts of intensely basophilic cytoplasm, marked 
anisokaryosis with bizarre coarsely clumped chromatin, thus resembling centroblasts 
(Figure 3.3A) and they were not detected in tissue of BIV-infected control animals 
(Figure 3.3B). There were scattered apoptotic bodies and some mitotic cells. The 
periphery of the marginal zone (parafollicular zone) was demarcated by a 
circumferential ring of neutrophils.   
 
  
 
Figure 3.2. Spleen tissue from a JDV-infected animal on the second day of febrile 
reaction (A) and from control animal (B). There was a severe attenuation of follicles 
with depletion and collapse of the germinal centres. The depleted and normal 
follicular germinal centres are shown (arrow). H&E stain, 10X magnification).  
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Figure 3.3. Paracortical area of spleen tissue from a JDV-infected animal on the 
second day of febrile reaction (A) and from a control animal (B). There was an 
abundant population of pleomorphic centroblast-like cells in JDV-infected tissue, 
mixed with a low number of small dark lymphocytes. Long arrows and short arrows 
point to representative pleomorphic centroblast-like cells and small dark 
lymphocytes, respectively. H&E stain, 100X magnification.  
 
 
Lymph nodes displayed a consistent set of changes although the severity of the 
lesions varied within and between lymph nodes from different anatomical locations 
(Figure 3.4). The germinal centre of the follicles was depleted and the remnant 
mantle zone was surrounded by a wide zone of pleomorphic centroblast-like cells 
arranged in densely packed sheets that coalesced to efface the outer cortex. The 
pleomorphic centroblast-like cells were found surrounding large endothelial venules, 
filling the outer section of medullary cords, and infiltrating the surrounding cortex. 
There were a few pleomorphic centroblast-like cells in medullary sinuses. The lumen 
of large endothelial venules was often filled with neutrophils. Sometimes 
subcapsular sinuses and medullary sinuses were expanded by oedematous fluid.  
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Figure 3.4. Mesenteric lymph node (A) and a prescapular lymph node (B) from a 
JDV-infected animal on the second day of the febrile reaction, showing depletion of 
follicular germinal centres. Arrows indicate representative depleted follicles. H&E 
stain, 10X magnification. 
 
In the liver, scattered portal areas were expanded by infiltrates of mononuclear cells, 
including many pleomorphic centroblast-like cells.  
In the kidney tissue of one (CB212) of the 2 animals, the interstitium surrounding 
some medium sized blood vessels was moderately expanded by a mononuclear cell 
infiltrate.  
In the heart occasional vessels had a perivascular infiltrate of mononuclear cells.  
In the bone marrow, there was a marked diffuse depletion of haematopoietic tissue, 
with a prominent lack of the myelocytic lineage storage pool band and segmented 
neutrophils. There were a few scattered pleomorphic centroblast-like cells in 
sinusoids.  
In the thymus there was a severe diffuse depletion of the cortex with loss of cortical 
thymocytes, leaving a collapsed stroma.   
In the lungs there was a mild diffuse expansion of the alveolar septa by fibrinous 
exudate, with some pleomorphic centroblast-like cells in the alveolar septa.  
In the pancreas, aggregates of leucocytes were seen trapped in post-mortem blood 
clots within the lumen of medium to large diameter blood vessels in the pancreas. 
Some of the trapped circulating cells were pleomorphic centroblast-like cells. 
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No lesions were observed in the brain, adrenal, uterus, ovaries, mammary, urinary 
bladder, or the alimentary tract. Peyer’s patches were small when present and could 
not be adequately examined in the tissues that were collected.  
Histological changes in early post-febrile phase 
In JDV-infected animals 5-6 days after the resolution of fever, there were no 
macroscopic abnormalities but there were a spectrum of microscopic lesions with a 
similar pattern of changes in all cattle.  
In the spleen there were reduced numbers of follicles and the remaining follicles 
were variably attenuated, ranging from loss of the germinal centres and marginal 
zones leaving a remnant focal aggregation of mantle (dark zone) cells to depletion of 
the germinal centres and moderate expansion of the mantles. The marginal zone of 
severely affected follicles was populated by moderate numbers of centroblast-like 
cells and some tingible body macrophages. In the marginal zone of less severely 
affected follicles, there were a few centroblast-like cells but more apoptotic bodies 
and tingible body macrophages. The periarteriolar lymphoid sheaths were populated 
by sheets of small lymphocytes mixed with variable numbers of centroblast-like 
cells, apoptotic cells and tingible body macrophages. The parafollicular zone was 
loosely populated by neutrophils.  
The lymph nodes of the recovered animals were similar to those of the febrile 
animals. The germinal centre of lymphoid follicles was depleted and the mantle zone 
was surrounded by a zone of pleomorphic centroblast-like cells. A striking 
difference, however, was that the corticomedullary junction was indistinct due to 
expansion of the paracortex by densely packed sheets of small dark lymphocytes. 
These were often mixed with many tingible body macrophages that were observed to 
have infiltrated and replaced the centroblast-like cells surrounding the follicles and 
populating the medullary cords. In some lymph nodes, the mantle zone of the 
follicles was expanded and some follicles had a sheet of centroblast-like cells 
occupying the germinal centres, characteristic of early reactive hyperplasia.  In the 
thymus, the cortex was observed to be normal to mildly hyperplastic with loosely to 
densely packed sheets of small dark lymphocytes.   56 
The haematopoietic tissue in the bone marrow was normocellular to hypercellular 
with a predominance of immature myeloid lineage cells with 10-20 % band 
neutrophils but no segmented neutrophils, indicative of a regenerative hyperplasia.  
There were multifocal perivascular mononuclear infiltrates in the kidneys.  
No lesions were apparent in other organs. 
Distribution of JDV CA in tissues during febrile phase 
JDV CA was detected in spleen tissues on the second day of the febrile phase and the 
distribution of immunolabelled cells was similar in the 2 animals (Figure 3.5A) and 
was not detected  in tissues from BIV-infected control cattle (Figure 3.5B). In the 
spleen, numerous large pleomorphic cells with strong cytoplasmic labelling were 
disseminated throughout the red pulp, largely sparing lymphoid follicles and 
periarteriolar lymphoid sheaths. The JDV CA-positive cells were large pleomorphic 
cells with eccentric nuclei and resembled plasma cells and contained dark brown 
intracytoplasmic labelling (Figure 3.6A). The morphology of the cell type involved 
and the distribution of the immunoreactivity within the cells was similar to the 
morphology and distribution of IgG-containing cells (Figure 3.6B), although the 
JDV-CA labelling reaction was much stronger than the reaction with IgG.  
 
  
Figure 3.5. Spleen tissue from a JDV-infected animal on the second day of febrile 
phase (A) and from a control animal (B), both reacted with anti JDV CA MAb. JDV 
CA-containing cells (dark brown labelling) were prominent in the JDV-infected 
tissues (A) but not in the BIV-infected tissue (B). Immunoperoxidase labelling, 10X 
magnification. No labelling was detected when tissues were reacted with normal 
mouse serum or when reaction with the primary antibody was omitted. 
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Figure 3.6. Spleen tissue from a JDV-infected animal on the second day of the 
febrile reaction, reacted with JDV CA MAb (A) and with polyclonal anti bovine IgG 
(B). The cells containing JDV CA were morphologically similar to those containing 
IgG: in both cases there was dark brown intracytoplasmic labelling of large cells 
with eccentric nuclei. Immunoperoxidase labelling, 100X magnification. No 
labelling was detected when tissues were reacted with normal mouse serum or when 
reaction with the primary antibody was omitted. 
 
 
In the lymph nodes and tonsils there were variable numbers of large JDV CA-
containing pleomorphic cells throughout the medullary cords, morphologically 
similar to those detected in spleen. There were fewer of these immunolabelled cells 
in the cortex and medullary sinuses and they were largely absent in the follicles. 
Occasionally, JDV CA was detected in cells in the lumen of large endothelial 
venules.  
In the liver, JDV CA was detected in many cells in the mononuclear cell infiltrates in 
the portal areas of the liver. A few JDV CA-containing cells were also scattered 
randomly throughout the sinusoids, and were also detected in the lumen of blood 
vessels (Figure 3.7).  
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In the lungs, JDV CA was mainly detected in cells in the alveolar septa, and 
sometimes in the lumen of large blood vessels.  
The kidney contained multifocal perivascular mononuclear cell infiltrates with a few 
JDV CA-positive cells and with low numbers of JDV CA-positive cells in the lumen 
of glomerular and interstitial capillaries.  
In the heart, the multifocal perivascular mononuclear infiltrates also contained many 
cells with intracytoplasmic JDV CA.  
In the bone marrow there were some cells containing JDV CA scattered diffusely 
throughout the sinusoids.  
In all other tissues, including the thymus, there were rare JDV CA-containing cells 
within the lumen of vessels.  
The characteristic reaction and the distribution of JDV-positive cells in a number of 
different tissues are presented in Figure 3.8 A-L, and the results are summarised in 
Table 3.4. 
 
 
 
 
 
 
 
 
 
 
Figure  3.7. Liver tissue section from JDV-infected animal on the second day of the 
febrile reaction, reacted with anti MAb BD2 against JDV CA, showing reactive cells 
in the sinusoids and lumen of a blood vessel (arrow). Immunoperoxidase labelling, 
40X magnification. 
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Figure 3.8. Representative tissue sections from JDV-infected animals on the second 
day of febrile reaction, reacted with MAb BD2 against JDV CA. JDV CA-positive 
cells were detected in a wide range of different tissues: A, spleen; B, prescapular 
lymph node; C, lungs; D, kidney; E, liver; F, bone marrow; G, ovary; H, uterus; I, 
retropharyngeal lymph node; J, mediastinal lymph node; K, mesenteric lymph node; 
L, heart. Immunoperoxidase labelling, 20X magnification. 
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Table 3.4. Summary of the distribution of JDV CA in tissues collected from 2 
animals (CB10 and CB212) on the second day of the febrile reaction, determined 
using an immunoperoxidase procedure with MAb BD2 against JDV CA. Results 
were indistinguishable in the 2 animals. 
Organ systems  Type of tissues   Results 
Lymphoid  Spleen 
Superficial lymph node 
Mesenteric lymph node 
Retropharyngeal lymph node 
Mediastinal lymph node 
Thymus 
Tonsil 
+++ 
++ 
++ 
++ 
++ 
++ 
+ 
Respiratory  Lungs  ++ 
Digestive  Rumen 
Omasum 
Abomasum  
Intestine 
Liver 
Pancreas 
+ 
+ 
+ 
+ 
+ 
+ 
Urinary  Adrenal cortex and kidneys  + 
Haematopoietic/circulation  Bone marrow and heart  + 
Reproductive  Ovaries and uterus  + 
Nervous   Cerebrum  - 
Positive (+) and negative (-) reactions were scored by qualitatively observing about 
100 positive cells on 20X magnification: +++, very strong reaction (≥100 cells per 
microscope field); ++, strong reaction (50-100 cells per microscope field); +, weak 
reaction (≤50 cells per microscope field); - ,no positive cells. 
 
 
Distribution of B-cells in tissue during febrile phase 
In the spleen, B-cells were identified using the CD79αcγ MAb that produced dark 
brown intra-cytoplasmic labelling in reactive cells that were pleomorphic and 
centroblast-like and located in the marginal zone and periarteriolar lymphoid sheath 
of the spleen (Figure 3.9). In the lymph nodes and tonsils, similar pleomorphic   61 
centroblast-like cells were observed within and surrounding the follicles, populating 
the cortico-medullary portion of medullary cords and in the paracortex. Similar cells 
were detected in the perivascular mononuclear infiltrate in the liver, kidney and 
heart, and megalokaryocytes and some round cells in the sinusoids of the bone 
marrow were also positive. 
 
 
 
Figure 3.9. Spleen tissue section from JDV-infected animal on the second day of the 
febrile reaction, reacted with anti-human CD79αcγ (a B-cell marker). Note the 
CD79αcγ
+ cells containing dark brown cytoplasmic labelling, around a depleted 
follicle. Immunoperoxidase labelling, 40X magnification.  
 
 
Distribution of T-cells in tissue during febrile phase 
In the spleen, T-cells that were identified by the presence of CD3 in the cytoplasm 
and cell surface, were unexpectedly scarce in the periarteriolar lymphoid sheaths due 
to apparent replacement by the pleomorphic centroblast-like B-cells (Figure 3.10). In 
the paracortex of lymph nodes and the tonsil there were multifocal but variably 
poorly demarcated islands of T-cells between the sheets of pleomorphic centroblast-
like cells.    62 
 
 
Figure  3.10. Spleen tissue section from a JDV-infected animal on the second day of 
the febrile reaction reacted with anti-human CD3, a T-cell marker. Note the scarce 
(relative to those detected in the post-febrile phase) population of CD3
+ cells (dark 
brown) in the periarteriolar lymphoid sheaths of a depleted follicle (arrow). 
Immunoperoxidase labelling, 10X magnification.  
 
 
Distribution of cells of monocyte/macrophage lineage in tissue during febrile 
phase 
Cells of the myelomonocytic lineage including granulocytes, circulating monocytes 
and a subset of (recent tissue emigrant) macrophages were identified using MAb 
MAC387. The majority of immunolabelled cells were identified as neutrophils on 
the basis of their segmented nuclei. Typically, a ring of neutrophils was observed 
surrounding the follicular mantle zone in the spleen (Figure 3.11) and the lumen of 
some large endothelial venules also contained neutrophils. Using serial sections, the 
distribution of these cells in other lymphoid compartment during the febrile phase of 
disease was less and differed to the distribution of cells that reacted with CD3, 
CD79αcγ and JDV CA MAb (Figure 3.12A-D). 
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Figure 3.11. Spleen tissue section from a JDV-infected animal on the second day of 
febrile reaction reacted with anti-human monoclonal antibody, MAC387. MAC387
+ 
cells are indicated by dark brown labelling and they were predominantly detected 
around the follicular mantle zone (arrow). Immunoperoxidase labelling, 10X 
magnification. 
 
      
     
Figure 3.12. Serial sections of a mesenteric lymph node from a JDV-infected animal 
on the second day of febrile reaction reacted with anti JDV CA MAb (A), anti-
human CD3, a T-cell marker (B), anti-human CD79αcγ, a B-cell marker (C) and 
anti-human MAC387 (D). The distribution patterns of the JDV CA-containing cells 
was generally different to the distribution of the CD3
+ cells and the MAC387
+ cells, 
but similar to the distribution of the CD79αcγ
+ cells. Immunoperoxidase labelling, 
10X magnification. 
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Distribution of JDV CA in tissues during early post-febrile phase 
In contrast to the febrile phase, viral antigen was not detected in tissues prepared 
from cattle euthanised during the post-febrile phase.  
Distribution of B-cells in tissues during early post-febrile phase 
CD79αcγ
+ B-cells were identified in follicular mantles and were present in low 
numbers as centroblast-like cells surrounding follicles, and loosely disseminated 
throughout the periarteriolar lymphoid sheaths and red pulp of the spleen. In the 
lymph nodes the remnant mantle zone of follicles was CD79αcγ
+ and there were 
moderate numbers of centroblast-like cells with cytoplasmic labelling forming loose 
remnants of the coalescing perifollicular zones and sheets in the medullary cords.  
Distribution of T-cells in tissues during early post-febrile phase 
Numbers of CD3
+ T-cells in the periarteriolar lymphoid sheaths in the spleen and the 
paracortical areas of the lymph nodes were expanded by sheets of densely packed 
CD3
+ T-cells that infiltrated amongst and replaced the CD3-negative centroblast-like 
cells. In contrast to the acute phase, a sparse population of CD3
+ T-cells was 
detected in lymphoid tissues (Figure 3.13A), an abundant  population of CD3
+ T-
cells was found in these tissues during the early post-febrile phase (Figure 3.13B).  
Distribution of cells of monocyte/macrophage lineage during early post-febrile 
phase 
The distribution of MAC387
+ cells was essentially the same as in the febrile animals, 
but the large endothelial venules of the lymph nodes were not packed with 
neutrophils as was detected during the febrile phase (data not shown). 
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Figure 3.13. Mesenteric lymph node section from a JDV-infected animal on the 
second day of febrile reaction (A) and during the post-febrile febrile phase (B), 
demonstrating the distribution of CD3
+ T-cells. A sparse population of CD3
+ T-cells 
was detected around depleted follicles during the febrile phase, but an abundant 
population of CD3
+ cells was detected in the same region during the immediate post-
febrile phase. The CD3
+ T-cells are indicated by dark brown cytoplasmic and/or cell 
membrane labelling. Immunoperoxidase labelling, 10X magnification.   
 
 
Discussion 
In the current study, typical clinical signs of Jembrana disease (Soeharsono et al., 
1995a; Soesanto et al., 1990) were induced by infection with JDVTab/87. In the 2 
control cattle that had been inoculated with BIV-R29 42 days previously there had 
been no clinical signs of infection as expected (McNab et al., 2010); these previously 
BIV-infected animals were used as controls in these current experiments to avoid the 
expense of purchasing additional non-infected cattle.  
The major histological changes during the febrile phase of the acute disease induced 
by JDV occurred in lymphoid organs and were characterised by severe attenuation of 
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lymphoid follicles, with depletion of germinal centres, and a marked parafollicular 
reaction of the lymph nodes and the non-follicular compartment of the spleen. 
Significant histological lesions were not observed in several tissues, namely the 
adrenal, uterus, ovaries, mammary, urinary bladder and the alimentary tract. The 
microscopic changes in lymphoid organs are typical of those reported previously 
(Dharma et al., 1991) and are a hallmark of Jembrana disease.  
The depletion of germinal centres during the febrile phase, a B-cell area, was thought 
to be associated with transient immunosuppression following JDV infection and the 
delayed development of antibody to the virus (Dharma et al., 1991; Dharma et al., 
1994; Hartaningsih et al., 1994; Wareing et al., 1999), similar to that reported in 
rapidly progressive SIV infection (Zhang et al., 2007). It was also thought that the 
intense proliferative changes that occurred in the non-follicular area of lymphoid 
tissues during Jembrana disease were probably associated with proliferation of T-
cells (Dharma et al., 1991). In the current studies, a marked proliferative reaction 
was also observed in the non-follicular regions but in the febrile phase the apparent 
proliferation was not due to an increase in CD3
+ T-cells but to an apparent 
infiltration of the areas with pleomorphic centroblast-like cells, which were not 
described previously (Chadwick et al., 1998; Dharma et al., 1991). The centroblast-
like cells were predominantly observed in the parafollicular zone of red pulp of the 
spleen and in the medullary cords of lymph nodes. In the non-lymphoid tissues, they 
were mainly observed aggregating around small blood vessels, indicating they were 
probably derived from the circulating blood and may have originated from lymphoid 
tissues.  
Five to 6 days after recovery from the febrile phase, a spectrum of microscopic 
lesions was still present in lymphoid tissues but they were of lesser severity and 
lesions were not detected in other organs. This change in the distribution of lesions 
and a decrease in the severity of the microscopic lesions in lymphoid tissues after the 
febrile period was also noted previously (Dharma et al., 1991). In the post-febrile 
phase, centroblast-like cells were still observed surrounding the follicles and around 
the medullary cords but their numbers were reduced and they were replaced by 
densely packed sheets of small dark lymphocytes.  
What subpopulations of CD3
+ cells were involved in the tissue changes detected was 
not determined. The polyclonal rabbit anti-human CD3 marker that was used is   67 
known to consist at least 4 different components (γ, δ, ε, ζ) with different 
distribution. In cattle, the distribution of γδ T-cells is localised to epithelial surfaces, 
particularly the skin and intestine and only 1-3% occur within lymph nodes, a 
percentage much less than the numbers of CD4
+ or CD8
+ T-cells that would be 
expected (Mackay and Hein, 1989). The dynamics of the T-cell response during the 
acute phase of Jembrana disease is interesting as, in the absence of an antibody 
response against the virus, it is probably related to a CD8
+ CTL-mediated immune 
response enabling recovery from the disease. In a previous study (Dharma et al., 
1994) changes in the lymph node follicles were associated with a decrease in the 
CD4
+:CD8
+ T-cell ratio. A further study to examine the changes in CD3
+ T-cell 
subpopulations that occur from the onset of the febrile phase and recovery is 
required to determine details of the changes occur in this period.  
There was no significant change in the number or distribution of MAC387
+ cells 
during the 2 phases of the acute disease process that were examined.  The majority of 
MAC387
+ cells appeared to be neutrophils and these cells were mainly observed 
surrounding the marginal zone of the spleen and they occurred in only low numbers 
in other organs.  
The presence of JDV CA in cells was used as an indication of JDV infection and the 
results obtained were similar to a previous study utilising the detection of virus RNA 
by ISH to demonstrate the distribution of virus in tissues (Chadwick et al., 1998). In 
both studies, the JDV-infected cells were detected predominantly in lymphoid 
organs, they were abundant in the non-follicular compartment of the spleen, and 
were  also present in the paracortex of the lymph nodes and tonsils. They also 
infiltrated around perivascular area of the liver, kidney, heart and the bone marrow, 
but their distribution in these tissues suggested whey were derived from the 
circulation and they  probably originated from the lymphoid organs. The JDV-
infected cells were morphologically consistent with the morphology of the 
pleomorphic centroblast-like cells detected in the non-follicular areas of lymphoid 
tissues especially during the febrile phase of the acute disease. The CD79αcγ B-cell 
marker reacted with these cells and IgG was detected in morphologically similar 
cells. The available evidence strongly suggests that the virus-infected cells were 
antibody-producing cells but further studies utilising double-labelling techniques are 
required to confirm this, and these studies were undertaken and are reported in   68 
Chapter 4. Both BIV and BLV have been shown to infect B-cells (Ban et al., 1993; 
Lavanya et al., 2008; Whetstone et al., 1997; Wu et al., 2003) and if confirmed in 
JDV infections it would explain the early loss of cells from the follicular 
compartments of lymphoid tissue and the delayed humoral immune response to JDV 
in infected cattle.    69 
Chapter 4 
Identification of the target cell of Jembrana disease virus in 
experimentally infected Bali cattle 
 
Summary  
A double immunofluorescent labelling method was developed to identify the subset 
of mononuclear cells in which the JDV CA protein could be detected. The protein 
was present in pleomorphic centroblast-like cells which were identified as B-lineage 
cells, possibly plasma cells, in lymphoid tissues. There was no evidence of infection 
of CD3
+ T-cells or MAC387
+ monocytes in tissues but large cells with a 
macrophage-like morphology in the lung were found to contain viral antigen, 
although they could not be conclusively shown to be productively infected. The 
tropism of JDV for mature B-cells may be relevant to the pathogenesis of Jembrana 
disease, particularly the delayed antibody responses and the genetic stability of this 
atypical lentivirus. 
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Introduction 
Experimental infection with JDV initially causes a non-follicular 
lymphoproliferative response in lymphoid organs with a loss of IgG-containing cells 
and a decreased CD4
+:CD8
+ T-cell ratio in lymphoid tissues during the febrile phase 
of the disease (Dharma et al., 1991; Dharma et al., 1994). The distribution of 
infected cells in tissues at this stage of the disease was found to be predominantly in 
the parafollicular areas of the spleen and lymph node with little or no evidence of 
infected cells in the follicles (Chadwick et al., 1998). During the febrile phase, the 
follicular architecture was found to be obliterated by proliferating cells and marked 
follicular lymphoid reactions and plasma cell formation were only observed again 
from the fifth week after infection (Dharma et al., 1991). The phenotype of the 
proliferating cells in the parafollicular regions of the lymphoid tissue during the 
febrile phase of the disease was originally suggested to be T-cells. However, in 
Chapter 3, B-lineage cells (CD79αcγ
+) were identified in the cortico-medullary 
region and were found to coalesce to efface the paracortex of lymph nodes and 
tonsils during the early stages of the febrile phase of the disease. A CD3
+ T-cell 
proliferative response was identified in lymphoid tissues in the immediate post-
febrile phase (Chapter 3).  
The cell-tropism of JDV was suggested to be lymphocytes and/or 
monocyte/macrophage lineage cells (Chadwick et al., 1998) but this has never been 
confirmed. The genetically related BIV exhibits a broad cell tropism in vivo which 
includes T-cells, B-cells and monocyte/macrophage cells although it is not clear 
whether all of these cell types are productively infected since only BIV proviral 
DNA was detected using PCR in these studies (Heaton et al., 1998; Whetstone et al., 
1997). Other experimental infection studies in cattle have reported that BIV could 
only be isolated from monocytes but not from T-cells (Onuma et al., 1992) and when 
inoculated into rabbits, BIV antigen was detected in atypical blastic mononuclear 
cells in the red pulp of the spleen, cells which were presumed to be of the 
macrophage lineage (Pifat et al., 1992). JDV strains in cattle in Bali island are 
genetically stable with little variation even in env sequences in isolates from over a 
period of 20 years (Desport et al., 2007) which could indicate that JDV has a narrow 
host cell range, potentially targeting long-lived cells with a slow turnover rate.   71 
Attempts to culture JDV in cell lines that support BIV infection have been 
unsuccessful and only in vitro cultivation of bovine mononuclear cells derived from 
peripheral blood could be shown to transiently support JDV replication when 
inoculated with plasma from infected cattle (Wilcox et al., 1992).  
Perturbations of the immune system are a consequence of many lentiviral infections 
and a hallmark of Jembrana disease is the transient immunosuppression and delay in 
the development of virus specific antibodies until 5-15 weeks after infection 
(Desport et al., 2009; Hartaningsih et al., 1994; Wareing et al., 1999). A lack of a 
virus specific humoral immune responses has been reported in rapid progressor HIV 
and SIV infections (Dykhuizen et al., 1998; Michael et al., 1997) attributed to a 
progressive depletion of proliferating B-cells as early as 20 days after infection 
(Zhang et al., 2007). 
To further define the tropism of JDV, double-immunofluorescent labelling was used 
to detect JDV CA in subsets of PBMC identified using specific antibodies in 
formalin-fixed tissues.  
 
Materials and methods  
Animals  
The tissues examined were from 2 female Bali cattle (CB10 and CB212) 6-12 
months of age purchased from Nusa Penida and confirmed as being free of JDV CA 
antibody using ELISA (Hartaningsih et al., 1994). The cattle were infected with 1 ml 
of a 10% homogenate of spleen in DMEM which had previously been prepared from 
an animal experimentally infected with JDVTab/87 (Soeharsono et al., 1995a). Rectal 
temperatures were monitored after infection and both animals were euthanised 2 
days after developing rectal temperatures ≥39.5
oC. Tissue samples were collected 
into 10% neutral buffered formalin from both animals, and included spleen, tonsil, 
lymph nodes, heart and bone marrow. Sections were prepared from each tissue at 4 
μm thickness, mounted on silane coated glass slides (ProSciTech) and stored for ≤3 
days before labelling to avoid tissue oxidation.    72 
Generation and testing of JDV CA MAb hybridomas  
Biotinylated recombinant JDV Gag protein constructs were expressed using Pinpoint 
Xa-1 vector (Promega) in Escherichia coli JM109 as described previously (Desport 
et al., 2005) and were kindly supplied by Dr Moira Desport. 
A murine MAb produced against Jgag6, a construct encoding the entire JDV CA 
protein, was produced by Mr Judhi Rachmat in our laboratory. Briefly, the construct 
was expressed and purified according to the manufacturer’s instructions and mixed 
with an equal volume of incomplete Freund’s adjuvant. Eight-week-old female 
BALB/c mice were immunised 3 times at 2-week intervals. Three days after the final 
injection, mouse spleen cells were isolated and fused with the mouse myeloma cell 
line NS0 using 43% polyethylene glycol, (PEG, MW 1300-1600) (Sigma) as 
described previously (Chan and Mitchison, 1982). The screening assays were 
performed during cell growth in hypoxanthine aminopterin thymidine (HAT) 
selection medium. Positive clones were subcloned twice by limiting dilution. The 
specificity of the MAb was determined using the JDV Gag protein constructs in 
Western immunoblots as previously described (Desport et al., 2005). Isotyping of the 
selected MAb (LD1) was done on culture supernatants using a mouse isotyping kit 
(BioRad) and determined to have an isotype of IgG2b.  
Antibodies and antigen retrieval  
JDV CA in cells was visualised using the MAb LD1. Cells of the myelomonocytic 
lineage were identified using either MAC387 (as described in Chapter 3) or EBM11 
(DAKO) and T-cells were identified using a human CD3 polyclonal antibody 
(DAKO) as described in Chapter 3. B-cells were identified using MAb anti-human 
CD79αcγ and a polyclonal rabbit anti-bovine IgG was used to identify IgG-
containing plasma cells as described in Chapter 3. Alexa Fluor 488 (green) and 568 
(red) conjugated anti-mouse or anti-rabbit secondary antibodies (Invitrogen) were 
used to specifically recognise primary antibodies in double-immunofluorescence 
labelling. Immunoperoxidase labelling was performed after sections were 
deparaffinised in xylene and rehydrated through graded alcohols as described in 
Chapter 3. Antigen retrieval was required for all antibodies and consisted of 
microwave treatment in Tris-EDTA buffer pH 9.2 as described in Chapter 3. An 
alternative antigen retrieval method was required for MAb EBM11 which after   73 
optimisation was found to be digestion in 0.1% proteinase-K (Invitrogen) for 5 min 
at room temperature.  
Immunoperoxidase labelling  
After antigen retrieval, all sections were treated with 3% H2O2 for 5 min before 
addition of primary antibody diluted in PBS containing 10% newborn calf serum for 
15-30 min at room temperature. Streptavidin-biotin reagents (LSAB2, DAKO) with 
specificity for mouse IgG were used to directly detect primary mouse antibodies 
using DAB as the substrate chromogen, as described in Chapter 3. Specificity of 
antibodies was confirmed by omission of primary antibody and testing uninfected 
tissues from control animals.  
Double immunofluorescence labelling  
The slides were incubated with mixtures of 2 primary antibodies, using dilutions 
which had been established after preliminary titrations, for 15-30 min at room 
temperature, as described in Chapter 3. After washing 3 times with Tris-buffered 
saline (TBS; 50 mM Tris, 150 mM NaCl, pH 7.8), the appropriate secondary 
antibodies labelled with Alexa Fluor 488 or 568, either from different species or with 
differing Ig subclasses, were applied in TBS and incubated in the dark for 15-30 min. 
Additional sensitivity was obtained, where necessary, by using a rat anti-mouse IgG 
biotinylated secondary antibody that was subsequently detected using streptavidin 
Alexa Fluor 488 (Invitrogen). Finally, slides were washed with TBS and dried in the 
dark for 15 min, before being mounted in DAPI mounting medium (Vector 
Laboratories).  
In situ hybridisation  
The protocol for ISH was as previously reported for detection of positive-sense JDV 
RNA using a digoxigenin-labelled riboprobe (Chadwick et al., 1998), with the 
following modifications. Prior to hybridisation, sections were pre-treated in a 
microwave in Tris-EDTA buffer (10 mM Tris, 0.1 mM EDTA, pH 9.2) as described 
for immunolabelling in Chapter 3. The digoxigenin-labelled probe was detected 
using a sheep anti-DIG-alkaline phosphatase conjugate (Roche) diluted 1:500 in the 
blocking solution and HNPP/Fast Red mixture (Roche). DAPI mounting medium 
was used to counterstain the nuclei (Vector Laboratories).   74 
Results  
Characterisation of JDV CA-specific MAb  
To undertake further investigations into the cell tropism of JDV during acute 
infection, a virus specific MAb was produced which was selected so that it was of a 
different isotype (IgG2b) compared to the cell surface markers that were used 
(IgG1). MAb LD1 was successfully produced using a recombinant CA protein as the 
immunising antigen in mice and was screened against a range of JDV truncated Gag 
proteins to determine the specificity of the antibody binding. The JDV gag sequence 
encoded by each of the DNA constructs is shown in Figure 4.1 together with the 
Western immunoblot results showing that the MAb was reactive against Jgag2, Jgag 
3, Jgag 5, Jgag 6 and Jgag 11. This indicated that MAb LD1 reacted with an epitope 
encoded by a region of the JDV genome between nucleotides 604-810 (Chadwick et 
al., 1995b).  
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 (A)  
(B)   
Figure 4.1 Mapping the reactivity of MAb LD1 against recombinant JDV CA. (A) 
Schematic representation of JDVTab/87 genome location (Chadwick et al., 1995b) of 
biotinylated JDV gag constructs expressed using Pinpoint X-A-1 system in E. coli. 
(B) Western immunoblotting with MAb LD1 revealed that its reactivity mapped to 
the amino terminus of CA in the region encompassed by Jgag11 (expressed by 
nucleotides 604–810). Lane 1, Marker; lane2, Jgag1; lane 3, Jgag2; lane 4, Jgag3; 
lane 5, Jgag4; lane 6, Jgag5; lane 7, Jgag6; lane 8, Jgag7; lane 9, Jgag11; lane 10, 
Jgag13. 
 
 
Analysis of infected cell phenotype  
Infection of bovine lymphocytes during acute infection with JDV was determined 
using immunofluorescence labelling techniques on formalin-fixed paraffin wax-
embedded tissues. JDV- infected cells were identified using MAb LD1 and a 
secondary goat anti-mouse antibody labelled with Alexa Fluor 568, without any   76 
further amplification of the fluorescent signal (Figures 4.2 A and B). CD3
+ T-cells 
were simultaneously labelled and were numerous in the lymphoid tissues examined 
(Figures 4.3 A and B). There was no co-localisation of signal when the fluorescent 
images for JDV CA and CD3 labelling were merged (Figures 4.4 A and B).  
 
 
 
 
Figure 4.2 Mesenteric lymph node from a JDV-infected animal on the second day of 
the febrile reaction, reacted with MAb LD1 against JDV CA and a secondary goat 
anti-mouse antibody labelled with Alexa Fluor 568, showing characteristic strong 
cytoplasmic labelling. Magnification 40X (A) and 100X (B).  
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Figure 4.3 Mesenteric lymph node from a JDV-infected animal on the second day of 
febrile reaction, reacted with polyclonal rabbit anti-human CD3 (a T-cell marker) 
and a secondary goat anti-rabbit antibody labelled with Alexa Fluor 488, showing 
characteristic strong surface and or cytoplasmic fluorescence. Magnification 40X (A) 
and 100X (B).  
 
B-cells identified using a monoclonal mouse anti-human CD79α were predominantly 
located in the germinal centres of the lymphoid follicles, as expected. No co-
localisation of labelling with MAb LD1 and JDV CA was observed with CD79α
+ 
cells in this location but approximately 10% of the CD79α
+ cells outside the 
germinal centres were also reactive with MAb LD1 indicating that a proportion of B-
lymphocytes were infected with JDV. The expression of CD79α on human B-cells 
ceases around the onset of plasma cell differentiation and plasma cells were 
identified in lymph node sections by detecting the presence of bovine IgG in the 
cytoplasm (Figure 4.5 A). A proportion of plasma cells were also found to contain 
JDV CA (Figure 4.5 B) and when the 2 images were merged, co-localisation 
between the IgG and JDV CA-positive cells was evident (Figure 4.5 C). 
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Figure 4.4 Mesenteric lymph node from a JDV-infected animal on the second day of 
febrile reaction, reacted with polyclonal rabbit anti-human CD3 (a T-cell marker) 
with a secondary goat anti-rabbit antibody labelled with Alexa Fluor 488 (green), 
and MAb LD1 with  a secondary goat anti-mouse antibody labelled with Alexa Fluor 
568 (red) to identify JDV CA-containing cells. No co-localisation was detected when 
the CD3 and MAb LD1 reactive cells were merged. Magnification 40X (A) and 
100X magnification (B). Nuclei stain blue with DAPI. 
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Figure 4.5 A mesenteric lymph node from a JDV-infected animal on the second day 
of the febrile reaction, reacted with rabbit anti-bovine IgG and a secondary goat anti-
rabbit antibody labelled with Alexa Fluor 488 (A), and anti CA MAb LD1 with a 
secondary goat anti-mouse antibody labelled with Alexa Fluor 568 (B). Co-
localisations were detected when the IgG and JDV CA-positive cells were merged 
(C). 100X magnification. Nuclei stain blue with DAPI. 
 
 
Distribution of cells of monocyte/macrophage lineage  
Blood-derived monocytes and neutrophils were identified in tissues using the MAb 
MAC387 (Figure 4.6). Despite similarities in the morphology and distribution of 
MAC387
+ cells and JDV CA-positive cells, there was no evidence of productive 
infection of monocytes or neutrophils. Antibodies directed against different regions 
of human CD68 and including MAb EBM11 have been used to successfully identify 
macrophages, and this has also been applied to identify macrophages in bovine 
tissues (Bielefeldt-Ohmann et al., 1988; Greywoode et al., 1990). Unfortunately, the 
antigen retrieval required for LD1 labelling was not compatible with that required for 
EBM11 and it was not possible to perform double immunolabelling with this 
combination of antibodies. However, when single immunolabelling was performed 
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on serial sections of lymph node, the distribution of JDV CA-positive cells in the 
medullary cords was different to the location of macrophages identified using 
EBM11, which were found predominantly in the medullary sinuses (Figure 4.7). The 
distribution of MAC387
+ cells and EBM11
+ cells was markedly different in the lung, 
confirming that these antibodies labelled different subsets of cells of the 
mononuclear phagocyte system.  
 
 
 
Figure 4.6. Spleen tissue from a JDV-infected animal on the second day of febrile 
reaction immunolabelled using MAb MAC387 and a secondary goat anti-mouse 
antibody labelled with Alexa Fluor 488 (green), and JDV anti-CA MAb LD1 JDV-
CA with goat anti-mouse antibody labelled with Alexa Fluor 568 (red). The 
morphology and size of the reactive cells was different, and no co-localisations were 
detected when the MAC387
+ and JDV CA-positive cells were merged. 
Magnification 100X. Nuclei stain blue with DAPI.   81 
 
 
Figure 4.7. Consecutive sections of prescapular lymph node from a JDV-infected 
animal on the second day of the febrile reaction, reacted with JDV CA MAb (A) and 
EBM11 (B), showing the different locations of the reactive cells. JDV CA-positive 
cells showed a stronger labelling reaction and were mainly observed in the medullary 
cords but macrophages identified with EMB11 were generally detected in the 
medullary sinuses with weaker reactivity. Positive reactions indicated by dark brown 
labelling. Immunoperoxidase labelling, 40X magnification.    
 
 
Morphology and distribution of infected cells  
Many cells containing JDV CA were found in lymphoid tissues, particularly 
throughout the red pulp of the spleen (Figure 4.8 A), and these cells were large and 
pleomorphic with coarsely clumped chromatin and an abundant cytoplasm (Figure 
4.8 B). Immunolabelled cells were often observed in close proximity to one another 
and were present mostly in non-lymphoid organs such as liver or kidney in 
mononuclear cell infiltrates. JDV CA was detected together with red blood cells in 
large vacuolated macrophage-like cells in the alveolar septae of the lung but it was 
not clear whether these cells were productively infected or merely phagocytosing 
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infected cells (Figure 4.9). IgG-containing cells had a similar morphology to the CA-
containing cells with a large vacuolated cytoplasm and eccentric nucleus (Figure 
4.10). The distribution and morphology of JDV RNA-positive cells was similar to 
that of JDV CA (Figure 4.11). 
 
   
Figure 4.8. Spleen tissue from a JDV-infected animal on the second day of febrile 
reaction, reacted with JDV CA LD1 MAb, to show distribution of JDV CA-positive 
cells predominantly around the red pulp of the spleen, which were large and 
pleomorphic with coarsely clumped chromatin and abundant cytoplasm. 
Immunoperoxidase labelling, magnification 40X (A) and 100X (B).  
 
 
 
Figure 4.9. Lung tissue from a JDV-infected animal on the second day of the febrile 
reaction, immunolabelled using mAb LD1 and anti-IgG2b-labeled Alexa Fluor 488 
(green), showing JDV CA in clusters of cells in this tissue and in occasional cells 
associated with red blood cell phagocytosis (arrows). 
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Figure 4.10. Spleen tissue from a JDV-infected animal on the second day of the 
febrile reaction, reacted with JDV CA monoclonal antibody (A) and rabbit 
polyclonal anti-bovine IgG (B), to show the similar morphology of the 2 reactive cell 
types, in both cases large cells with a vacuolated cytoplasm and an eccentric nucleus. 
The reactive cells contained dark brown cytoplasmic label. Immunoperoxidase 
labelling, magnification 100X. 
 
   
Figure 4.11. Spleen tissue from a JDV-infected animal on the second day of the 
febrile reaction, showing JDV RNA-positive cells detected using ISH with Fast Red 
(A) and JDV CA-positive cells detected using an immunoperoxidase labelling 
technique (B). In both cases, the reactive cells had a very similar morphology: large 
cells with vacuolated cytoplasm and an eccentric nucleus. Magnification 100X. 
 
Discussion  
The precise cell-tropism of JDV during the febrile phase of Jembrana disease in Bali 
cattle has not been identified previously but preliminary investigations reported in 
Chapter 3 suggested that JDV-infected cells were morphologically similar to cells 
that were immunolabelled with B-cell markers and expressed IgG, and therefore the 
virus probably replicates in mature B-cell lineage cells. The cell tropism of JDV was 
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further examined in the current study by the co-localisation and distribution of the 
major subsets of T-cells, B-cells, monocyte/macrophage lineage cells and cells 
containing JDV CA as an index that they were infected.  
Observations reported in Chapter 3 indicated that the intense proliferative response 
detected in the T-cell areas of lymphoid tissues was not due to an expansion of CD3
+ 
cells but to an apparent infiltration of the areas with pleomorphic centroblast-like 
cells that appeared to be antibody-producing and probably of B-cell lineage, and that 
the distribution of T-cells and JDV-infected cells was different. The use of a pan T-
cell CD3 marker and a JDV CA MAb for co-immunolabelling of T-cells and JDV-
infected cells in the current study confirmed that CD3
+  T-cells were not infected 
with JDV. The apparent tropism of JDV for cells of a non-T-cell lineage is perhaps 
not surprising as there are large differences in the disease pathogenesis and genetic 
variability of JDV compared to most of the other lentiviruses, particularly those that 
are T-cell tropic (Desport et al., 2007; Soesanto et al., 1990).  
The detection in the current study of JDV CA in a sub-population of B-lineage cells 
and including mature antibody producing B-cells, possibly plasma cells, confirmed 
that JDV can replicate in cells of this lineage. The location of the infected cells in the 
mantle zone, outside of the germinal centres, suggests that productive infection 
occurs in mature rather than proliferating immature B-cells. Infection of B-cells by 
lentiviruses is not unusual. They are infected at a low frequency by SIVsmmPBj14, an 
acutely lethal lentivirus infection in pigtail macaques (O'Neil et al., 1999) with 
similarities in pathogenesis to Jembrana disease. B-cells, particularly IgG-containing 
cells, are a major reservoir for FIV in chronically infected cats (English et al., 1993) 
and are both stimulated to proliferate and infected during the early stages of BIV 
infection (Heaton et al., 1998; Whetstone et al., 1997).  
In the current study, pleomorphic centroblast-like cells were identified using 
CD79αcγ that effaced the normal T-cell population in the paracortex of lymphoid 
tissue during acute infection with JDV (Chapter 3). This suggests that, similar to 
what has been reported for BIV, there is a transient proliferation of B-cells during 
the acute stage of Jembrana disease (Whetstone et al., 1997). A putative polyclonal 
B-cell stimulatory epitope has been identified in the carboxyl-end of the envelope 
glycoprotein of HIV-1, specifically associated with Nef (Chirmule et al., 1994; 
Chirmule et al., 1990). Tmx, which is an accessory protein of unknown function   85 
expressed from a similar region of the genome by the bovine lentiviruses, has been 
suggested to have a function analogous to Nef and it is possible that these viruses 
have evolved a mechanism to stimulate proliferation of their target cells in vivo 
(Chadwick et al., 1995b; Garvey et al., 1990).  
Other non-primate lentiviruses exhibit a tropism for cells of the 
monocyte/macrophage lineage. Of these, FIV and BIV have been shown to have 
relatively broad cell tropisms (English et al., 1993; Heaton et al., 1998) whilst the 
small ruminant lentiviruses (CAEV and MVV) and EIAV are predominantly 
macrophage-tropic (Gendelman et al., 1985; Sellon et al., 1992; Zink et al., 1990). 
While there are similarities between the pathogenesis of EIAV infections in horses 
and Jembrana disease in Bali cattle, macrophages have not been identified as a target 
cell population for infection by JDV. The population of monocyte/macrophage cells 
identified using the MAC387 MAb was clearly not productively infected by the 
virus. MAC387 recognises leucocyte protein L1 (calprotectin) which is present in 
neutrophils and blood monocytes and is lost during their maturation into tissue 
macrophages (Brandtzaeg, 1988; Poston and Hussain, 1993). CD68 is an 
intracytoplasmic marker of mature tissue macrophages and is commonly used to 
identify macrophages infected by primate and other lentiviruses (Chakrabarti et al., 
1991; Fischer-Smith et al., 2004). EBM11 has been successfully applied to identify 
cells bearing CD68 in fixed bovine tissues and was found to label a different 
population of cells when compared to MAC387 (Ackermann et al., 1994; Bielefeldt-
Ohmann et al., 1988). The distribution of EBM11
+ cells in lymphoid tissues from 
JDV-infected cattle was not the same as the cells containing JDV CA although there 
were similarities in the size and morphology of the infected cells. Macrophage-tropic 
lentiviruses are often associated with neuropathology and infections in the brain 
(Andresdottir et al., 1998; Smit et al., 2001). The lack of convincing evidence for 
infection of macrophages by JDV is supported by the fact that the virus has never 
been detected in brain tissue (Chadwick et al., 1998) nor associated with any 
neurological signs (Soesanto et al., 1990). In addition, the genomes of the bovine 
lentiviruses differ from other non-primate lentiviruses by not encoding an 
identifiable dUTPase (Chadwick et al., 1995b; McGeoch, 1990). Retroviral 
dUTPases have a central role in productive viral replication in non-dividing cells, 
such as macrophages, where cellular dUTPases and the pool of available   86 
deoxynucleotides are at low levels (Chen et al., 2002; Terai et al., 1991; Whetstone 
et al., 1997). The accumulation of G- to-A substitutions in CAEV has been shown to 
be prevented by the virally encoded dUTPase (Turelli et al., 1997) and replication in 
macrophages without a mechanism for preventing these substitutions leads to a drift 
of the genome towards poly(A).  
The genomes of the bovine lentiviruses differ from the other lentiviruses by 
exhibiting dramatic differences in their genome compositions in their 5’ compared to 
3’ halves. Whilst lentiviral genomes are characteristically A–rich, the BIV genome is 
only A-rich in the 5’ half and both JDV and BIV are less A-rich in their pol 
sequences compared to the other lentiviruses (Foley et al., 2000). Both BIV and JDV 
appear to be genetically stable over time with much lower mutation rates than the 
other lentiviral genomes which may be related to their tropism for plasma cells with 
a long life span (Carpenter et al., 2000; Desport et al., 2007). The identification of 
cells containing JDV CA and RNA in the circulation as well as in tissues and the 
delayed humoral antibody response after the acute phase of infection are further 
indicators that the tropism of JDV is for B-cells rather than monocyte/macrophage- 
lineage cells. Circulating monocytes are only rarely infected in other lentiviral 
infections, for example in EIAV infections, and usually it is only after maturation to 
tissue macrophages that productive viral replication occurs (Sellon et al., 1992).  
One of the hallmarks of JDV infection is the delay until at least 5 weeks and often 
much later after infection for seroconversion to viral antigens (Desport et al., 2009; 
Hartaningsih et al., 1994). This indicates that during the acute phase of the disease 
the normal process of antigen presentation and antibody production is disrupted. The 
presence of virus in plasma cells might be anticipated to affect the production of IgG 
and the decline in the number of these cells during the acute phase of the disease 
(Dharma et al., 1994) indicates that they do not survive being hijacked by JDV. This 
immunosuppressive effect is not restricted to JDV antigens as delayed responses 
have also been observed after vaccination with other antigens given at the end of the 
febrile response (Wareing et al., 1999). 
JDV is often described as an atypical lentivirus because of the acute nature of the 
disease pathogenesis, the absence of viral variation, the delayed antibody response 
and the ensuing immunological events that develop after infection and prevent 
heterologous infections and relapses. The apparent tropism of JDV for B-cells and   87 
lack of replication in T-cells and macrophages provides the basis for understanding 
these observations and indicates a fundamental difference from the other members of 
the lentivirus family. The role of macrophages in JDV infection of Bali cattle, 
however, is unclear. JDV proviral DNA is certainly present in the circulating PBMC 
population (Lewis et al., 2009) and yet monocytes identified using MAC387 are not 
infected and tissue macrophages identified using EBM11 are not in the same location 
as the CA-containing cells. All of the other members of this virus family, including 
BIV, are able to infect macrophages and JDV would indeed be an exceptional 
lentivirus if it were found to be solely B-cell tropic. The co-localisation of JDV CA 
and CD79αcγ
+ labelling in approximately 10% of infected cells together with the 
close proximity of infected cells observed within the tissues indicate that other cells 
types could be involved and that infection of neighbouring cells without the 
necessary viral receptors may occur. Further studies with a larger panel of bovine 
cell surface markers are required to confirm the precise tropism of JDV.  
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Chapter 5 
Flow cytometric analysis of changes in lymphocyte subsets 
in Bali cattle experimentally infected with Jembrana 
disease virus  
 
Summary 
Five Bali cattle were experimentally infected with JDV and all developed typical 
clinical signs of Jembrana disease characterised by a transient febrile response, 
enlargement of superficial lymph nodes and a significant leucopenia. Flow 
cytometric analysis of PBMC during the acute disease process showed that the 
reduced number of lymphocytes was due to significant decreases in CD4
+ and CD8
+ 
T-cells, and CD21
+ B-cells. At the end of the febrile phase, both CD8
+ T-cells and 
CD21
+ B-cells increased significantly but CD4
+ T-cells remained below normal 
values resulting in a significantly reduced CD4
+:CD8
+ ratio. These results suggest 
that in the absence of the production of specific antibodies to JDV for several weeks 
after recovery, a cell-mediated immune response involving CD8
+ cells may play a 
critical role in the recovery process. 
 
 
 
 
 
 
 
 
 
   89 
Introduction  
The majority of experimentally JDV-infected Bali cattle survive the acute clinical 
disease and do not develop any further clinical disease (Soeharsono et al., 1990; 
Soesanto et al., 1990) but the immune mechanism responsible for recovery from the 
acute disease and continued immunity has not been defined. There is no evidence 
that antibody plays a role in recovery as JDV-specific antibodies are not detectable 
until some weeks after recovery from the acute disease (Dharma et al., 1994; 
Hartaningsih et al., 1994; Wilcox et al., 1995). The cellular immune response, 
predominantly through interleukin activation of CD8
+ cytotoxic T lymphocytes, has 
been considered to play a critical role in EIAV infections (Murakami et al., 1999) 
and HIV infections (Migueles et al., 2002) and is also possible in JDV infections. 
Hyperplasia of T-cell areas and depletion of B-cell areas of lymphoid tissues during 
acute Jembrana disease is a hallmark of the disease (Dharma et al., 1994). Depletion 
of the CD4
+ T-cell and CD8
+ T-cell populations was observed histologically in JDV-
infected Bali cattle and significant differences were found during acute illness in 
follicular compartments of lymph nodes (Dharma et al., 1994). It was suggested 
(Dharma et al., 1994) that the gradual depletion of CD4
+ T-cells may have been due 
to the infection of T-cells. However, although T-cells are the predominant target cell 
of some lentiviruses, including HIV (Alcami, 2004b; Blankson et al., 2002; 
Brenchley et al., 2004; Clapham and McKnight, 2001; Penn et al., 1999; Samuelsson 
et al., 1997), SIV (Brown et al., 2007; Dykhuizen et al., 1998; Mattapallil et al., 
2005; Picker, 2006) and FIV (Ackley et al., 1990), there is no evidence for infection 
of T-cells by JDV (Chapter 4) and the mechanism for the changes in T-cell 
populations in Jembrana disease remain unknown.  
Although lymphopenia is a characteristic feature of Jembrana disease (Soesanto et 
al., 1990), changes in circulating lymphocyte subsets during the acute disease have 
remained uncharacterised. In this Chapter, flow cytometric analysis of the circulating 
CD4
+ and CD8
+ cell populations during the febrile and early post-febrile phases was 
undertaken to better understand the acute disease process associated with JDV 
infection, and the results are reported in this Chapter. 
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Materials and methods  
Experimental animals and sample collection 
Five Bali cattle were infected with JDV using procedures described in Chapter 3 and 
the febrile phase in the inoculated animals occurred from 5-11 days after infection. 
Blood samples were obtained daily from all animals for 14 days after infection and 
again at day 21 when the experiment was terminated. Sterile EDTA-containing 
vacutainer tubes (Greiner Bio-One) were used to collect blood samples for recovery 
of lymphocytes used for the studies described in this Chapter, and also for the 
cytokine expression studies that are reported in Chapter 6.  
Lymphocyte preparation 
Lymphocytes were isolated using Ficoll-Paque plus (Amersham Biosciences) 
following the manufacturer’s instructions, then washed twice in FACS buffer 
(Dulbecco’s phosphate-buffered saline [Thermo Scientific] supplemented with 5% 
heat inactivated foetal calf serum (FCS; Bovogen Biologicals) and 0.05% sodium 
azide [Sigma-Aldrich]). The washed lymphocytes were resuspended in FACS buffer 
and adjusted to a density of 1 x 10
7 cells/ml, and kept at 5
oC until they were 
immunolabelled on the same day. Some aliquots of lymphocytes were stored at -
80
oC until RNA was extracted for the studies reported in Chapter 6. 
Antibodies and cellular markers  
Lymphocytes were labelled with either 2.5 µg/ml mouse anti-bovine CD4 MAb 
(Serotec), 5 µg/ml mouse anti-bovine CD8 MAb (Serotec) or 20 µg/ml mouse anti-
bovine CD21 MAb (Santa Cruz), a B-cell marker. An Alexa Fluor (AF488) 
conjugated goat anti-mouse cross absorbed secondary antibody (Invitrogen) was 
used to detect all reactive MAb antibodies (Table 5.1). 
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Table 5.1. Primary and secondary antibodies used for flow cytometric analysis of 
lymphocytes from cattle infected with JDV. 
Antibody  Source  Isotype / clone  Cat./Lot No 
Primary antibody       
Mouse anti-bovine CD4  Serotec  IgG2a/CC8  MCA1653G   
Mouse anti-bovine CD8  Serotec  IgG2a/CC63    MCA1653G   
Mouse anti-bovine CD21  Santa Cruz    IgG2b/CC51        SC-101835 
Secondary antibody       
Goat anti-mouse  Invitrogen  Alexa Fluor 488  A-11029 
 
 
Cell surface labelling of lymphocytes 
Lymphocytes were labelled for single-colour analysis using a previously published 
protocol (Foster et al., 2007; Rocchi et al., 2007) with slight modification. Following 
lymphocyte preparation, 1 ml of the lymphocyte suspension was incubated with 100 
µl of primary antibody in FACS buffer for 30 min at 4
oC, followed by 3 washes with 
FACS buffer (by centrifugation for 1 min at 479 g at 4
oC). Secondary antibody (100 
µl) diluted in FACS buffer was applied and incubated for 30 min at 4
oC in the dark. 
The cell suspensions were then gently washed 3 times in FACS buffer, then washed 
once with PBS and the cells then resuspended in 200 µl of fixation buffer 
(Dulbecco’s phosphate-buffered saline supplemented with 4% paraformaldehyde) 
for 5 min at 37
oC. Finally, the cells were washed with 200 µl of ice-cold Dulbecco’s 
phosphate-buffered saline supplemented with 1% bovine serum albumin (BSA; 
Sigma Aldrich) and resuspended in 1 ml of freezing medium (Dulbecco’s phosphate-
buffered saline supplemented with 1% BSA and 10% dimethyl sulfoxide [Sigma 
Aldrich]) before being transferred to freezing vials and then stored  at -80
oC. 
Samples were stored for up to 2 months in Bali prior to transport to Australia for 
FACS analysis.    92 
Flow cytometric analysis  
Prior to flow cytometric analysis, cryopreserved lymphocytes samples were thawed 
rapidly at 37
oC in a water bath, then washed once with wash buffer (Dulbecco’s 
phosphate-buffered saline supplemented with 0.1% BSA) and resuspended in 1 ml of 
labelling buffer (Dulbecco’s phosphate-buffered saline supplemented with 10% heat-
inactivated FBS and 0.1% sodium azide [Sigma Aldrich]). The immunolabelled 
samples were analysed using a BD FACSCalibur flow cytometer (BD Bioscience) 
with a 488 nm excitation laser. Lymphocytes were gated in a forward/side scatter 
plot (FCS vs SSC). AF488 fluorescence emission was collected with 530/30 nm 
band pass filter and acquired in the log scale. A bandpass-specific filter (FL1, 530 ± 
15 nm) was used for Alexa Fluor 488. A minimum of 10,000 lymphocytes were 
examined per sample and an AF488 fluorescence histogram was used to compare the 
samples. Sample data were analysed using BD CellQuest Pro V5.2 (BD Biosciences) 
which is the standard operating software on the FACSCalibur. Experimental data 
were analysed and population statistics calculated using FlowJo V7.2.5 (Tree Star 
Inc., USA) flow cytometry analysis software. 
Statistical analysis 
The absolute numbers of lymphocyte subsets was calculated by multiplying the 
percentage of each lymphocyte subset obtained from flow cytometry analysis with 
the total lymphocyte counts/ml, and were reported as a mean ± standard deviation 
(SD). A one-way ANOVA (SPSS® 17.0) was used to assess group differences in the 
lymphocyte populations, while differences between time points during infection 
were analysed using Bonferroni’s multiple comparison. A value of p<0.05 was 
considered significant for all analyses. 
 
Results 
Evaluation of lymphocyte samples  
In a preliminary experiment, sample preparation techniques were evaluated to 
optimise the quantity and quality of lymphocytes which were crucial for cell surface 
labelling. Flow cytometric analysis of normal lymphocyte samples isolated using 
Ficoll-Paque plus and immunolabelled following established protocols with a   93 
representative cell-marker (CD4) showed that the samples had a high purity (66.4%), 
with few dead cells (less than 5%) or non-lymphocyte contaminants. The CD4
+ T-
cell population (31.98% of the total population) (Figure 5.1) was in agreement with 
reported values for a normal bovine peripheral blood CD4
+ T-cells of 29 ± 4% 
(McBride et al., 1999).  
 
 
 
Figure 5.1.  Flow-cytometry dot plots (left) and histogram (right) of normal 
lymphocytes prepared using Ficoll-Paque plus reacted with CD4 marker, showed a 
pure lymphocyte population and good surface labelling. Fluorescence intensity is 
depicted on the X-axis. 
 
Flow cytometric analyses 
There were significant differences in the mean (of 5 animals) absolute number of 
lymphocyte subsets at the 3 major time points: pre-infection (day 0 prior to JDV 
infection), during the febrile phase and during the immediate post-febrile phase 
(Table 5.2). During the febrile phase, the total number of CD4
+ T-cells decreased 
significantly (p<0.001) and remained below normal values until well after the febrile 
phase (Figure 5.2). Conversely, the total number of CD8
+ 
 T-cells reduced slightly 
during this period but increased significantly (p<0.001) above normal values in the 
post-febrile phase (Figure 5.3). Due to the dramatic depletion of CD4
+  T-cell 
populations and significant increase in CD8
+ T-cells after JDV infection, the 
CD4
+:CD8
+ T-cell ratio also decreased significantly (p<0.05) from 0.5:1 at pre-
infection  to 0.25:1 and 0.01:1 during the febrile phase and post-febrile phase, 
respectively (Table 5.3). The population of CD21
+ B-cells reduced slightly during 
the febrile phase then increased significantly (p<0.001) as did CD8
+ T-cells during   94 
the post-febrile phase (Figure 5.4). The changes in the lymphocyte subsets during the 
3 time points after JDV infection are illustrated in Figure 5.5. 
 
 
Table 5.2. Comparison of lymphocyte subsets during 3 major phases after JDV 
infection.  
Lymphocyte population 
Mean absolute number cells/ml
 ± SD 
Pre-infection  Febrile phase  Post-febrile phase 
T-helper cells, CD4
+  2418 ±277
a  176± 171
b  45 ±10
 b 
Cytotoxic T-cells,CD8
+  1210±206
 b  768±489
b  3187±601
 a 
B-cells, CD21
+  1799 ± 404
 b  2065±823
b  4225 ± 841
 a 
Means in a row with different superscripts are significantly different by Tukey’s 
HSD (p<0.05). 
 
 
Table 5.3. Changes in CD4
+:CD8
+ T-cell ratio during the course of JDV infection. 
Days 
after 
infection 
Mean CD4
+ 
(number/ml) 
SD  Mean CD8
+ 
(number/ml) 
SD  CD4
+:CD8
+ 
ratio 
0  2418  713  1210  14  0.5:1 
2  248  11  869  12  0.28 :1 
4  217  8  740  12  0.29 :1 
5  274  24  1236  31  0.22 :1 
6  229  18  605  18  0.38 :1 
7  138  11  367  11  0.37 :1 
9  28  0.4  709  21  0.04 :1 
19  36  0.2  3187  32  0.01:1 
   95 
 
 
Figure 5.2. Flow cytometric analysis of lymphocyte CD4
+ T-cells before and after JDV 
infection. CD4-AF488 fluorescence histograms for representative cattle (left) CB5 and 
(right) CB7 showed a significant reduction of CD4
+ T-cells from pre-infection through 
the acute and early recovery phases. For each histogram, CD4-AF488 
immunolabelled samples (thick black line) are compared to a non-labelled sample 
(thin black line). 
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Figure 5.3. Flow cytometric analysis of lymphocyte CD8
+ T-cells before and after JDV 
infection. CD8-AF488 fluorescence histograms for representative cattle (Left) CB5 and 
(Right) CB7 showed a significant increase of CD8
+ T-cells from pre-infection through the 
acute and early recovery phases. For each histogram, CD8-AF488 immunolabelled 
samples (thick black line) are compared to a non-labelled sample (thin black line). 
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Figure 5.4. Flow cytometric analysis of lymphocyte CD21
+ B-cells before and after JDV 
infection. CD21-AF488 fluorescence histograms for representative cattle (Left) CB5 and 
(Right) CB7 showed an increase of CD21
+ T-cells from pre-infection through the acute 
and early recovery phases. For each histogram, CD21-AF488 immunolabelled 
samples (thick black line) are compared to a non-labelled sample (thin black line. 
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Figure 5.5 Lymphocyte subset changes following JDV infection. There was an 
elevated rectal temperature (red line) from 5-9 days after infection (febrile phase) 
and the population of CD4
+ T-cells decreased significantly (p<0.001) before the 
onset of the febrile phase and remained below normal values beyond the febrile 
phase. The total number of CD8
+ T-cells reduced slightly during the early febrile 
phase then increased significantly (p<0.001) above normal in the post-febrile phase. 
CD21
+ B-cells increased prior to the febrile phase, reduced gradually during the 
febrile phase then increased significantly (p<0.001) again at the end of the febrile 
phase. Data presented are means of values from 5 animals ± SD. 
 
 
Discussion 
The nature of the response of Bali cattle to JDV infection, an acute disease process 
with a short incubation period, a case fatality rate of about 17% and no recurrence of 
disease in those animals that recover, is unusual for a lentivirus.  The lack of any 
recurrence of disease in animals that recover suggests the development of a strong 
protective immunity. The absence of JDV-specific antibody until at least 5 weeks 
and not in most cattle until 11 weeks after infection (Hartaningsih et al., 1994; 
Soeharsono et al., 1995b) implies that cell-mediated immune responses play a major 
role in the recovery of the infected animals and probably in their continuing 
immunity. The current study assessed the responses of peripheral blood lymphocyte 
subsets to JDV infection in experimentally infected animals to gain insights into the 
kinetics of the lymphocyte response following infection. 
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The use of flow cytometric analysis confirmed the previous report of the significant 
decrease in CD4
+:CD8
+ T-cell ratio of lymphocytes in lymphoid tissues during the 
acute phase of Jembrana disease but not during early post-febrile stages (Dharma et 
al., 1994). In this current study, both CD4
+ and CD8
+ T-cells in peripheral blood 
significantly decreased during the febrile phase compared to before infection, and 
this period corresponds to the duration of the lymphopenia reported during the 
febrile phase of Jembrana disease (Soesanto et al., 1990). The population of CD8
+ T-
cells was greater than CD4
+ T-cells during the febrile phase but increased markedly 
during the post-febrile phase. Due to the significant increase of CD8
+ T-cell numbers 
at the end of the febrile phase and a continuous depletion of CD4
+ T-cells, this 
resulted in the dramatic increase in the CD4
+:CD8
+ T-cell ratio.  
The significant increase in the CD8
+ T-cell population after the febrile phase 
strongly correlated with the expansion of CD3
+ T-cell numbers seen in lymphoid 
tissues during this stage and reported in Chapter 4. This positive correlation may 
indicate that the majority of the CD3
+ T-cells were CD8
+ T-cell subsets. Further, the 
increased population of CD8
+ T-cells during JDV infection, in the absence of JDV-
specific antibody until several weeks after JDV-infection (Hartaningsih et al., 1994; 
Soesanto et al., 1990), provides additional support for the role of these cells in the 
recovery from the acute disease process. Virus-specific CD8
+ cytotoxic T-cells may 
play an important role in host defence against lentivirus infections (Levy, 1993; Salk 
et al., 1993). The antiviral role of CD8
+ cytotoxic T lymphocytes has been 
considered to be important in the inhibition of the progression of early EIAV 
infection before the production of virus neutralising antibody (Hammond et al., 
1997; McGuire et al., 2004; McGuire et al., 1994).  It is also thought to be important 
in non-progressor HIV-infected individuals (Cao et al., 1995; Migueles et al., 2002), 
and in controlling SIV replication and protection against SIV challenge (Genesca et 
al., 2009; Genesca et al., 2008; Jin et al., 1999). It is only in the transition to chronic 
infection that the impressive early potency of the antiviral CD8
+ cytotoxic T-cells 
may wane (Pantaleo et al., 1997a) possibly due to a reduction of perforin production 
linked with the inability the immune system to control viral replication and spread of 
the virus (Migueles et al., 2002; Pantaleo et al., 1997a; Zhang et al., 2003). As with 
other lentivirus infections, at least during acute infections, the result of this study 
tend to support to the current hypothesis that virus-specific CD8
+ CTL may play a   100 
crucial role in host defence against lentivirus infections (Levy, 1993; Salk et al., 
1993). 
It is unclear why CD8
+ T-cells increased and CD4
+ T-cells were dramatically 
decreased despite the absence of infection of T-cells by the virus (Chapter 4). For the 
T-cell tropic lentiviruses, a gradual depletion of CD4
+ T-cell subsets is associated 
with infection of these cells, evident in HIV infections (Alcami, 2004b; Blankson et 
al., 2002; Brenchley et al., 2004; Clapham and McKnight, 2001, 2002; Penn et al., 
1999; Samuelsson et al., 1997), SIV infections (Brown et al., 2007; Dykhuizen et al., 
1998; Mattapallil et al., 2005; Picker, 2006; Shen et al., 2003; Steger et al., 1998; 
Veazey et al., 2003; Veazey et al., 2000) and FIV infections (Ackley et al., 1990). 
However, reduction of CD4
+ T-cell populations is not always related to their 
infection by viruses. In EIAV infections, for example, both circulating CD4
+ and 
CD8
+ T-cell subsets are reduced significantly during acute infection, although 
mature macrophages and not T-cells are the main target cells of the virus (Cook et 
al., 2001; Murakami et al., 1999; Oaks et al., 1998; Sellon et al., 1992). In EIAV 
infection, depletion of the T-cell subsets is possibly an indirect affect of the virus 
infection or virus components (Murakami et al., 1999).  
The population of CD21
+ B-cells increased prior to the febrile phase, indicating a 
transient proliferation of B-cells or release of B-cells into the peripheral blood during 
this phase, similar to that reported during BIV infection (Whetstone et al., 1997). 
The reason for this is unknown but in HIV-1, a putative polyclonal B-cell 
stimulatory epitope has been found in the carboxyl end of the envelope glycoprotein 
of the virus, specifically associated with Nef (Chirmule et al., 1994; Chirmule et al., 
1990). Tmx, an accessory protein of unknown function that is expressed from a 
similar region of the genome as is nef by bovine lentiviruses (Chadwick et al., 
1995b; Garvey et al., 1990) might be involved similar to Nef in the proliferation B-
cells in vivo but this hypothesis would need to be confirmed. During the febrile 
phase, there was a progressive reduction in the numbers of CD21
+ B-cells which 
may be associated with replication of virus in these cells. This is supported by 
evidence presented in Chapter 4, not only that B-cells were infected with virus but 
that at least some infected B-cells were mature IgG-containing cells or plasma cells.   
In conclusion, the present study has clearly demonstrated dramatic changes in the 
population of T-cell subsets and B-cells during the course of Jembrana disease. B-  101 
cells, possibly mature B-cells, that appear to be the host of JDV, increased in 
peripheral blood prior to the onset of the febrile phase and then declined in numbers 
and this decline corresponded to the decrease in numbers of these cells in tissues 
during the febrile phase of the disease. CD8
+ T-cell numbers increased during the 
acute disease and may well play a role in the recovery process before the production 
of neutralising antibody.   102 
Chapter 6 
A preliminary investigation of cytokine expression in Bali 
cattle experimentally infected with Jembrana disease virus  
 
Summary 
Real-time RT-PCR was used to investigate the expression of pro-inflammatory 
cytokines IL-2, IFN-γ, and TNF-α in PBMC following JDV infection. There was an 
up-regulation of IFN-γ mRNA expression during the febrile phase, and there was 
significant up-regulation of both IL-2 (p<0.05) and IFN-γ (p< 0.001) cytokines 
during the post-febrile phases that coincided with the significant reduction of JDV 
RNA (p<0.001) to undetectable values in this phase, suggesting these cytokines may 
have a significant role in the recovery process. The up-regulation of IL-2 and IFN-γ 
genes correlated with a significant increase of CD8
+ T-cells during the febrile and 
immediate post-febrile phases of Jembrana disease that were reported in Chapter 5, 
and support a hypothesis that the cell-mediated immune response is a significant 
factor in recovery of animals.    103 
Introduction 
The pathogenesis of infection with the acutely pathogenic JDV in Bali cattle is 
poorly understood. The disease process is an unusual one for a lentivirus, with an 
acute disease process after a short incubation period, recovery of most (~80%) 
animals, and no subsequent recurrence of any disease attributable to the virus 
infection. There is a delayed antibody response to the virus until several weeks after 
the acute disease process (Dharma et al., 1994; Hartaningsih et al., 1994) perhaps 
attributable to replication of the virus in IgG-producing cells (Chapter 4). The 
absence of an antibody response until several weeks after the apparent recovery from 
the acute disease has suggested that a T-cell-mediated immunity must be responsible 
for recovery and the survival of cattle. A significant increase of CD8
+ T-cells in the 
post-febrile phase was demonstrated (Chapter 5) and provides evidence that they are 
involved.  
Cytokines play a crucial role in regulating adaptive immune response, and T-cells 
are an important source of cytokines of both primary and memory immune 
responses. CD4
+ T-cells are a main source of T-cell cytokines, and based on their 
cytokine profiles these cells are divided into a Th1 type (producing IL-2, IFN-γ and 
TNF-α) and a Th2 type (producing IL-4, Il-5, IL-6 and IL-10) (Mosmann and Sad, 
1996; Mosmann et al., 1986).  
Much of the research on the antiviral CD8
+ T-cell response has focused on the 
cytolytic abilities of these cells (Binder and Kundig, 1991; Kagi et al., 1994; 
Lukacher et al., 1984). However, like CD4
+ T-cells, CD8
+ T-cells have also been 
considered as the major source of T-cell-derived cytokines including IFN-γ, TNF-α, 
IL-2, granulocyte macrophage-colony stimulating factor (GM-CSF), RANTES 
(regulated upon action T-cell expressed and secreted), macrophage inflammatory 
protein MIP-1α and MIP-1β during viral infection (Kristensen et al., 2004; Paliard et 
al., 1988). Three of these cytokines, IFN-γ, TNF-α and IL-2, have been widely 
investigated and associated with many aspects of infection. IFN-γ is also produced 
by natural killer (NK) cells and NK T-cells as part of the innate immune response, 
which is involved in many functions including inhibition of viral replication, tumour 
control, macrophage activation, and up-regulation of both major histocompatibility 
complex (MHC) class I and II (Boehm et al., 1997; Rosenzweig and Holland, 2005).   104 
The pro-inflammatory cytokine TNF-α is produced mainly by macrophages and 
mast cells in addition to T-cells, with a primary role in the regulation of immune 
cells, induction of apoptotic cell death, activation of macrophages and cytotoxic 
cells, induction of inflammation and inhibition of tumorigenesis and viral replication 
(Corral et al., 1999; Locksley et al., 2001). Elevated levels of TNF-α have been 
associated with the fever, malaise, and weight loss that accompany chronic 
infections, and reduction in levels of TNF-α have been linked with the reduction of 
clinical signs in a number of disease states (Moreland et al., 1997; Tracey and 
Cerami, 1992). The cytokine IL-2 synthesised by T-cells is crucial for proliferation 
and activation of mainly cytotoxic CD8
+ T-cells but also CD4
+ T cells and B-cells; it 
maximises the killing efficacy of macrophages and regulates T-cell proliferation 
(Karasuyama et al., 1989; Roitt et al., 2001b).  
In response to viral infection, T-cell subsets may function in different ways. In 
lymphocytic choriomeningitis virus infection, CD4
+ T-cells are not essential for 
virus-induced T-cell-mediated inflammation (Marker et al., 1995). In HIV-infection, 
the reduction of CD4
+ T-cells causes dysfunction of CD8
+ T-cells, NK cells and B-
cells which results in high levels of virus production in the chronic (AIDS) stage of 
infection (Flint et al., 2004b). In some lentiviral infection, CD8
+ T-cells play a 
critical role in the early stages of infection (Jin et al., 1999; Matano et al., 1998; 
Pantaleo et al., 1997a) and also during late stages of non-progressor infections, 
suggesting these cells secrete antiviral substances (Copeland et al., 1995; Migueles et 
al., 2002; Zagury et al., 1998).  
In JDV infections, although populations of CD4
+ T-cells were depleted, CD8
+ T-
cells increased significantly during the febrile and post-febrile phases (Chapter 5) 
and as a majority of JDV-infected animals survive the acute disease without further 
recurrence of clinical signs, suggests that CD8
+ T-cells are important in recovery. 
These and other cells, such as NK cells and macrophages, might also produce pro-
inflammatory cytokines and these cytokines could play a significant role not only in 
the inflammatory process but also in recovery from infection.  
The studies reported in this Chapter were conducted to examine the expression of 
cytokines IL-2 , IFN-γ and TNF-α by PBMC following infection with JDV and to 
determine the correlation between these responses and the apparent hyperplasia of   105 
CD3
+ T-cells in lymphoid tissues observed during the early post-febrile phase of 
Jembrana disease (Chapter 3) and the significant proliferation of CD8
+ T-cells in the 
circulation during the early post-febrile phase that was demonstrated by flow 
cytometric analyses (Chapter 5). 
 
Materials and methods 
Experimental animals, sample collection and PBMC preparation 
The 5 Bali cattle infected with JDVTab/87 described previously in Chapter 5 were also 
used as a source of blood for the derivation of PBMC for detection of cytokine 
mRNA.  Blood samples were obtained daily from the animals for 19 days following 
JDV infection using EDTA-containing vacutainer EDTA tubes (Greiner Bio-One). 
The blood samples were centrifuged to recover PBMC and plasma, as reported in 
Chapter 5, and the preparations were frozen at -80
oC until they were used for 
extraction of RNA. 
Primers 
Oligonucleotide primers for cytokine genes IL-1, IL-2, IL-6, TNF-α and IFN-γ, and 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as an internal control, were as 
described previously (Konnai et al., 2003; Leutenegger et al., 2000). All 
oligonucleotide primer sequences (Table 6.1) were checked using the BLASTIN 
program (Zhang and Madden, 1997). Oligonucleotide primers for JDV RNA 
quantification were those described previously (Stewart et al., 2005). 
RNA extraction 
For cytokine mRNA analysis, total RNA (tRNA) was extracted from PBMC with 
RNeasy Plus with genomic DNA (gDNA) eliminator columns (Qiagen), following 
the manufacturer’s instructions. To remove any residual gDNA, the extracted tRNA 
was treated with 1 U of DNAase (Promega) per 1 ug tRNA at 37
oC for 30 min 
followed by inactivation of the enzyme with DNAase Stop solution at 65
oC for 10 
min. Concentrations of the enzyme-treated tRNA were determined using a 
spectrometer (Nano-drop 1000), after which the samples were stored on ice until 
they were tested on the same day; they were not frozen to avoid RNA degradation. A 
normalisation procedure was used to correct for experimental error during the   106 
extraction and processing of the RNA, as previously described (Bustin, 2000, 2002; 
Bustin and Nolan, 2004). Forty ng per reaction of enzyme-treated tRNA was used as 
template for amplification in each RT-PCR. 
 
Table 6.1. Sequence of oligonucleotide primers for real-time RT-PCR. 
Gene  Primer sequences (5’-3’) 
(forward & reverse) 
Length 
Primer(bp)
a  Product (bp) 
IL-1α
 b  GATGCCTGAGACACCCAA 
GAAAGTCAGTGATCGAGGG 
18 
19 
173 
IL-2
b  TTTT TAC GTC CCC AAG GTT AA 
CGT TTA CTG TTG CATCATCA 
20 
20 
217 
IL-6
 b  TCCAGAACGAGTATGAGG 
CATCCGAATAGCTCTCAG 
18 
18 
236 
TNF-α
c  TCTTCTAAGCCTCAAGTAACAAGT 
CCATGAGGGCATTGGCATAC 
N/A  103 
IFN-γ
 c  TGGATATCATCAAGCAAGACATGTT 
ACGTCATTCATCATCACTTTCATGAGTTC 
N/A  151 
GAPDH
 c  GGCGTGAACCACGAGAAGTATAA 
CCCTCCACGATGCCAAAGT 
N/A  120 
JDV pol
d  GGGAGACCCCGTCAGATGTGGA 
TGGGAAGCATGGACAATCAG 
N/A  121 
a bp: base pairs 
b Konnai et al (2003). 
c Leutenegger et al. (2000). 
d  Stewart et al. (2005).  
 
 
Viral RNA was extracted from thawed plasma samples using a QIAamp Viral Mini 
Kit (Qiagen) according to the manufacturer’s instructions. Prior to extraction, plasma 
samples were clarified by centrifugation (8,000 x g for 5 min). Viral RNA was then 
extracted from 140 µl of plasma, eluted in a final volume of 50 µl of elution buffer 
(AVE buffer; QIAGEN), and stored at -80
oC until tested. 
cDNA synthesis from RNA 
A 1 µg tRNA sample was transcribed to cDNA using SuperScript III RT (Invitrogen) 
following the manufacturer’s instructions. The primer pairs listed in Table 6.1 were 
used to synthesise cDNA and the PCR products were sequenced to verify their 
specificity using a standard sequencing procedure (Applied Biosystems 3730 DNA 
sequencer, DNA Sequencing Facility, Murdoch University).    107 
Cloning of cDNA 
DNA samples remaining after sequence analysis were electrophoresed in a 2.5 % 
agarose gel for 2 h at 65 V. DNA bands were visualised by labelling with SYBR 
Green (Promega) and were excised from the gel and the DNA extracted using a 
QIAquick Gel Extraction Kit (Qiagen) following the manufacturer’s instructions. 
The purified PCR products were cloned into pCR 2.1 using a TA Cloning System 
(Invitrogen) as recommended by the manufacturer. Following transformation of E. 
coli, selected white (transformed) E. coli colonies were cultured in YT medium pH 
7.2 containing 10 g bacto-yeast extract and 5 g NaCl in 1 l of double distilled H2O. 
The cloned DNA plasmids were purified from bacterial cells using a QIAamp DNA 
Mini Kit (Qiagen) according to the manufacturer’s instructions. Plasmids were 
screened for the appropriate inserts by Eco RI digestion (Promega), according to the 
manufacturer’s instructions.  
For further sequence analysis and preparation of standard curves, the purified cloned 
plasmid DNA was amplified by PCR. Briefly, 2 µl of  plasmid DNA was mixed with 
2.5 µl 10X buffer, 1.25 µl of 25 mM MgCl2, 0.2 µl of 2.5 mM DNTPs, 1 µl of 20 
pM forward and reverse primers, 0.125 µl Taq polymerase (5.5 unit/µl) and made up 
to a total 25 µl by addition of extra PCR grade water. The PCR assays were 
conducted  using a 3 min denaturising step at 94
oC, 35 cycles of  94
oC for 30 
seconds, 52
oC for 1 min, 72
oC for 1 min, 72
oC for 10 min, and then held at 14
oC. 
After visualisation of the products in agarose gels as described above, DNA bands 
were extracted from the gels and the concentration of the extracted DNA was 
determined spectrophotometrically at 260 nm, and the concentration was adjusted to 
1 µg DNA/ml. The purified DNA was directly sequenced to confirm the identity of 
the PCR products.  
Preparation of standard curve for quantitative analysis 
To quantitate cytokine mRNA expression, calibration curves were prepared using the 
measured fluorescence of serial 10-fold dilutions from 10
-2 (0.01 ng/ml) 
 to 10
-6 of 
the synthesised cDNA that had been adjusted to 1 µg DNA/ml as described above, 
and the concentrations were derived by extrapolation from the standard curve. The 
mass of every plasmid (Table 6.2) was converted to moles and multiplied by 
Avogadro’s number, to estimate the copy number of cytokines in each reaction   108 
mixture. The number of cytokine copies detected in each reaction was automatically 
determined using a software package (SYBR-green, Corbett Research). Generation 
of standard curves and regression analysis were performed by using a Rotor-Gene 
program (Corbett Research).  
Standard curves for quantifying JDV RNA were prepared as previously reported 
(Stewart et al., 2005). 
 
 
Table 6.2. Plasmid mass used to estimate cytokine copy number. 
Gene 
Gene size  
(bp) 
Vector size 
(bp) 
Total size  
(bp) 
RNA copy 
number  
(x 10
8/µl) 
IL-1  173  3015  3188  2.91 
IL-2  217  3015  3232  2.87 
IL-6  236  3015  3251  2.85 
IFN-γ  151  3015  3166  2.93 
TNF-α  103  3015  3118  2.97 
GAPDH  120  3015  3136  2.96 
 
 
Analysis of bovine cytokine expression by real-time PCR 
RT-PCR assays were performed using a Rotor-Gene 3000 (Corbett Research) 
according to the manufacturer’s instructions. The SYBR Green RT-PCR reaction 
was performed with 2 µl RNA containing 40 ng of DNAase-treated RNA as the 
template. The 2 µl RNA sample was added to 8 µl reaction mix consisting of 5 µl of 
2X SYBR Green RT-PCR reaction mix (Bio-Rad), 1 µl of 300 nM of each primer, 
0.2 µl iScript RT for one-step RT-PCR (Bio-Rad) and 0.8 µl of nuclease-free water 
(Bio-Rad). The PCR mixtures were analysed in duplicate but the standards were 
analysed in triplicate.    109 
Statistical analysis 
A one-way ANOVA (SPSS
® 17.0) was used to assess group differences in the 
expression of cytokine, and differences between time points during JDV infection 
were analysed using Bonferroni’s multiple comparison. A value of p ≤0.05 was 
considered significant for all analyses. 
 
Results  
RNA preparation 
As shown in Figures 6.1 and 6.2, the addition of 40 ng DNAase per reaction 
completely eliminated gDNA from tRNA samples.  
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Figure 6.1 Real-time RT-PCR analysis of TNF-α showing a complete removal of 
gDNA from tRNA samples. A. Example of a standard curve for TNF-α, linear 
representation. B. Non-DNAase-treated tRNA (left arrow) and DNAase-treated tRNA 
(right arrow). No amplified products were detected when RT was omitted, indicating 
gDNA was completely removed. The reaction patterns from other genes were similar. 
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Figure 6.2. Agarose gel electrophoresis of RT-PCR products showing a complete 
removal of gDNA from the extracted RNA and the reaction products for 4 different 
primer pairs. Lanes 1 and 14, 100 bp DNA marker (Promega); lanes 2, 5, 8, and 11, 
DNAase-treated RNA of GAPDH, TNF-α, IFN-γ and IL-2, respectively; lanes 3, 6, 
9 and 12, non-DNAase treated RNA of GAPDH, TNF-α, IFN-γ and IL-2, 
respectively; lanes 4,7,10 and 13, RT
- control for GAPDH, TNF-α, IFN-γ and IL-2, 
respectively. The PCR reaction products of GAPDH were ~120bp, TNF-α ~103 bp, 
IFN-γ ~151 bp and IL-2 ~217 bp. Although IL-1 and IL-6 assays were developed, 
these cytokines were not analysed in JDV-infected cattle. 
 
 
 
Confirmation of successful cloning and sequencing 
The DNA products generated using the cytokine primers (Table 6.1) were 
successfully cloned into pCR 2.1 (Figure 6.3). The purified DNA inserts were 
amplified by PCR to provide DNA samples for sequence analysis and preparation of 
standard curves (Figure 6.4). Sequence analysis of the PCR products confirmed their 
identity as the respective bovine cytokine genes (Figure 6.5).  
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                             1       2       3      4      5      6      7      8      9     10     11 
Figure 6.3. Agarose gel electrophoresis of the non-PCR product of plasmid DNA 
constructs, digested with EcoR1, to confirm the successful cloning. Lanes 1 and 11: 
100 bp DNA ladder (Promega); lane 2, IL-1 (173 bp), lane 3, IL-2 (217 bp), lane 4, 
IL-6 (236 bp), lane 5, IFN-γ (151 bp); lane 6, TNF-α (103 bp); lane 7, GAPDH (120 
bp); lane 8, control plasmid with DNA insert supplied by the manufacturer (from a 
white colony); lane 9, control plasmid (from a blue colony) with no insert; lane 10, 
water control. Although IL-1 and IL-6 assays were developed, these cytokines was 
not analysed in JDV-infected cattle. 
 
 
 
 
 
                             1      2        3      4       5       6        7        8      9      10 
Figure 6.4. Agarose gel electrophoresis of PCR-products shown in Figure 6.3. Lanes 
1 and 10, 100 bp. DNA ladder (Promega); lane 2, IL-1 (173 bp), lane 3, IL-2 (217 
bp), lane 4, IL-6 (236 bp), lane 5, IFN-γ (151 bp); lane 6, TNF-α (103 bp), lane 7, 
GAPDH (120 bp), lane 8, primer control (IL-1 DNA) and lane 9, water control. The 
DNA products correspond to the plasmid DNA constructs shown in Figure 6.2. 
Although IL-1 and IL-6 assays were developed, these cytokines were not analysed in 
JDV-infected cattle. 
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1. GENE ID: 280943 TNF|tumor necrosis factor(TNFsuperfamily, member 2) 
[Bos taurus] (Over 10 PubMed links) Score = 91.6 bits (49),   
Expect = 1e-15 Identities = 49/49 (100%), Gaps = 0/49 (0%) Strand=Plus/Plus 
Query  29   TCTCCGGGGCAGCTCCGGTGGTGGGACTCGTATGCCAATGCCCTCATGG  77 
            ||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  330  TCTCCGGGGCAGCTCCGGTGGTGGGACTCGTATGCCAATGCCCTCATGG  378 
 
 
2. GENE ID: 281237 IFNG | interferon, gamma [Bos taurus] (Over 10 PubMed links)  
Score =  104 bits (114),  Expect = 3e-19 Identities = 58/59 (98%),  
Gaps = 0/59 (0%) Strand=Plus/Plus 
Query  16   TGNACTCATCAAAGTGATGAATGACCTGTCGCCAAAATCTAACCTCAGAAAGCGGAAGA  74 
            || |||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  402  TGAACTCATCAAAGTGATGAATGACCTGTCGCCAAAATCTAACCTCAGAAAGCGGAAGA  46 
 
 
3. GENE ID: 280822 IL2 | interleukin 2 [Bos taurus] (10 or fewer PubMed links)  
Score =  255 bits (282),  Expect = 5e-65 Identities = 167/180 (92%),  
Gaps = 3/180 (1%) Strand=Plus/Plus 
Query  8    ATGTTAAGAGTTTACTTGAAGAA-TCAA-CTTCTAGAGGAAGTGCTAAATTAAGCTCCAA  65 
            || ||||| ||||||| |||||| |||| |||||||||||||||||||||| |||||||| 
Sbjct  234  ATCTTAAGTGTTTACTAGAAGAACTCAAACTTCTAGAGGAAGTGCTAAATTTAGCTCCAA  293 
 
 
Query  66   GCACAAAGG-GAAACCCAGAGAGATCAAGGATTCAATGGACAATATCAACCGAATCGTTT  124 
            ||| |||   ||| |||||||||||||||||||||||||||||||||||  ||||||||| 
Sbjct  294  GCAAAAACCTGAACCCCAGAGAGATCAAGGATTCAATGGACAATATCAAGAGAATCGTTT  353 
 
Query  125  TGGAACTACAGGGATCTGAAACAAGATTCACATGTGAATATGATGATGCAACAGTAAACG  184 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  354  TGGAACTACAGGGATCTGAAACAAGATTCACATGTGAATATGATGATGCAACAGTAAACG  413 
 
 
4. gb|EU276071.1|   Bos taurus interleukin 6 (IL6)  
mRNA,complete cds Length=641 GENE ID: 280826 IL6 | interleukin 6 (interferon, 
beta 2) [Bos taurus] (10 or fewer PubMed links) Score =  320 bits (354),  Expect = 
3e-84 
 Identities = 177/177 (100%), Gaps = 0/177 (0%) Strand=Plus/Plus 
 
Query  26   CAGAACACTGATCCAGATCCTGAAGCAAAAGATCGCAGATCTAATAACCACTCCAGCCAC  85 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  446  CAGAACACTGATCCAGATCCTGAAGCAAAAGATCGCAGATCTAATAACCACTCCAGCCAC  505 
 
Query  86   AAACACTGACCTGCTGGAGAAGATGCAGTCTTCAAACGAGTGGGTAAAGAACGCAAAGAT  145 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  506  AAACACTGACCTGCTGGAGAAGATGCAGTCTTCAAACGAGTGGGTAAAGAACGCAAAGAT  565 
 
Query  146  TATCCTCATCCTGAGAAACCTTGAGAATTTCCTGCAGTTCAGCCTGAGAGCTATTCG  202 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  566  TATCCTCATCCTGAGAAACCTTGAGAATTTCCTGCAGTTCAGCCTGAGAGCTATTCG  622 
 
Figure 6.5 Sequence of PCR-amplified bovine cytokine genes. The percentage 
identity (92% to 100%) with reference standards is shown. 
 
 
Clinical signs, JDV RNA and cytokine response in JDV-infected cattle 
RT-PCR assays were used to quantitate JDV RNA load in plasma and the expression 
of IL-2, TNF-α and IFN-γ mRNA in PBMC. A representative melting curve analysis 
of the RT-PCR assay for IFN-α with a coefficient of correlation of 0.998 is shown in 
Figure 6.6, and similar results were obtained with all other RT-PCR assays.  
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Figure 6.6. Melting curve analysis (left) and coefficient of correlation (right) for the 
RT-PCR for IFN-γ expression in one animal (CB5), showing a single peak for a 
specific PCR reaction, and the expected R value and gradient (M value).The melting 
curve analysis and coefficient of correlation patterns for the RT-PCR for other 
cytokines tested and from other animals used in this study were similar.   
 
 
There was a significant increase in plasma JDV RNA concurrent with the 
development of the transient febrile period 4 to 7 days after infection (Figure 6.7A). 
Peak levels of JDV RNA in plasma occurred 9 days after infection. The levels then 
decreased and JDV RNA was undetectable in plasma in the post-febrile period 
(Figure 6.7A). IL-2 mRNA expression was low before and during the febrile period 
but significantly increased (p<0.05) in the post-febrile period and then remained 
above the pre-infection values until the termination of the experiment 21 days after 
infection (Figure 6.7B). TNF-α mRNA expression was not significantly increased 
(p=0.284) during the pre-febrile and early febrile phase of JDV infection but levels 
increased slightly during the later stages of the febrile phase and in the immediate 
post-febrile phase (Figure 6.7C). IFN-γ mRNA expression increased in a biphasic 
mode: it increased during the early stages of the febrile phase, it then decreased but 
remained above pre-infection levels during the remainder of the febrile phase, it then 
again increased significantly (p <0.001) again at the end of the febrile phase and 
remained high until about 16-17 days after infection (Figure 6.7D).  
Representative patterns of gene expression as determined by RT-PCR in the 5 JDV-
infected cattle are shown in Figure 6.8.   
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Figure 6.7. Summary of febrile response, virus load and cytokine mRNA expression 
(genome copies) of 5 cattle following infection with JDVTab/87. A. Febrile response 
and plasma JDV RNA levels. B, IL-2 mRNA expression. C. TNF-α mRNA 
expression. D. IFN-γ mRNA expression. Results represent the mean values in the 5 
infected cattle and error bars showing SD are indicated.   
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Figure 6.8. Representative pattern of the expression of cytokine mRNA and JDV 
RNA in a single animal (CB7) which was the strongest responder, although all data 
from other animals used in this study were similar. Standard curves are shown on the 
left and test samples on the right. (A) IL-2; (B) TNF-α; (C) IFN-γ; (D) plasma JDV 
RNA. 
 
 
Discussion 
The real-time RT-PCR methodology used in this investigation has been previously 
used for in vivo studies of cytokine gene expression in cattle (Konnai et al., 2003; 
Usui et al., 2007; Waldvogel et al., 2000; Zaros et al., 2007). The technique is 
sensitive and simple and has advantages over other techniques for the quantification 
of cytokine mRNA (Blaschke et al., 2000; Giulietti et al., 2001; Malinen et al., 2003;   116 
Wang and Brown, 1999). The technique enabled samples to be collected in Indonesia 
and their subsequent importation to Australia where the assays were conducted. It 
was also determined that plasma IFN-γ protein levels detected using a commercial 
ELISA correlated with IFN-γ gene expression determined by RT-PCR (data not 
shown), confirming that the IFN-γ mRNA was translated into protein in vivo. 
GAPDH was selected as a control general housekeeping gene to verify the quality of 
RNA extracted and to standardise the assays; it is widely employed as an 
endogenous control gene in quantifying cytokine expression (Dheda et al., 2004; 
Lang and Heeg, 1998; Leutenegger et al., 2000; Pico de Coana et al., 2004). 
The cytokines IL-2, IFN-γ and TNF-α were investigated to verify if changes in the 
level of their expression would correlate to the pathological changes occurring in 
Jembrana disease. Expansion of this study to include additional cytokines would 
have provided more comprehensive information and while methodology was 
developed for quantification of bovine IL-1 and IL-6, these assays were not 
conducted and reported in this thesis due to time limitations. However, the 
significant expression of IL-2 and IFN-γ mRNA correlated well with the significant 
increase of CD8
+ T-cells detected by flow cytometry (Chapter 5), suggesting that 
these cytokines were probably produced by the proliferating CD8
+ T-cells and, in the 
absence of JDV-specific antibody until well after recovery, these events have a 
crucial role in controlling JDV infection and enabling the majority of JDV-infected 
cattle to survive the acute disease. 
A role of other cell types in expression of these cytokines is also possible but is 
unlikely to be due to the production of cytokines by Th1 CD4
+ T-cells as the number 
of CD4
+  T-cells was reduced significantly until well after recovery (Chapter 5). The 
reason for the reduction of CD4
+ T-cells during the febrile period is unknown, but in 
HIV-infection, expansion of these cells can be affected by circulating IL-2 (Ganusov 
et al., 2007; Stapleton et al., 2009). However, while IL-2 expression was 
significantly up-regulated during the post-febrile phase of Jembrana disease, the 
CD4
+ T-cell populations in plasma remained low (Chapter 5).  
The cytokines IL-2 and IFN-γ have a well defined role in the pathogenesis of other 
viral infections. IFN-γ is produced predominantly by NK and NK T-cells as part of 
the innate immune response, and by CD4
+ Th1 cells and CD8
+ cytotoxic T-  117 
lymphocyte effector T-cells once antigen-specific immunity develops (Schoenborn 
and Wilson, 2007). It plays a critical role in the immune process, enhancing the 
microbicidal action of macrophages and stimulating the production of IgG (Boehm 
et al., 1997; Harrington et al., 2006; Schoeborn and Wilson, 2007; Weaver et al., 
2006). The up-regulation of IFN-γ expression during the febrile phase of Jembrana 
disease, and its known role in the anti-viral effector function of CD8+ T-cells, 
correlated with the decrease in viral load at the end of the febrile phase.  
IL-2 is an example of an autocrine growth factor, produced by all T-cells early in 
their activation and is very important in up-regulating T-cell proliferation and the 
activation of macrophages and cytotoxic CD8
+ T-cells, maximising the killing 
efficacy of these cells (Karasuyama et al., 1989; Roitt et al., 2001b). The low levels 
of IL-2 expression during the febrile phase of Jembrana disease, when viral loads in 
plasma are very high, paralleled the low levels of CD4
+ T-cells and CD8
+ T-cells in 
plasma during this period (Chapter 5). The up-regulation of IL-2 expression 
determined during the post-febrile phase of JDV infection coincided with expansion 
of CD8
+ T cells (Chapter 5) and suggests a role for IL-2 in the proliferation of these 
cells and therefore in the recovery process and survival of a majority of JDV-
infected cattle. 
The role of TNF-α during Jembrana disease is unclear. TNF-α is involved in the 
regulation of immune cells, inducing acute phase reactions, triggering apoptotic cell 
death, and inhibiting viral replication (Abbas et al., 1996). In the JDV-infected 
animals, TNF-α was only slightly up-regulated during the febrile and post-febrile 
phase of acute Jembrana disease and while it may contribute to the induction of the 
clinical signs of Jembrana disease and in reducing viral load at the end of the febrile 
phase, the evidence for this is minimal.  
In conclusion, this is the first report quantifying cytokine expression during 
Jembrana disease. The results indicated up-regulation of IL-2 and IFN-γ expression, 
which was associated with the expansion of CD8
+ T-cells during this period, 
suggesting these events may be responsible for viral clearance and recovery from the 
disease. Further investigations are required to broaden the range of cytokines 
examined and to investigate the role of these cytokines in the acute disease process.    118 
Chapter 7 
General discussion  
Bali cattle, descendent from wild Banteng, are important to beef production in 
Indonesia (Martojo, 2003; Wiryosuhanto, 1996). They are adapted to the tropical 
climate experienced in many regions of Indonesia, they can be used not only for beef 
production but also as draught animals for preparation of rice fields for planting, and 
they have therefore been invaluable in the development of new transmigration areas 
within Indonesia (Martojo, 2003). These cattle are now widely distributed through 
Indonesia from Aceh in the west to West Papua in the east. They are the predominant 
cattle breed in Indonesia, about 2.6 million of a total cattle population of about 5.3 
million distributed in several areas but especially Bali, Sumatra, Kalimantan, 
Sulawesi and Maluku (Talib et al., 2002). Unfortunately, Bali cattle are extremely 
susceptible to Jembrana disease and this disease is therefore a major problem that 
continues to affect the cattle industry in Indonesia.  There is not only a direct 
economic loss as a consequence of the effects of the disease but an indirect loss as a 
consequence of the restriction of the transportation of cattle from areas where the 
disease is endemic (Bali, Java, Sumatra and Kalimantan) to disease-free regions.  
Although the cause of the disease was identified as a previously unknown bovine 
lentivirus (Chadwick et al., 1995a) and this enabled a series of studies that have 
resulted in an improved understanding of the response of Bali cattle to JDV 
infection, many aspects of the pathogenesis of the infection in Bali cattle have not 
been investigated. In particular, the precise cell-tropism of JDV and the 
immunopathological response to the virus have not been explored. Because of 
histological observations of an intense cellular proliferation in the non-follicular (T-
cell) compartments of lymphoid tissues and haematological findings of 
lymphopenia, which are hallmark features of Jembrana disease (Soesanto et al., 
1990), there has been an assumption that JDV probably infects T-cells (Dharma et 
al., 1991; Dharma et al., 1994), even though the closely related BIV is pantropic 
(Heaton et al., 1998). 
The studies reported in Chapter 3 of this thesis demonstrated for the first time that 
the intense proliferation of cells in the non-follicular areas of lymphoid tissues   119 
during the febrile phase of the disease was not due to proliferation of CD3
+ T-cells 
but instead was due to infiltration of these areas by centroblast-like cells that 
expressed IgG and therefore appeared to be antibody-producing cells of the B-cell 
lineage. The population of these centroblast-like cells decreased during the post-
febrile phase when a significant proliferation of the CD3
+ T-cell population in 
parafollicular areas was detected. JDV infection, evident by the detection of JDV CA 
by immunoperoxidase techniques, appeared to be of cells with the same distribution 
and morphological appearance to the centroblast-like cells, and not of T-cells or 
macrophages. Confirmation of the identity of the infected cells was sought using 
double-immunolabelling techniques as used by others for investigating viral tropism 
(Espinoza and Kuznar, 2009; Mason et al., 2000; Valnes and Brandtzaeg, 1984) and 
concordance between cells containing JDV CA detected by immunofluorescence and 
some IgG-containing cells and CD79α
+ cells supported the identification of the JDV-
infected cells as antibody-producing B-cells. 
Because of the marked differences in the disease process following JDV infection 
and that of other lentiviruses (Soesanto et al., 1990), especially the acute nature of 
the disease and the unusual genetic stability of the virus (Desport et al., 2007) ,the 
apparent predilection of the virus for B-cells and not T-cells or macrophages as with 
most lentiviruses is perhaps not surprising. The tropism of the virus for cells of B-
cell lineage would explain the depopulation of B-cell (follicular) areas (Dharma et 
al., 1991) and the delayed antibody response to JDV and to other immunogens 
(Hartaningsih et al., 1994; Wareing et al., 1999) during the post-febrile phase. It is 
probable that the normal process of antibody production is disrupted by the infection 
and death of these cells. Both BIV and JDV appear to be genetically stable over time 
with much lower viral mutation rates than the other lentiviral genomes and this may 
be related to their tropism for plasma cells with a long life span (Carpenter et al., 
2000; Desport et al., 2007). 
The lack of replication of JDV in macrophages might explain the absence of 
neurological lesions in Jembrana disease. Neurologic lesions reported in HIV-
infected individuals were associated infection of microglia cells (Gonzalez-Scarano 
and Martin-Garcia, 2005) and in SIV infections, the presence of CNS disease has 
also associated with the presence of SIV-infected monocytes/macrophages in the 
brain (Bissel et al., 2008).   120 
The apparent predilection of JDV for cells of the B-cell lineage and apparent lack of 
replication in T-cells or macrophages is unusual and has not been observed with 
other lentiviruses. Although some lentiviruses do infect B-cells they infect other cell 
types as well. Of these, the genetically related BIV infects B-cells, T-cells and 
monocytes (Heaton et al., 1998), SIV infects CD4
+ and CD8
+ T-cells, macrophages 
and B-cells in vivo (O'Neil et al., 1999), and HIV-1 infects CD4
+ T-cells, 
macrophages and dendritic cells, although it is not clearly associated with direct 
infection of B-cells (Clapham and McKnight, 2002; Conge et al., 1998; Muro-Cacho 
et al., 1995; Shirai et al., 1992). Other lentiviruses producing acute disease 
syndromes are not specifically B-cell tropic: EIAV in horses targets tissue 
macrophages (Murakami et al., 1999; Oaks et al., 1998; Sellon et al., 1994) and 
SIVsmmPBj14 in pig-tailed macaques targets macrophages (Fultz et al., 1989).  It will 
be interesting to determine the nature of the receptor utilised by JDV and its 
distribution in different cell types, and if the receptor involved has an unusual 
distribution in Bali cattle that might help to explain the specificity of the disease for 
Bali cattle and the mild or subclinical nature of the disease in other ruminants 
(Soeharsono et al., 1990; Soeharsono et al., 1995a; Soeharsono et al., 1995b). 
To understand the cellular mechanism responsible for the recovery process in the 
majority of experimentally JDV-infected cattle, changes in lymphocyte subsets 
during JDV infections were investigated (Chapter 5). Flow cytometric analysis 
confirmed that the lymphopenia, a characteristic haematological change occurring 
during the febrile phase of Jembrana disease (Soesanto et al., 1990) was due, at least 
in part, to a significant reduction of both CD4
+ T-cells and CD8
+ T-cells. As the 
virus appeared to not infect CD3
+ T-cells, including CD4
+ and CD8
+ T-cells, it is 
probable that the mechanism for the reduction of the CD4
+ T-cells found in JDV 
infection is similar to that reported in EIAV infection, an indirect affect of products 
produced during viral replication (Murakami et al., 1999). The reduction in CD4
+ 
cells during Jembrana disease would likely contribute to the immunosuppression and 
the increased occurrence of secondary diseases, such as haemorrhagic septicaemia, 
reported in cattle affected with Jembrana disease (Dharma et al., 1994). 
A significant expansion of CD3
+ T-cells in lymphoid tissue during the early post-
febrile phase (Chapter 3) coincided with significantly increased CD8
+ T-cell 
population, demonstrated by flow cytometric analysis (Chapter 5). The trigger for   121 
the marked proliferation of these cells after recovery from the febrile phase is not 
known. In the acutely pathogenic SIVsmmPBj14, Nef was assumed to have mitogenic 
properties and to activate resting lymphocytes (Stephens et al., 1998), and although 
nef is not present in JDV, a tmx gene is located in the same region of the genome as 
nef in the primate lentiviruses (Chadwick et al., 1995b) and might express a protein 
with a Nef-like function.  
The increased CD8
+ T-cell population might be associated with the recovery of 
animals and the survival of a majority of JDV-infected cattle from the acute disease 
(Soesanto et al., 1990). It might also be associated with their resistance to further 
infection and the absence of any further clinical signs of disease attributable to JDV 
infection (Soeharsono et al., 1990). An increased CD8
+ T-cell population was 
reported in asymptomatic HIV-1 positive individuals (Copeland et al., 1995; Zagury 
et al., 1998), and in SIV infections (Mandl et al., 2007) even though it failed to 
eradicate viral infection at the later stages of infection (Migueles et al., 2002; 
Pantaleo et al., 1997a). While the results obtained and reported in Chapter 5 suggest 
qualitative factors within the CD8
+ T-cell response might be the principal 
determinants of control over JDV replication and disease progression during the 
acute disease, it will be essential to extend this finding to determine the kinetics of 
the response after the immediate post-febrile phase, beyond the duration of the 
current experiment.  
The in vivo studies reported in Chapter 6 indicated that JDV infection induced 
changes in cytokine gene expression, determined by measurement of cytokine-
specific mRNA activity.  Increased IFN-γ mRNA expression detected using RT-PCR 
was in accordance with increased IFN-γ expression detected by an IFN-γ ELISA. 
Although similar ELISA kits were not used to check the concordance between 
mRNA activity and protein expression of the other cytokines it is likely that a 
correlation would occur. The increased mRNA expression occurred primarily with 
IL-2 and IFN-γ under Th1 cell regulation (Abbas et al., 1996). The changes in the 
IL-2 and IFN-γ cytokine mRNA correlated with the significant increase in peripheral 
blood CD8
+ T-cells, which provided additional evidence that up-regulation of these 
cells in vivo and the synergistic actions of these cytokines may have been associated 
with recovery from the acute disease process. A similar up-regulation of both IL-2 
and IFN-γ cytokine mRNA was considered responsible for the absence of persistent   122 
lymphocytosis in Bovine leukaemia virus infection (Kabeya et al., 1999). More 
extensive investigation of the kinetics and duration of the expression of these 
cytokines and other related cytokines should be undertaken not only in peripheral 
blood but also in lymphoid tissues to increase our understanding of the role of 
cytokines in the inflammatory response and recovery.  
In conclusion, the research undertaken and presented in this thesis has greatly 
improved the understanding the cellular response of animals to JDV infection. 
Determination of a significant role of B-cells in the pathogenesis of JDV infection 
has paved the way for a better understanding of the disease process.  It might also 
facilitate development of methods for the cultivation of JDV in vitro. The changes in 
T-lymphocyte sub-populations associated with recovery provide additional support 
for the importance of a cell-mediated immune response in the recovery of a majority 
of JDV-infected animals. The demonstration of increased expression of cytokine 
mRNA by CD8
+ T-cells, particularly IFN-γ and IL-2, suggests a role for these genes 
in the infectious process and recovery.   123 
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